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PREFACE 
 
My research activity has been focused to the use of oligonucleotides and 
oligonucleotide analogues in a broad range of fields. At first, I worked on the 
synthesis and structural characterization of a novel G-Quadruplex structure able to 
form higher order assemblies; secondly, I explored the properties of PNA as an 
efficient target protector agent to be used in the treatment of the Cystic Fibrosis; 
finally, but not less intriguing, in view of the simple and easy development of PNA-
based biosensors, I synthetized a novel PNA quadruplex and characterized it by the 
means of SERS analysis; To achieve all these goals, I gained valuable experience in 
the synthesis of biologically relevant molecules, in the purification and in biophysical 
and biological characterization of such biomolecules. 
The results of my contributions in my thesis research area will be discussed in the 
following chapters, and they have been published in the papers listed below: 
• Chemistry Open, 2017, 6, 599 –605. 
In this work, by using a combination of spectroscopic techniques and HPLC analysis, 
it has been proved that the sequence d(5’-CGG-3’-3’-TGGC-5’) - containing a 3’-3’ 
phosphodiester bond that reverse the polarity in the strand thus creating two 5’-ends 
- formed the quadruplex monomeric building block that was able to form long G-
wires. 
• Molecules 2017, 22(7), 1144. 
I worked on the synthesis of new PNA sequences to be used for as target protector 
agent useful for the development of an innovative approach of the CF disease gene. 
• Biochimica et Biophysica Acta (BBA), 2016, 1861, 5, 1222-1228. 
In this work we exploited a new technique to demonstrate the ability to form G-
Quadruplex structure of a CD-unfriendly complex. 
 
 
Finally, during these years, I have been also involved in other works concerning the 
chemical synthesis and structural characterization of small organic molecules. The 
findings of these works are reported in: 
• Mahal, A., D' Errico, S., Borbone, N., Pinto, B., Costantino, V., Oliviero, G., 
Secondo, A., Tedeschi, V., Piccialli, V., Piccialli, G. Synthesis of cyclic N (1)-
pentylinosine phosphate, a new structurally reduced cADPR analogue with 
calcium-mobilizing activity on PC12 cells, Beilstein Journal of Organic 
Chemistry, 2015, 11, 2689-95. 
• D' Errico, S., Oliviero, G., Borbone, N., Nici, F., Piccialli, V., Pinto, B., 
D'Alonzo, D., Mayol, L. and Piccialli, G. Synthesis of C6-Pyridylpurine 
Nucleosides by Reaction of Nebularine N1-Oxidewith Pyridinyl Grignard 
Reagents, Eur. J. Org. Chem. 2015, 2244–2249. 
ii 
 
• D' Errico, S., Oliviero, G., Borbone, N., Piccialli, V., Pinto, B., De Falco, F., 
Maiuri, M.C., Carnuccio, R., Costantino, V., Nici, F. and Piccialli, G. Synthesis 
and Pharmacological Evaluation of Modified Adenosines Joined to Mono-
Fuctional Platinum Moieties, Molecules 2014, 19, 9339-9353. 
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SHORT ABSTRACT 
 
Oligonucleotides and oligonucleotide analogues are extremely versatile molecules 
from a biotechnological point of view, since they could be used as scaffolds for the 
development of new drugs in therapeutics, but also for the development of new 
materials in nanotechnology.  
The present thesis is included in this context and it is aimed at the discovery of all 
potential applications of these molecules. 
 
In particular, my work is mainly focused on:  
 
✓ The synthesis and characterization of a novel G-rich ODN sequence for the 
development of long G-wires; 
✓ The synthesis and characterization of PNA sequences to be used in a novel 
approach for the treatment of Cystic Fibrosis; 
✓ The synthesis and characterization of a short sequence of PNA conjugated to 
a novel bifunctional linker aimed at the obtainment of PNA-based quadruplex. 
 
This has been possible exploiting my knowledge in solid phase and solution 
synthesis and by means of spectroscopic techniques.  
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LONG ABSTRACT  
 
Gli oligonucleotidi sintetici (ON) sono corti filamenti di acidi nucleici di opportuna 
sequenza e lunghezza attualmente impiegati nel trattamento di importanti malattie 
dell’uomo, quali cancro e infezioni virali. Zamecnik e Stephenson furono i primi che 
proposero nel 1978 l’uso di oligonucleotidi sintetici per scopi terapeutici (1). Da quel 
momento, la comunità scientifica ha sempre di più riconosciuto l’importanza di tali 
molecole e proposto il loro uso nell’ambito della medicinal chemistry per la 
progettazione di nuovi farmaci. Gli oligonucleotidi, difatti, sono molecole capaci di 
interagire selettivamente ed in maniera stabile con sequenze di DNA o con l'RNA che 
possiedano una sequenza complementare, formando legami ad idrogeno tra le basi 
azotate, in accordo al modello di Watson-Crick. 
Attualmente gli oligonucleotidi sintetici trovano applicazione come modelli di studi 
strutturali di strutture non canoniche di DNA, come molecole per la diagnosi e quindi 
nella progettazione di farmaci di nuova generazione. In questo contesto essi possono 
essere catalogati, in funzione del loro meccanismo di azione, come oligonucleotidi 
“antisenso”, “antigene” ed “aptameri”.  Tuttavia, anche in questo tipo di approccio è di 
estrema importanza valutare la risposta farmacocinetica, farmacodinamica e 
tossicologica di tali molecole. Infatti, è estremamente importante valutare, oltre 
l’attività biologica, anche la stabilità nei compartimenti intracellulari ed extracellulari, 
la capacità di tali molecole di attraversare le membrane biologiche e di giungere allo 
specifico bersaglio, in dosi efficaci e non tossiche. Gli ODN sintetici ‘naturali’ 
mostrano tuttavia una ridotta attività in vivo, dovuta sia a scarsa permeabilità delle 
membrane cellulari agli ODN naturali, che ad una rapida degradazione ad opera 
delle nucleasi cellulari. A questo proposito, l’attenzione della comunità scientifica si 
sta incentrando, in misura sempre maggiore negli ultimi anni, sulla ricerca e la sintesi 
di analoghi oligonucleotidici, chimicamente modificati o nel ponte zucchero-fosfato o 
nelle basi azotate o eventualmente coniugati con molecole, a basso o medio peso 
molecolare, capaci di conferire al composto ibrido una maggiore permeabilità alle 
barriere biologiche e una maggiore resistenza alle nucleasi cellulari. Diverse 
modifiche chimiche sono state quindi apportate con lo scopo di migliorare le proprietà 
farmacocinetiche degli oligonucleotidi (2, 3). Ed è in questo contesto che si collocano 
i PNA, ovvero gli Acidi Peptido-Nucleici. Essi sono dei mimici del DNA, in cui uno 
scheletro di tipo peptidico, dato dalla condensazione di unità monomeriche di 2-
amminoetilglicina, sostituisce lo scheletro zucchero-fosfato degli acidi nucleici su cui 
sono innestate le normali basi adenina, timina, guanina e citosina (4). Tale struttura 
ha il vantaggio di essere non ionica e del tutto stabile alle nucleasi, alle proteasi e 
alle peptidasi. Ideati da Peter Nielsen nel 1991, i PNA sono capaci di formare con 
DNA e RNA composti dotati di elevata stabilità termica, e questo è reso possibile 
dalla mancanza di repulsione elettrostatica tra i filamenti che rende i duplex ibridi 
PNA/DNA e PNA/RNA molto più stabili degli omo ed etero-duplex (5).  
La spiccata stabilità in vivo, la specifica ibridizzazione con gli acidi nucleici e 
l'assenza di tossicità, anche a concentrazioni relativamente elevate, hanno 
contribuito a rendere i PNA molecole promettenti per le applicazioni terapeutiche. 
 
Sempre in questo contesto, negli ultimi decenni, numerosi studi sono stati rivolti 
anche verso un altro tipo di strutture: le strutture G-quadruplex. Le G-quadruplex 
sono strutture non canoniche di acido nucleico che si formano in sequenze ricche di 
guanine in presenza di cationi monovalenti come K+ e Na+. Tali guanine hanno una 
naturale propensione ad auto associarsi in quartetti coplanari (o tetradi), stabilizzate 
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da legami a idrogeno di tipo Hoogsteen. Inoltre l’impilamento di diverse tetradi di 
guanine consente l’instaurarsi di interazioni di tipo π tra i diversi piani, e ciò 
contribuisce ulteriormente a stabilizzare tali strutture.  
Nel 1910, Bang fu il primo a dimostrare che l’acido guanilidico era in grado di 
formare, in alte concentrazioni, una sostanza dalla consistenza gelatinosa, 
suggerendo quindi che sequenze ricche di guanine nel DNA avessero la capacità di 
formare strutture di ordine superiore (6). Tuttavia, la prima caratterizzazione di una 
struttura G-quadruplex risale solo al 1962 (7). Da quel momento, l’interesse 
scientifico verso le G-quadruplex non si è mai esaurito ma è anzi cresciuto in 
maniera esponenziale, arrivando al suo apice nel 2013, quando il gruppo di ricerca 
del prof. Balasubramanian ha pubblicato un articolo in Nature Chemistry, in cui ha 
descritto un metodo per la visualizzazione quantitativa in vivo delle G-quadruplex e 
fornito quindi prove sostanziali e dirette della loro naturale formazione all’interno del 
genoma umano (8). 
Aldilà dell’interesse da un punto di vista biologico, tali strutture stanno riscuotendo 
ampi consensi anche nell’ambito delle nanotecnologie, per la loro capacità di formare 
strutture di ordine superiore tramite processi di autoassemblaggio (o self-assembly), 
idrogels, biosensori e nanomacchine. L’autoassemblaggio è il processo con il quale 
specifiche componenti si associano spontaneamente a dare un’architettura 
supramolecolare complessa e definita.  Molte strutture biologiche si originano 
spontaneamente per autoassemblaggio di strutture chimiche più semplici ed il 
complesso biologico supramolecolare più celebre è sicuramente il DNA. Quello a cui 
generalmente ci si riferisce come la molecola del DNA è infatti un aggregato di due 
distinte macromolecole polinucleotidiche trattenute insieme da interazioni non 
covalenti. L’appaiamento tra le basi è il migliore esempio di come fattori geometrici e 
specificità elettronica delle interazioni determinino l’assunzione della struttura 
supramolecolare garantiscano la funzionalità della struttura stessa. 
Le strutture G-quadruplex presentano anch’esse tale proprietà, difatti, grazie 
all’elevato grado di polimorfismo (9), possono dare origine ad un’ampia famiglia di 
strutture stabili, la cui plasticità conformazionale permette di sviluppare strutture 
molecolari superiori. 
In quest’ambito le G-quadruplex sono state utilizzate per la costruzione di 
nanostrutture a base di DNA, quali G-wires. Tali sovrastrutture presentano diverse 
proprietà che le rendono estremamente interessanti da un punto di vista 
nanotecnologico. Studi teorici suggeriscono infatti che esse hanno buona capacità 
conduttiva, basso potenziale ossidativo e sono dotate inoltre di un’alta rigidità e 
buona stabilità termica e meccanica il che le rende eccellenti candidati nel campo 
delle nanotecnologie, nano elettronica e nello sviluppo di biosensori (10, 11).  
I biosensori possono essere direttamente rappresentati come dispositivi che 
convertono un evento fisico o biologico in un segnale misurabile; essi sono composti 
dunque da un elemento di rilevamento biologico che fornisce selettività, e un 
trasduttore che converte le reazioni chimiche in segnali processabili. Le strutture G-
quadruplex si stanno facendo molto spazio in questo contesto, in particolar modo per 
segnalare presenza di potassio in campioni biologici ed ambientali e sono 
particolarmente intriganti in quanto garantiscono bassi costi, selettività, efficienza e 
soprattutto semplicità (12). Risultati molto interessanti possono essere potenziati 
coniugando filamenti ricchi di guanine a nanoparticelle d’oro (13).  
Una volta consolidata la possibilità delle G-quadruplex ad organizzarsi in 
sovrastrutture, numerosi ricercatori si sono interrogati sulla capacità degli analoghi 
oligonucleotidici -ricchi di guanine - di formare strutture di ordine superiore, in modo 
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tale da ottenere nuovi materiali nell’ambito delle nanotecnologie. Anche in questo 
caso, l’acido peptido-nucleico è il protagonista indiscusso in questo tipo di indagine. 
Oggigiorno però, esistono ancor pochi lavori che riportano la completa 
caratterizzazione di quadruplex a PNA (14, 15). Molti ricercatori infatti hanno 
soprattutto dimostrato la formazione di quadruplex di natura ibrida DNA-PNA, o 
addirittura di chimere PNA-DNA (16, 17). Lo studio della capacità del PNA ad 
arrangiarsi in strutture G-quadruplex dotate di elevato polimorfismo resta quindi una 
sfida aperta nell’ambito delle biotecnologie.  
 
Il mio lavoro di tesi è dunque inserito in questo contesto ed è focalizzato 
principalmente sui seguenti punti:  
 
▪ Sintesi e caratterizzazione di nuove sequenze oligonucleotidiche capaci 
di formare strutture G-quadruplex di ordine superiore 
 
La caratterizzazione di strutture di ordine superiore a partire da strutture G-
quadruplex rappresenta uno degli obiettivi principali dei ricercatori nell’ambito delle 
nanotecnologie. Le strutture G-quadruplex si sono rivelate strutture molto versatili per 
la costruzione di sovrastrutture e biosensori, e ciò è dovuto principalmente alla 
facilità con cui esse possono essere ottenute, e all’elevato grado di polimorfismo a 
cui possono dare origine.  
Recentemente, nel gruppo di ricerca del prof. Piccialli è stata identificata una nuova 
modalità di dimerizzazione di strutture G-quadruplex attraverso uno stacking testa-
testa di due blocchi di quadruplex derivanti dal filamento 5’-CGGTGGT-3’: attraverso 
diversi studi spettroscopici è stato dimostrato che le citosine all’estremità 5’ agivano 
da colla idrofobica tra i due blocchi di quadruplex (18). Tale lavoro è stato 
successivamente ampliato, andando a sintetizzare una piccola libreria di 
oligunucleotidi a sequenza diversa, e dimostrando anche in questo caso, la 
possibilità di formare dimeri di quadruplex stabili (19). 
In questo contesto si inserisce il mio lavoro di dottorato: l’idea è quella di sintetizzare 
un nuovo filamento oligonucleotidico contente un’inversione di polarità in modo tale 
da poter ottenere due estremità 5’ nello stesso filamento. La capacità di questo 
filamento di formare blocchi G-quadruplex, in grado poi a loro volta, di polimerizzare 
formando strutture G-wire di ordine superiore sfruttando le estremità “adesive” in 5’, è 
stata poi ampiamente indagata attraverso l’utilizzo di tecniche quali PAGE, SEC-
HPLC e studi spettroscopici.  
In particolar modo, una volta annilato il nostro campione in presenza di potassio, è 
stato possibile visualizzare, in base alla loro diversa mobilità elettroforetica, una 
distribuzione di oggetti quadruplex, a partire dalla specie monomerica (specie più 
veloce) fino ad arrivare ad una miscela indistinguibile di oggetti di ordine superiore 
(specie più lente). Particolarmente interessante è stata poi l’analisi SEC-HPLC; i 
cromatogrammi ottenuti ci hanno permesso di identificare, analizzando i tempi di 
ritenzione, tutti i multimeri formatisi dalla specie in esame e di isolare tali oggetti. 
Variando inoltre le condizioni sperimentali, è stato possibile dimostrare che il pattern 
dei picchi è concentrazione-temperatura dipendente. Ancora, le spettroscopie di 
dicroismo circolare e di NMR hanno contribuito a caratterizzare ulteriormente tali 
strutture di ordine superiore, mentre, infine, l’analisi AFM ha permesso di visualizzare 
tali strutture e di definirne le dimensioni. 
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▪ Sintesi e caratterizzazione di nuove sequenze di PNA da utilizzare in una 
nuova strategia diretta al trattamento della Fibrosi Cistica 
 
La fibrosi cistica (FC) è la malattia genetica rara più diffusa che solo in Italia colpisce 
circa 1 neonato su 3.000. La malattia si verifica quando un bambino eredita due 
copie alterate del gene CFTR (Cystic Fibrosis Transmembrane Regulator), una da 
ciascun genitore (20).  
Il gene CFTR codifica la sintesi della proteina CFTR che se ben funzionante regola il 
movimento del cloro, al quale segue il movimento dell’acqua, dall’interno verso 
l’esterno delle cellule epiteliali delle ghiandole mucose. Il malfunzionamento o 
assenza della proteina CFTR interessa tutte le ghiandole a secrezione mucosa 
determinando una carenza di cloro e acqua nelle secrezioni. Le secrezioni mucose 
povere di acqua e vischiose tendono a ristagnare provocando così l’ostruzione degli 
organi interessati, e continue infiammazioni-infezioni degli stessi. La terapia di questa 
malattia ha avuto negli ultimi anni notevole sviluppo. Infatti, accanto ad una terapia 
dei sintomi oggigiorno si stanno facendo spazio sempre più le terapie geniche che 
mirano ad una correzione del difetto di base in alcune forme geniche di FC. Una 
delle terapie che ha riscosso più successo è quella che prevede il bersagliamento dei 
miRNA, ovvero delle brevi sequenze di RNA non codificante coinvolte nella 
patogenesi della malattia. Infatti questi, essendo complementari al 3’UTR 
(UnTranslated Region) del trascritto del gene CFTR, sono responsabili della 
riduzione dell’espressione della proteina, causando la malattia o l’aggravarsi del suo 
fenotipo. I microRNA, inoltre, sembrano essere responsabili del mantenimento di 
bassi livelli di CFTR negli adulti (21). Il bersagliamento dei miRNA può essere 
effettuato usando molecole quali il PNA. Nel gruppo di ricerca del professor Piccialli 
sono state precedentemente esplorate le potenzialità del PNA come agente anti-
miRNA (22–24). Studi spettroscopici hanno dimostrato che tali PNA sono capaci di 
formare ibridi stabili con il target, mentre studi in vitro hanno dimostrato che i PNA 
riconoscono i target nelle cellule. Nonostante i promettenti risultati ottenuti, il 
sequestro dei miRNA potrebbe portare, a lungo andare, a tutta una serie di effetti 
collaterali in quanto responsabili anche di altri ruoli biologici. In questo contesto si è 
inserito il mio lavoro di dottorato, ovvero nel mettere a punto una nuova strategia che 
non mirasse più ai miRNA, ma avesse come target la regione 3’UTR del gene 
(strategia target protector). In questo modo, mascherando la regione di legame del 
miRNA, quest’ultimo è libero di svolgere le sue funzioni, e contemporaneamente, 
l’effetto dovrebbe essere quello di incrementare la produzione della proteina CFTR. 
A questo proposito dunque, sono state sintetizzate e caratterizzate 2 sequenze di 
PNA, di 13 e 7 basi (e relative sequenze scrumble usate come controllo negativo) e 
attraverso studi spettroscopici, quali dicroismo circolare e UV, è stata valutata la loro 
abilità di formare strutture ibride con il target: da tali esperimenti è emerso che 
entrambe le sequenze PNA sono in grado di formare eteroduplex di tipo antiparallelo 
con il bersaglio, la cui stabilità termica è stata valutata attraverso CD melting. Tali 
risultati sono stati supportati da studi di dinamica molecolare. Infine, preliminari saggi 
biologici eseguiti sul costrutto della luciferasi, hanno messo in evidenza che l’azione 
del PNA è in grado di ripristinare significativamente l’attività luciferasica.  
 
 
Sintesi e caratterizzazione di un breve segmento di PNA coniugato ad un linker 
bifunzionale con lo scopo di ottenere nuove quadruplex a PNA bimolecolari  
 
viii 
 
In questo contesto, l’obiettivo del mio lavoro di dottorato è stato quello di continuare 
ad indagare sulle infinite potenzialità del PNA, questa volta non da un punto di vista 
biologico, ma valutando la sua capacità di formare nuove strutture del tipo G-
quadruplex, utili per la costruzione di nuovi nanomateriali. Sfruttando come punto di 
partenza l’expertise del gruppo di ricerca del prof. Piccialli nella sintesi di linker 
ramificati (25–28), l’approccio ha previsto la preliminare sintesi di un nuovo tipo di 
linker bidentato, funzionalizzato poi da sequenze di PNA ricche in guanine. La 
molecola così ottenuta, chiamata bel-PNA, è stata poi sospesa in potassio e la 
capacità di assemblarsi in quadruplex è stata valutata attraverso studi spettroscopici. 
In particolare, attraverso la preliminare analisi di dicroismo circolare è stato possibile 
dimostrare che il bel-PNA è in grado di strutturarsi in quadruplex di tipo antiparallelo; 
tuttavia, essendo il PNA una molecola achirale, l’analisi CD richiede il supporto di un 
altro tipo di tecnica. In questo contesto si inserisce la spettroscopia SERS, che si è 
dimostrata uno strumento indispensabile per la caratterizzazione strutturale di tale 
tipo di molecola. 
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1 Introduction 
Chapter 1 
“DNA comes in many forms” (1) 
 
1.1 Introduction 
Nucleic acid structures are fundamental to cellular function and the regulation of several 
biological events (2). Oligonucleotides (ODNs) are short sequences of nucleic acids, 15-100 
nucleotides in length, usually obtained by chemical synthesis and they represent the 
simplest form of nucleic acid endowed with therapeutic function. The term oligonucleotide is 
derived from the Greek “oligo,” which means few or small. The length of the oligonucleotide 
is usually denoted by the term “mer,” which is Greek for “part.” 
In the last few years, the scientific community has recognized the importance of synthetic 
oligonucleotides as new therapeutic agents to be used in the field of medicinal chemistry, 
as they are molecules capable to selectively and firmly interact with DNA and RNA. This 
ability is based on the single-strand DNA property to recognize a DNA or RNA strand that 
possesses a complementary sequence through the constitution of hydrogen bonds between 
the bases based on the Watson-Crick model. Despite the non-covalent nature of the bonds, 
the whole number of joints makes the affinity between two complementary strands extremely 
high (kd= 1x10-15 Mol/L); moreover, the hybridization events between the bases allows a 
highly specific target recognition.  
In 1978, Zamecnik and  Stephenson were the first to demonstrate the potential of a synthetic 
ODN to attenuate the expression of selected genes (3). As from their pioneeristic work, the 
era of oligonucleotide (ON) therapeutics began.  
 
1.1.1 Therapeutic application of synthetic ODN 
Synthetic oligonucleotides possess a wide range of applications, including structural studies 
of non-canonical DNA secondary structures, studies in diagnostic field, and development of 
new drugs.  
In recent years, a new pharmacological approach has developed and this involves the use 
of ODN as highly selective molecules in regulating gene expression and in which they act 
much more upstream than traditional drugs that typically target proteins. For instance, they 
can be catalogued considering their target and mechanism of action, as “antisense” or 
“antigene” agents, when they target a specific mRNA or a tract of duplex DNA, respectively, 
or as “aptamers”, when selectively recognize a specific protein. 
In the antisense therapy, short sequences of ODN bind the cytosolic messenger RNA 
(mRNA) produced by the gene by duplex formation, with the effect of inactivating and turning 
off the gene (4). This synthesized nucleic acid is termed an "anti-sense" oligonucleotide 
(ASO) because its base sequence is complementary to the gene's messenger RNA 
(mRNA), which is called the "sense" sequence. 
Antisense oligonucleotides have been researched as potential drugs for diseases such as 
cancers, diabetes, amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, 
spinal muscular atrophy and more. In 1998, the US FDA approved an antisense 
oligonucleotide (ASO), Vitravene, for the treatment of AIDS-related cytomegalovirus retinitis 
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(5).The recent approval of Kynamro (6) confirms the clinical potential of the antisense 
approach.  
In the antigene approach, oligonucleotides can bind with a high specificity of recognition to 
the major groove of double helical DNA by forming Hoogsteen type bonds with purine bases 
of the Watson-Crick base pairs, resulting in triple helix formation. Consequently, triplex-
forming oligonucleotides (TFOs) can selectively inhibit gene expression at the transcriptional 
level or repair genetic defect by direct genome modification in human cells (7). Targeting 
oligonucleotides to the gene itself (the antigene or triple helix strategy) presents several 
advantages as compared to antisense oligonucleotides or ribozymes which are heading to 
messenger RNAs, since there are only two copies (two alleles) of the targeted gene whereas 
there may be thousands of copies of a messenger RNA. This means that by blocking mRNA 
translation even by inducing sequence-targeted cleavage of the RNA chain does not prevent 
the corresponding gene from being transcribed, thereby repopulating the RNA pool (8) . 
Nucleic acid aptamers are short, single-stranded DNA or RNA molecules (20–100 
nucleotides in length) with defined structures that can specifically bind to a molecular target 
via three-dimensional structures. These three-dimensional interactions, including 
hydrophobic and electrostatic interactions, hydrogen bonding, van der Waals forces, shape 
complementarity and base stacking, are essential for aptamer binding affinity and specificity 
and drive the formation of aptamer–target complexes (9). An example of aptamer is 
embodied by pegaptanib, an aptamer-derived anti-VEGF compound shown to be effective 
in treating age-related macular degeneration (10). It received FDA approval in 2004.  
 
1.2 G-quadruplexes 
It is well known that ODN sequences can fold into a huge number of structural motifs, in 
order to assemble the functional structural conformation for their precise biological roles in 
the cellular environments. These motifs include duplexes, hairpins, triplexes, and G-
quadruplexes (2) (Fig.5). 
 
 
Figure 5: Top: Schematic illustration of the duplex, triplex, G-triplex, and G-quadruplex structures. Bottom: 
Examples of base pairing. 
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In particular, Guanine (G)-rich sequences can self-associate into stacks of G-quartets to 
form G-quadruplexes. In 1910, Bang demonstrated that guanylic acid formed gels at high 
concentration, providing the first evidence that guanine (G)-rich sequences might form 
higher-order structures (11); however, the first characterization of a G-tetrad structure was 
obtained in 1962 by Gellert and co-workers who demonstrated that guanylic acid owned the 
ability to form tetrameric structures by self-association (12). Considered just an oddity for a 
long time, their effective biological relevance has been recognized only three decades later, 
being discovered once in eukaryotic chromosomal telomeric DNA and later in gene promoter 
regions (13), in a number of human genes involved in growth and proliferation (14), in 
immunoglobulin switch regions (15), as well as in ribosomal DNA (16) and RNA (17, 18). 
The evidence for the formation of G-quadruplex structures in the genome of human cells 
was eventually demonstrated in 2013 by the research group of Prof. Balasubramanian, with 
a work published on Nature (19).  
The "bricks" at the base of the construction of these structures are the G-quartets (Fig.6); 
the four guanine bases form a square co-planar array where each base is both a hydrogen 
bond donor and hydrogen bond acceptor. Involvement of both the N1 and N2 of one face 
with the O6 and N7 of the second face on guanosine yields eight hydrogen bonds per planar 
G-quartet.  
 
 
Figure 6: The planar arrangement of four guanine bases bonded by eight Hoogsteen hydrogen bonds. 
 
The square planar layout creates a central cavity delimited by the carbonylic oxygen of the 
guanine bases; This cavity constitutes a specific binding site for metal ions, essential for the 
formation and stabilization of these macromolecular complexes. The most effective cations 
in the stabilization of G-quadruplex structures are K+ and Na+; Each ion has a precise 
coordinate geometry, particularly in the case of K+, an anti-prismatic bipyramid coordinate 
geometry is observed with the involvement of two G planes, for a total of eight carbonyl 
oxygen equally coordinating the central cation (Fig.7).  
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Figure 7: The position of potassium in the central cavity and between two quartets. 
 
The overlapping of guanine planes, positioned at a distance of 3 Angstrom from each other, 
contributes to further stabilizing the quadruplex structure by π-π stacking interactions (20). 
From the association of four G-rich oligonucleotide strands, a right-handed helicoidal 
structure is obtained (Fig.8). 
 
 
Figure 8:  The right-handed elicoidal structure obtained from the association of four G-rich oligonucleotides. 
 
1.2.1 Structural variability of G-Qs 
Structural studies of G-quadruplexes have demonstrated that the G-rich sequences can 
form highly polymorphic G-quadruplexes (21), and the variation in these structures depends 
on the sequences and the experimental conditions (e.g. coexisting metal ions, metal ion 
concentration, and degree of molecular crowding) (22); in particular, the G-quadruplexes 
can differ by the stoichiometry of strands, their orientation and glycoside conformation of the 
guanines involved in each tetrad (Fig.9). 
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Figure 9: Polymorphism of G-quadruplexes. 
 
First of all, G-Quadruplex structures may form from the folding of a single oligonucleotide 
chain (giving rise to a monomolecular G-quadruplex) (23) or from the interaction between 
two (Bimolecular G-quadruplex) (24) or four (tetramolecular G Quadruplex) (25) different 
oligonucleotide strands.  
 
NMR spectroscopic analysis showed that oligonucleotides containing short guanine runs, 
for example XnGpXn (with Xn any nucleotide of length n and Gp any number of guanines 
involved in tetrad formation of length p) are able to form highly symmetrical G-quadruplexes 
having four parallel strands. Structures containing these short guanine runs, such as 
d(TGGGGT)4 have been determined by crystallographic and NMR methods to reveal a 
parallel stranded arrangement, where the phosphate backbone runs in the same direction 
and all the bases are in an anti glycosidic orientation (25, 26).  
More complex structures and topologies can form from strands containing two guanine 
repeats separated by non-guanine nucleotides, for example XnGoXpGoXn, where Xn is any 
non-guanine nucleotide of length n, Go is any number of guanines involved in tetrad 
formation of length o, and Xp is any nucleotide of length p involved in loop formation. An 
oligonucleotide with these Guanine-rich regions can fold into a hairpin by the formation of 
Hoogsteen-type bonds between guanines belonging to different regions. The dimerization 
of a hairpin leads to the formation of a bimolecular G-quadruplex. The topology of these 
quadruplexes depends on which of the strands are connected together. The element linking 
the strands together can be diagonal, lateral (edgewise), or external (propeller, strand 
exchange, double-chain-reversal) to the quadruplex. These linking nucleotides are critical in 
determining quadruplex stability in term of length and sequence. An example of this type of 
G-quadruplex is provided by the fragment of the telomeric sequence of Oxytricha, d 
(G4T4G4) (Fig.8), which, from NMR studies in solution with Na+ ions, revealed the ability to 
organize in a bimolecular G-quadruplex with diagonal loops (27). 
 
A single G-rich oligonucleotide strand with the general sequence XnGoXpGoXpGoXpGoXn, 
with Xn is any non-guanine nucleotide of length n, Go is any number of guanines involved in 
tetrad formation of length o, and Xp is any nucleotide of length p involved in loop formation, 
may fold to form a monomolecular G-quadruplex structure with three loops. The folding 
topologies available to monomolecular quadruplex are more varied and complex than those 
available to the tetramolecular or bimolecular quadruplex due to the additional linking 
nucleotides. Loops generally force the strands of the structure to fit in antiparallel; An 
indicative example of this type of structure is given from the Thrombin-Binding Aptamer 
(TBA), d(GGTTGGTGTGGTTGG) (Fig.9) (28). By NMR studies, it has been seen that in 
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solution this oligonucleotide forms a monomolecular quadruplex that is shaped like a chair, 
with two stacked G-quartets connected by two TT loops and a central 3-base TGT loop. 
G-Qs can be also classified because of orientation of the strands and the connecting loops. 
G-Q structures possessing all the strands in the same orientation are parallel quadruplexes, 
while opposite orientation of the strands give rise to antiparallel or hybrid quadruplexes. In 
general, parallel quadruplexes have all the guanosine glycosidic angles in the anti-
conformation, while antiparallel quadruplexes show both anti and syn glycosidic angles 
(Fig.10). 
 
 
Figure 10: glycosidic bond conformations. 
 
Regarding the connecting loops, propeller type loops are those which connect the bottom 
G-quartet to the top G-quartet of adjacent strands with the same orientation; lateral loops, 
also known as edge-wise loops, link adjacent strands, while diagonal loops join opposite 
strands (Fig.11). 
 
 
Figure 11: Propeller loops (left), lateral loops (center) and diagonal loops (right). 
 
Finally, a fundamental role is played by the cations on the folding and thermodynamics of 
G-Qs (29) (Fig.12).   
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Figure 12: G-tetrad with the Metal Ion in the central cavity. 
 
The cation and quadruplex interaction is based primarily on the kind of ion located at the 
central channel formed by the quartet arrangement. The positions of the ions can be in the 
quartet plane or between the planes of the quartet depending on the ion and the structure 
of the GQ. The ions contribute to charge screening, by reducing the strong negative 
electrostatic potential generated by the guanine O6 oxygen atoms. Molecular dynamics 
simulation studies suggest that lack of cations at the centre of the quartet destabilizes the 
GQ structure as it is electronically unfavourable. 
For their physiological relevance, the most extensively studied ions are K+ and Na+. Their 
different behaviour about their location within the cavity result from their dimension: the 
smaller sodium cations can reside in plane with the G-quartet, whereas potassium can 
coordinate between two tetrads. However, several other monovalent and divalent ions have 
also been shown to influence the structure and stability of GQs. Some of the very early 
studies on role of cations on the stability of GQ structures suggested the order as K+ > Ca2+ 
> Na+ > Mg2+ > Li+ and K+ > Rb+ >Cs+. 
 
1.2.2 The biological role of G-Qs 
G-quadruplex structures have attracted considerable interests because of their importance 
in regulating biological functions, such as gene expression, gene regulation, and in being 
pharmaceutical targets (30). The presence of thousands of sequences capable of forming 
G-Quadruplex structures in important regions of many genes, including the telomeric ends 
of eukaryotic chromosomes and promoter regions of genes and oncogenes, has been 
demonstrated, thus suggesting a possible role of the G-quadruplexes in the regulation of 
transcriptional and replicative processes. For instance, in human cells, the telomeric ends 
of chromosomes consist of a double-stranded repeat of G-rich sequence TTAGGG, and of 
a ∼200-nt single-stranded G-rich overhang beyond the double-stranded region, which is 
able to assemble into G-quadruplex structures. During each round of chromosome 
replication, telomeres shorten by 50-200 base pair, until they reach a critical length below 
which the programmed death of the cell (or apoptosis) occurs. The ribonucleoprotein 
telomerase provides such a compensatory mechanism. Since somatic cells progressively 
undergo to a decrease of the telomerase expression, it follows that the shortening of 
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telomeres is at the base of the cell aging process. On the other hand, the telomerase enzyme 
is overexpressed in more than 85% tumours, so tumour cells have unlimited proliferative 
potential. Subsequently, small molecules able to induce or stabilise telomeric G-quadruplex 
structures have been studied for their ability to inhibit telomerase activity and act as 
anticancer agents (31). Therefore, the G-quadruplexes could be considered promising 
targets for the development of novel anti-tumour drugs.  
Further interest in quadruple helix structures is due to the fact that they constitute the 
scaffold of many aptamers. Aptamers are small DNA or RNA molecules able to assume 
specific three dimensional structuring in order to achieve a very high binding affinity towards 
specific proteins, such as thrombin or some HIV proteins, thus demonstrating promising 
biological properties and possible pharmacological applications (32). Particularly, one of the 
most studied G-quadruplex-based aptamer class is that of thrombin-binding aptamers 
(TBAs), which bind to α-thrombin, a key protein involved in the clotting process, preventing 
the pathological process of thrombosis. It was also demonstrated that in this case the 
structuring in the G-quadruplex and its consequent stability, are essential requirements for 
the explication of biophysical and biological effects of TBA (33). 
 
1.2.3 G-Qs and biotechnology. 
1.2.3.1 G-Qs self-assembly. 
In recent years, G-quadruplexes have become the focus of attention because they can be 
used as building blocks to create supramolecular structures.  In fact, G-rich oligonucleotides 
are able to self-assemble into high-ordered structures by multimerization between G-
quadruplex units (34). 
Self-assembly of biological important small molecules into nanostructure has evolved as an 
attractive strategy for fabricating materials with a broad range of potential applications in 
catalysis, sensing, electronics, medical diagnostics and drug delivery. 
In literature examples of polymeric species arising from quadruplex structures have already 
been reported. Several studies have shown that the G-quadruplex can give rise to 
supramolecular structures such as G–wires, in which each quadruplex building block is 
stacked one upon the other; the resulting superstructure grows along the axis orthogonal to 
G-tetrad planes and reaches the length of thousand nanometers (Fig.13). 
 
 
Figure 13: AFM images of G-wire and model of a typical G-wire. 
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Marsh and al., in 1994, showed that sequence 5’GGGGTTGGGG3’, corresponding to 
telomeric repetition of Tetrahymena Thermophila, can assume different conformations (34, 
35). The G-rich strand can fold and dimerize giving rise to the formation of a bimolecular G-
Quadruplex with parallel, lateral opposite or diagonal loops. On the other hand, the oligomer 
may also associate with other three G-rich strands resulting in tetrameric structure. In this 
condition, the oligonucleotide can spontaneously self-assemble in high-ordered structures 
by interaction between deoxyguanosine quartets located at terminals 5 ‘and 3’ (Fig.14). 
Atomic force microscopy (AFM) and layer scanning microscopy (HLSTM) are among the 
most commonly used technique to investigate the formation of such polymers.  
 
 
Figure 14: On the left, comparison of G-DNA conformations that Tet 1.5 may adopt and G-wire model on the 
right. Tet 1.5 adopts an out of register (slipped) tetrameric association forming G4-DNA domains stabilized by 
monovalent cations. Theoverlapping slipped G4-DNA structuresare responsible for the formation of the G-
wire. 
 
More recently, the research group of Prof. Wu studied the geometrical size of Na2(5′-GMP) 
supramolecular structures at pH 8 by a combination of diffusion NMR and DLS methods 
(36); In general, two distinct types of aggregate species are present in an aqueous solution 
of Na2(5′-GMP). One type consists of stacking 5′-GMP monomers, and the other contains 
stacking G-quartets. Both types of aggregates can be modeled as rod-like cylinders. The 
cylinder diameter is 10 and 26 Å for monomer aggregates and quartet aggregates, 
respectively. For Na2(5′-GMP) concentrations between 18 and 34 wt %, the cylinders formed 
by stacking G-quartets have an average length between 8 and 30 nm, corresponding to a 
stack of ∼24-87 G-quartets (Fig.15). 
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Figure 15: Schematic illustration of the molecular cylinder formed by Na2-(5′-GMP) self-assembly. 
 
Another possible way of forming higher aggregates is through an interlock mode as 
observed by Krishnan-Ghosh et al. (37): they demonstrated, by means of spectroscopic 
techniques, that a tetranucleotide sequence d(GGGT) has been shown to self-assemble into 
an interlocking quadruplex dimer; in particular the novel structure arose from the 
dimerization of a parallel, “slipped” tetramolecular quadruplex that has its diagonal strands 
staggered by one base. This “slippage” results in two guanine bases at the 5′ end of the 
quadruplex being presented diagonally that are not involved in tetrads. Two such “slipped” 
quadruplexes dimerize via these free G-bases at the 5′ ends by forming an extra G-tetrad 
(Fig.16).  
 
 
Figure 16: interlocked quadruplex formed by the dimerization of two staggered or “slipped” quadruplexes. 
 
Nishigaki and Biyani proposed another model, tentatively called “G-Lego” for higher-
molecular weight aggregates formed by the sequence d(G11T) (38). In this model, the single 
strand loop back on itself to form a transient structure; Then, two of such folded monomers 
form a parallel or antiparallel/later or diagonal bimolecular G-quadruplex structure by sharing 
the hydrogen bonds between each pair of strands, thus constituting a starting unit of G-Lego 
(c). Next, the access of two of such unitary G-quartets may fall into a stable binding due to 
the unique contribution of terminal thymine-thymine interactions and thus may lead to 
rearrange their hydrogen bonding and thus associate to recombine and formed a 
tetramolecular parallel G-quadruplex (d). By continuing the same process, higher order 
aggregates can propagate linearly towards nano-structures like a modular toy “Lego” 
(Fig.17). 
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Figure 17: model for the g-Lego. 
 
It has been demonstrated that such supramolecular structures are also extraordinarily 
stable; heating at 80 °C or dissolving in 8 M urea did not denature them (39). This one and 
other properties make the G-wires extremely interesting from a nanotechnological point of 
view. Theoretical studies suggest that they have good conductivity, low oxidative potential 
and are also equipped with a high rigidity and optimal thermal and mechanical stability that 
make them good candidates in the field nanotechnologies, nano-electronics and the 
development of biosensors. 
 
1.2.3.2 Hydrogels 
G-quadruplex multimerization could be extended to a fibrous network to form 
supramolecular hydrogels (40). In recent years, hydrogels have been applied extensively in 
the development of platforms for biomedical and bioengineering purposes. With a three-
dimensional network, hydrogels can encapsulate a large amount of cargos, protect the 
cargos from environmental variations, and/or control cargo release by designing the gel 
structure in response to microenvironment variations. Stimuli-sensitive hydrogels are ideal 
candidates for developing self-regulated drug-delivery and -release systems. For many 
years, hydrogels have been generally developed by using long and complex procedures, 
and once produced, the release of the cargo didn’t exhibit a constant rate, but a two-step 
release profiles. In a very recent work, Shi and co-workers suggested the construction of a 
new G-quadruplex based hydrogel (Fig.18).  
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Figure 18: Schematic Representation of the multicomponent Self-Assembly of Guanosine, 2-FPBA, TAEA, 
and KCl and the Dissociation of the G-Quadruplex Hydrogels. 
 
In particular, in this work, they developed supramolecular G-quadruplex hydrogels by 
multicomponent self-assembly of guanosine, TAEA, and 2-FPBA. On the basis of the 
formation of a G-quartet via Hoogsteen-type hydrogen bonding among four guanosines 
mediated by potassium cations, the stacking of G-quartets and the iminoboronate bonds 
spontaneously and synergistically formed among guanosine, Tris(2- aminoethyl)amine 
(TAEA), and 2- formylphenylboronic acid (2-FPBA). The iminoboronate bonds contribute to 
facilitate the formation of the hydrogel and also endowed it with glucose and acid 
responsiveness. This kind of supramolecular G-quadruplex hydrogel formed by 
multicomponent self-assembly of small molecules with features of versatility and commercial 
availability of building blocks, pH and glucose-responsiveness, and zero-order drug-release 
behaviour may be a promising candidate for application in biological fields. 
 
1.2.3.3 Biosensors 
Not less important in the field of nanotechnology is the use of G-quadruplexes for the 
development of biosensor. Biosensors are analytical tools that combine biological materials, 
such as proteins, DNA/RNA and other selective chemicals to physicochemical signal 
transducer.  
An example of the use of G-quadruplex-based sensor was furnished by Takenaka’s group 
(41) (Fig.19). They used a modified TBA as a fluorescent indicator for detecting K+ in water, 
by anchoring pyrene groups to the 5’ and 3’ ends to the TBA sequence; the probe that they 
obtained was coined “Potassium Sensing Oligonucleotides (PSO)-py”. The mechanism that 
makes the biosensor work is very simple: in the absence of K+, the PSO-py is in the unfolded 
state, so it provides only a little excimer emission, while in the presence of K+, the 5’ and 3’ 
ends of the folded DNA stacks pyrenes in a face-to-face geometry to give a new excimer 
band. This system represents a promising sensor for the real-time detection of K+ in 
biological and environmental samples, due to its simplicity, high-responsiveness, and 
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selectivity. In fact, the presence of other cations gives only little interferences, since K+ binds 
with high affinity to the TBA G-quadruplex. 
 
 
Figure 19: Chemical structure of the PSO-py and the expected G-quadruplex induced by potassium binding. 
Pyrene excimer emission occurs in the presence of potassium.  
 
1.2.3.4 Conjugation to Gold-nanoparticles (AuNPs). 
G-quadruplexes have also been also conjugated with metallic nanoparticles producing more 
sensitive biosensors. In this frame, the gold nanoparticles (GNPs) have resulted very 
attractive as a colorimetric indicator. In fact, they have a high extinction coefficients and 
distance-dependent optical properties. The colour of the GNP suspension is greatly affected 
by the particle stability and inter-particle distance. For example, the dispersed GNPs give 
wine-red suspensions, while their aggregation produces a blue-purple colour. For example, 
as reported in literature, by connecting AuNPs (as probes) and suitable G-rich fragments 
(as the recognition element) is possible to obtain a rapid, simple, high sensitive and excellent 
selective sensor for the determination of K+, exploiting the conformation change from the 
“random coil” to a compact rigid G-quadruplex formed by the aggregation of the 
nanoparticles in solution. In the work of Chen et al. potassium ions (K+) were detected by 
gold nanoparticles (AuNPs) (Fig.20). To assay for K+ ions, the thiolated aptamers were 
conjugated to AuNPs separately via the strong Au-S bond. In the absence of K+, the 
aptamer-modified AuNPs dispersed well in the solution, and the G-rich nucleic acid was in 
the random coil state. However, once a solution containing K+ was introduced, K+ could 
specifically bind to the aptamer and induced the aptamer-AuNPs switching from a well 
dispersed state to an aggregated one, resulting in a change in the UV-vis absorption spectra 
of the solution. The linear range of the colorimetric aptasensor covered a large variation of 
K+ concentration from 5 nM to 1 μM and the detection limit of 5 nM was obtained. Moreover, 
this assay was able to detect K+ with high selectivity and had great potential applications 
(42). 
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Figure 20: Schematic diagram showing the principle of colorimetric detection of potassium ions using aptamer-
functionalized gold nanoparticles. The gold particles are represented in two colours to demonstrate the colour 
change observed after addition of K+. 
 
1.2.3.5 Nanomachines 
Another intriguing application of G-quadruplex in biotechnology is the development of “DNA 
nanomachines”: DNA nanomachines are nanorobots made entirely or partially of DNA. DNA 
nanomachines can switch among defined molecular conformations and can be used as 
sensing, computing, actuating or therapeutic nanodevices. For instance, Quadruplex 
structures comprise a wide class of well-defined conformational states. Their conformation 
and stability can be tuned by varying the sequence and/or the length sequences, by 
modifying different solution conditions, such as salt composition or pH, or by using small 
molecules that specifically bind to them (43). Furthermore, the G-quadruplex based machine 
exhibits a rapid response in comparison to using highly expensive instruments and 
complicated sample preparation (44).  For example, Alberti and Mergny, by using the FRET 
techniques, demonstrated the conformational equilibrium between the duplex DNA and the 
G-quadruplex DNA. They defined a nanomachine. This nanomachine could be cycled 
between the folded G-quadruplex state and the duplex by sequential addition of DNA 
strands, the so-called “C-fuel” and “G-fuel”:  the C-fuel extends the F21T quadruplex to 
generate a duplex conformation, while by adding the G-fuel, the C-fuel is removed from 
F21T that can refold in a quadruplex form (Fig.21). 
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Figure 21: Principle of the device and sequence of the oligomers with The Tm of the two duplexes. 
 
1.3 Oligonucleotide analogues. 
Nucleic acids are subjected to several chemical base modifications in vivo, such as 
methylation or phosphorylation, in order to obtain derivatives endowed of precise cellular 
functions. Inspired by nature, and moved by the aim to develop molecules with improved 
features, very soon, synthetic chemists realized the necessity of including chemical 
modifications to ODNs. In fact, ODNs are susceptible to nucleases, and so unstable in 
biological fluids; for these reasons their use for therapeutic applications has been limited. 
Furthermore, the effective delivery of oligonucleotides in vivo represents the major challenge 
for the scientific community. 
The introduction of the phosphorothioate modification by Fritz Eckstein in 1966 is arguably 
one of the most important contributions to the field of therapeutic ODN (45). Nowadays, 
various chemically modified oligonucleotides have been synthesized (46); they incorporate 
modifications not only to the phosphodiester backbone (first generation of analogues), but 
also to the sugar (second generation of analogues) or nucleobases portions. Not less 
important is the third generation of analogues, that includes Locked Nucleic Acids (LNAs), 
morpholinos and Peptide Nucleic Acids (PNAs). In particular, PNAs have revealed 
themselves as the most powerful and intriguing ODN analogues having a variety of 
biotechnological application. They were developed by the biochemist Peter Nielsen in 1991 
(47). PNAs are DNA/RNA mimic in which the phosphate deoxyribose backbone is replaced 
by uncharged N-(2-aminoethyl)-glycine linkages (Fig.2). 
 
 
Figure 2: structure of PNA 
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Nucleobases, attached through methylene carbonyl linkages to the glycine amino group, 
recognize complementary sequences by standard Watson-Crick pairing. Because PNAs 
have a neutral backbone, hybridization doesn’t suffer the intra-strand repulsion and, on the 
contrary, it occurs with enhanced affinity and rates of association. Moreover, PNA doesn’t 
seem to be substrates for nucleases or proteases and absence of a repetitive charged 
backbone also prevents PNA from binding to proteins that normally recognize polyanions, 
avoiding a major source of nonspecific interactions (48, 49). They have been synthetized 
through the selective alkylation at the N9 position of the purine or the N1 position of the 
pyrimidines, as showed in Figure 3. 
 
 
Figure 3: key steps in the chemical synthesis of PNA monomer. 
 
Due to the peptide nature of its backbone, the PNA subunits are generally assembled 
through the well-established Solid Phase Peptide Synthesis (SPPS) protocols and can be 
easily performed on automated synthesizers.  
PNAs hybridize with complementary DNA and RNA strands to form right-handed, double-
helical complexes based on the Watson–Crick rules. Because the PNA backbones do not 
bear negatively charged phosphate groups, they are not affected to charge repulsion and 
the formed complexes own higher thermal stabilities than DNA counterparts (50). It is also 
known that the PNAs recognize and bind complementary strands in both directions, parallel 
and antiparallel. In the antiparallel-type hybridization, PNA amino termini face the 3′-end of 
the DNA strand, whereas PNA amino termini face the 5′-end of the purine DNA strand in the 
parallel-type hybrids (51). From a thermodynamic point of view, the antiparallel binding 
mode is preferred.  
Furthermore, homopyrimidine PNA oligomers form triplex complexes. These complexes are 
extremely stable and contain an internal PNA–DNA–PNA triplex involving combined 
Hoogsteen (parallel orientation) and Watson–Crick (anti-parallel orientation) base pairing 
and an unbound DNA strand displaced in a D-loop structure (52). 
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Figure 4: PNA-DNA binding mode. 
 
Due to their notable properties, such as high chemical and thermal stability, resistance to 
enzymatic degradation as well as the very favourable RNA and DNA hybridization 
properties, they have been exploited in a variety of contexts, including the antigene and 
antisense strategy, diagnostic applications and, more recently, as aptamers. 
 
1.4 G-quadruplexes from Synthetic ODN analogue 
G-quadruplexes can also form from oligonucleotide analogues.  
Among all the ODN analogues, Peptide Nucleic Acid (PNA) represent the most fascinating 
derivative; in PNA the anionic phosphate backbone is replaced by neutral N-(2-aminoethyl) 
glycine linkages. For its hybrid nature, PNA have widespread application in many areas of 
molecular biology.  
 
To date, in literature only few papers report the characterization of complex PNA-based 
quadruplex and the study of the ability of PNA to form G-quadruplexes represents a 
challenging field for many researchers. For example, Armitage and colleagues 
demonstrated that PNA strands can invade DNA G-quadruplex to form hybrid PNA2-DNA2 
G-quadruplexes (53). For instance, FRET measurements using labelled polymers indicated 
that strands were organized such that the two DNA strands are parallel with each other and 
the 5’-ends of the DNA point in the same direction as the N-Termini of the PNA strands. 
Furthermore, they also observed, from the CD melting profile, that the hybrid G-quadrupled 
had a faster association kinetics compared to the natural counterpart, and it was probably 
due to the lack of negative charges along the PNA backbone and to the electrostatic 
attraction of the positively charged PNA and the anionic DNA (Fig.22).  
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Figure 22: Possible structure of a PNA2-DNA2 hybrid quadruplex. 
 
After Armitage’s paper, Balasubramanian and co-workers reported the formation of 
intermolecular G-quadruplex composed only of four short PNA strands that aligned in an 
anti-parallel fashion (54). Later Armitage showed that also longer sequences were able to 
form either a four-stranded G-q or a two stranded hairpin dimer (55).  
Most recently Giancola and colleagues described the formation of a G-q formed by chimeras 
sequences that contain a single PNA residue at the end of a ODN strand (Fig.23). They also 
demonstrated that the chimeras were more stable of the natural counterparts (56).  
 
 
Figure 23: Structure of DNA/PNA Chimera 
 
Altering the polymer backbone, it is possible new G-quadruplexes with a variety of potential 
applications in supramolecular chemistry, biotechnology and nanotechnology. In addition, 
studies on ODN analogues may lead to a deeper knowledge amount G-quadruplex potential 
and may clarify the structural factors that control issues about the thermodynamics and 
kinetics of the G-quadruplex motif in the parent DNA.  
 
1.5 Aim of my research 
My project is included in this wide context and it is aimed at exploiting the several features 
and applications of oligonucleotides and analogues. In particular, my research activity is 
devoted to unravel the use of oligonucleotides and oligonucleotide analogues in a broad 
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range of fields, which includes the development of new approaches for the simple 
construction of biosensors and the development of novel drug candidates to gene regulation. 
Specifically, my research activity is focused on the synthesis and characterization of suitable 
G-rich oligonucleotides able to form supramolecular structures, the synthesis and 
characterization of new PNA sequences for the development of an innovative approach to 
the treatment of Cystic Fibrosis, and, finally, the synthesis and characterization of a PNA 
Quadruplex for the construction of new K+ sensing probes. 
 
Objective 1. Supramolecular structures from G- Quadruplex 
This part of the PhD research program was focused on the synthesis of suitable G-rich 
oligonucleotides and on of their ability to form supramolecular structures. The formation of 
high-ordered aggregates should depend by the cation species, temperature, pH, 
concentration, sequence, length and polarity of the G-rich ON employed. In this frame, the 
study of all the necessary conditions for the structuring of polymeric species arising from G-
quadruplexes remain a big challenge in the field of self-assembly. 
Recently, in the research group of Professor Piccialli, it was proved that the sequence 
CGGXGGT (where X = T, A, C or G) can form a nanostructure of about 4 nm in length, 
consisting of eight well organized strands. This octamer formation takes place through a 
dimerization process, which is allowed by the 5'-5' stacking of two tetramolecular G-
quadruplex subunits, and assisted by the formation of an unusual G(:C):G(:C):G(:C):G(:C) 
octad arrangement, involving C1 and G2 bases of each CGGXGGT strand. In this context, 
my PhD work has been focused on the synthesis of a novel G-rich sequence and on the 
study of its ability to form supramolecular structures, with the aim to obtain long G-wires 
poly-(Q)n like. 
 
Objective 2.  Peptide Nucleic Acid (PNA) as fascinating tool in gene regulation. 
Encouraged by the positive results given by PNAs, we decided to explore the several 
properties of this molecules in a biological context, by synthetizing new PNA sequences, 13 
and 7 bases long, complementary to a sequence within the promoter of the CFTR gene. The 
aim of our work is to clarify the role of PNAs as new therapeutic agents for all the Cystic 
Fibrosis (CF) cases characterized by mutations that do not completely abolish the protein 
function, with the final goal to improve or resolve a severe CF phenotype by virtue of the 
increased expression of the protein and the increased chloride flow. 
 
Objective 3. Peptide Nucleic Acid (PNA) for the construction of new PNA-based 
Quadruplex scaffold. 
In this context, the aim of my work was to carry on the investigation the infinite potential of 
PNAs, this time not only from a biological point of view, but considering its ability to form 
new PNA-based quadruplex, useful for the construction of new nanomaterials. The 
approach envisaged the preliminary synthesis of a new type of ambident linker, then 
functionalized by short sequences of G-rich sequences of PNA. Through the use of 
spectroscopic techniques, the ability of that molecule to form quadruplex structures was then 
evaluated. This work is aimed at obtaining new types of sensors. 
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Chapter 2 
Synthesis and characterization of new supramolecular structures from G-rich 
oligonucleotide sequences. 
 
2.1 Introduction 
In recent years, DNA and DNA-based polymers have attracted the researchers’ attention for 
their versatile and programmable structure. In particular, in the field of nanotechnology and 
molecular electronics, double strand DNA (dsDNA) has been considered, for a long time, a 
promising building block for the construction of electronic devices, such as conductive wires, 
due to its self-assembling and molecular recognition properties and for its structure that 
allows the charge transport along the molecule (1, 2); on the other hand, recent studies on 
DNA-based systems failed, showing contradictory or irreproducible results (3). 
The possibility to develop advanced systems for the construction of DNA-based wires and 
devices remains a considerable challenge for all the scientific community. 
Among all the possible systems, the most attracting candidate was embodied by G-
quadruplexes for their ability to form higher-order assemblies by multimerization between 
several G-quadruplex units (4–7), confirming their use in the fields of nano-biomaterials and 
nano-biodevices (8–10). Several studies have shown that G-quadruplexes can give rise to 
supramolecular structures such as the most studied “interlocked slipped strands”, 
characterized by intercalation of g-rich strand oligonucleotides (11), and the “g–wires”, in 
which the quadruplex are piled one upon the other by end-to-end stacking (5); the resulting 
superstructure grows along the axis orthogonal to G-tetrad planes and reaches the length 
of thousand nanometers. These structures were extraordinarily stable; heating at 80 °C or 
dissolving in 8 M urea did not denature them (12). One of the identified structural moieties 
required for supramolecular assembly of G-quadruplexes is the presence of a stretch of 
guanines at the 5' or 3' termini of parallel G-quadruplex-forming GROs. The presence of 
even a single base other than G at 5' or 3' termini seems to prevent the dimerization (11). 
Starting from these data, with a paper published on NAR (Nucleic Acid Research) on 2011, 
the research group of Professor Piccialli identified a novel dimerization pathway (13). In 
particular, they observed that the sequence 5’-CGGTGGT-3’ is able to fold in a dimeric 
structure (2Q), that is a highly symmetrical octamer in which the 5’-end cytosine does not 
prevent the adhesive 5’-5’ stacking and acts like an “hydrophobic glue” between the two G-
quadruplex tetramers. The dimerization is allowed by head-to-head stacking between two 
unusual octads (Fig.1). 
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Figure 1: Structural model for the (dCGGTGGT)8 octamer and proposed structure of the 
G2(:C1):G2(:C1):G2(:C1):G2(:C1) octad.  
 
In another paper, they built a small library of G-rich oligonucleotide strands having the 
sequence XGTGYGGT and they demonstrated that, as well as in that case, the dimerization 
occurred and the monomeric quadruplexes formed by d(XGTGYGGT)4 strands formed 
stable quadruplex dimer 2Q-like, especially when X= C or T and Y= T or A (14). 
The aim of my research work is included in this context. The basic idea is to create a stable 
monomeric G-quadruplex having two 5’-CG ends able to polymerize using its two 5’-sticky 
ends and thus to obtain long g-wires like poly-(Q)n exploiting the 5’-5’ π-stacking between 
G(:C) G(:C) G(:C) G(:C) octads formed by 5’-CG ends. So, the 7-mer d(5’-CGG-3’-3’-TGGC-
5’) containing a 3’-3’ phosphodiester bond that reverse the polarity in the strand thus creating 
two 5’-ends, has been synthetized. Thanks to several analytical techniques, such as Nuclear 
Magnetic Resonance (NMR), Size Exclusion Chromatography (SEC analysis), Circular 
Dichroism (CD) and PAGE, it has been proved that the 7-mer formed the quadruplex 
monomeric building block that was able to form long G-wires (Fig.2). 
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Figure 2: Formation of the G-quadruplex building block Q1 and its multimerization into Qn G-wire polymers 
starting from the ODN 5’-CGG-3’-3’-TGGC-5’. 
 
2.2 Results and discussion 
The first step required the synthesis of the 7-mer d(5’-CGG-3’-3’-TGGC-5’) that contains a 3’-
3’ phosphodiester bond that reverse the polarity in the strand thus creating two 5’-sticky 
ends. It has been synthetized by using the solid-phase DNA automated synthesis following 
the standard b-cyanoethyl phosphoroamidite protocols. The inversion of polarity has been 
realized by using different phosphoramidites: the 5’-phosphoroamidites have been used for 
the first four coupling steps, while the 3’-phosphoroamidites have been used for the 
remaining steps. After the synthesis and the purification, the target sequence has been 
dissolved in K+ 1.0 M and subjected to annealing procedure. Its ability to form G-quadruplex 
or G-wires superstructure has been so assessed by means of PAGE and SEC-HPLC 
analysis and spectroscopic techniques.  
 
2.2.1 Page  
In order to get information about the propensity of the sequence 5’CGG3’-3’TGGC5’ to fold 
into a monomeric G-quadruplex (Q1) building block and thus into a polymeric structure poly-
Q type, PAGE experiments have been performed.   
On the following Table, all the samples loaded in the gel have been reported, while Figure 
3 shows the PAGE containing the 7-mer sequence in 1.0 M K+ buffer, (lane 3) in comparison 
with d(TG4T) (lane 1) in 1.0 M K+ buffer, used as the size marker of a tetramolecular 
monomeric quadruplex, and d(CGGTGGT) (lane 2) in 1.0 M K+ buffer, used as the size 
marker of a dimeric quadruplex. The 7-mer sequence (lane 3) migrated like a ladder of bands 
in which the fastest moving band showed the same rate of migration as the monomeric in 
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lane 1 and the 2nd fastest band migrated with the same mobility as the dimeric quadruplex 
in lane 2. The remaining slower bands, in lane 3, pointed to the presence of multimeric 
species the size of which can be approximately evaluated by comparison with single strand 
oligonucleotides used as the size markers (lane 8). 
 
 
Table 1: List of all the samples loaded on the PAGE. 
Figure 3: Electrophoretic mobility of the ODNs under study annealed in 1.0m K+ buffer. 
 
It should be noted that the distance between the two fastest bands of the multimeric mixture 
in lane 3 corresponded to about 32-24 nucleotides (nts) considering the nucleotide 
composition of the markers in lanes 1 and 2 and the oligonucleotide ladder in lane 8. These 
data should exclude the formation of G-wire multimers formed by slipped G-rich strands. In 
fact, in that case the sequential addition of the G-rich 7-mer sequence, would have produced 
closer bands having only 7 nucleotides in migration distance.  
The lanes 4-7 contained the multimeric species isolated by HPLC Size Exclusion 
Chromatography (Figure 5 and related discussion). In particular, the products in lanes 4-7 
corresponded respectively with the monomeric quadruplex (Q1, lane 4), dimeric quadruplex 
(Q2, lane 5), trimeric quadruplex (Q3, lane 6), and tetrameric quadruplex (Q4, lane 7).  
The whole PAGE data suggested that the 7-mer sequence, could self-assemble in 
multimeric species, like poly-Qn, due to the sequential aggregation of a quadruplex building 
block by using its two “adhesive” 5’-CG terminal faces. 
 
2.2.2 SEC analysis 
The 7-mer, annealed in 1.0 M of K+ buffer at single strand concentration of 0.1 mM has been 
analyzed by Size Exclusion Chromatography (SEC-200 Column) and the HPLC profile has 
been reported in Figure 5. The annealed 7-mer migrated as a distribution of product-peaks 
in the range 15-22 min in which the species of low molecular weight (m.w.) had greater 
retention times. To obtain information on the m.w. of the analyzed species, the single strand 
dT7, the monomeric quadruplex d(TG4T) and the dimeric quadruplex d[(CGGTGGT)4]2 have 
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been used as size markers (Fig.5). On the basis of the retention times it appeared that in 
the profile of multimerization products the wide peak at higher retention time could be 
attributed to the single strand 7-mer and the two peaks before could be assigned to a 
monomeric and dimeric quadruplex (Q1 and Q2). The slight difference in retention time 
between the quadruplex d(TG4T)4 and Q1 could be attributed to the lower m.w. of the former 
(24 nts) compared to the Q1 containing 28 nts.   
 
 
Figure 5: HPLC-SEC profiles of 0.1 mM 1 (A), dT7 (B), dTGGGGT (C) and dCGGTGGT (D) annealed in 1.0 
M K+ buffer and stored at 4 °C for 24 h. ss = single strand (left panel); HPLC-SEC profiles of 0.1 mM annealed 
in 1.0 M K+ buffer and stored at 4 °C for 24 h and of Q1, Q2, Q3 and Q4 injected 24 h after their recovering from 
profile A (profiles E-H, respectively). 
 
From these data, it was reasonable to hypothesize that each peak in the HPLC-SEC profile 
was due to a species which differed from those of the adjacent peaks in m.w. corresponding 
to a quadruplex formed by four DNA strands 7 nts long (formed by 28 nts). The HPLC-SEC 
profile of the multimerization of 7-mer was strongly reminiscent of its PAGE ladder profile 
thus further supporting the hypothesis that the 7-mer in K+ buffer forms G-wires species like 
poly-Qn due to the aggregation G-quadruplex building blocks.  
Exploiting the good separation of the peak-species on SEC-200 column, the latest species 
attributed to Q1-Q4 have been isolated and their purity and PAGE mobility checked (Figure 
3, PAGE). The chromatographic analyses on the same SEC column confirmed that the 
product peaks Q1-Q4 resulted almost pure with very low contamination from the adjacent 
 28 
 
2 Supramolecular Structures from G-rich DNA 
product peaks. Furthermore, the PAGE analyses of Q1-Q4 confirmed their purity and the 
correspondence between the ladder bands of the PAGE with the HPLC-SEC product peaks 
distribution of the 7-mer multimerization. 
SEC analysis also revealed a strong connection between the ODN concentration and the 
possibility to form longer G-wires. In particular, at higher concentration (1.6 mM in single 
strand) it was possible to observe more polymeric species (Qn, with n<8) that appeared like 
distinguishable and almost equally populated peaks, while the intense envelope peak at 
higher retention time (Rt = 13.6 min) could be attributable to longer G-wire (Fig.6).  
 
 
Figure 6: HPLC-SEC profile of Qn distribution obtained by annealing 1.6 mM in 1.0m K+ containing buffer. 
ss=single-stranded. 
 
The HPLC-SEC analysis has been also performed to have an insight on the dependence of 
polymerization from temperature. For this reason, samples have been injected at different 
temperatures (25°C, 45°C, 65°C, 85°C) 30 minutes after heating and equilibration. As the 
figure below shows (Fig.7), the profile analyzed at 25°C shows the same distribution of that 
analyzed at 4°C, with the only difference that the species Q2 was the most abundant among 
the others. This means that at room temperature the most favorite species in solution was 
the dimeric species. By heating the samples at 45°C, the situation changed, bringing to an 
increase of the single-strand species and the contextual reduction of multimeric species Qn; 
furthermore, in the peak distribution, the trimeric species became more abundant than the 
dimeric one at this temperature. When the temperature reached 65°C, the profile suggested 
the presence of the single-strand species as the more copious in solution, while it became 
the only species in solution at higher temperature. This suggested that the melting of the 
polymer Qn represented a cooperative event and confirmed the high stability of this 
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supramolecular structures, respect to the G-quadruplex building block, as confirmed through 
CD melting experiments. 
 
 
Figure 7: HPLC-SEC profiles of 0.1 mM 1 annealed in 1.0 M K+ buffer and stored at 4 °C for 24 h before being 
injected 30 min after heating at 25 (A), 45 (A1), 65 (A2) and 85 °C (A3). 
 
2.2.3 Circular Dichroism 
CD spectroscopy provides essential information about conformational properties of DNA, 
including the B, A and Z-form of DNA, guanine quadruplexes, cytosine quadruplexes, 
triplexes and other less characterized structures.  
In the simple case of parallel G-quadruplexes, generated by the association of four 
independent G-rich strands (intermolecular) in which the glycosidic bonds are all anti 
conformation are characterized by a positive ellipticity maximum at 264 nm and a negative 
minimum at 240 nm. The anti-parallel (intramolecular) complexes – containing both syn and 
anti glycosidic - bonds usually possess a positive maximum at 295 nm and a negative 
minimum at 265 nm(15, 16). However, recent studies reported that the structural variability 
of G-quadruplexes could be increased by introducing modifications on the structure, such 
as on the base, sugar backbone, but also by introducing an inversion of polarity site (17, 
18).  
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In Figure 8, the CD spectra of our species has been reported. All the structures, from the 
polymer Qn to the isolated species Q1, Q2, Q3, Q4, showed the same profile, characterized 
by positive signals at 246 nm and 300 nm and a negative one at 270 nm. 
 
 
Figure 8: CD spectra of Qn distribution (dashed curve) and isolated Q1 (black curve), Q2 (green curve), Q3 (red 
curve) and Q4 (blue curve) G-quadruplexes. CD denaturation profiles of 0.1 mM annealed in 1.0 M K+ buffer 
(Qn, purple), and of the G-quadruplexes Q1 (black), Q2 (green), Q3 (red), Q4 (cyan) isolated by HPLC-SEC from 
Qn. All curves were recorded at 268 nm, 24 h after isolation (for Q1-4) and storage at 4°C. 
 
As demonstrated, the CD profiles did not match literature data regarding parallel and 
antiparallel quadruplex so far reported. This was not quite surprising, considering the 
structural features presented in the novel complexes that could be ascribed to the presence 
of the inversion of polarity site. Indeed, despite PAGE and HPLC-SEC data demonstrated 
the exclusive formation of tetra-stranded G-Q building block, the occurrence of the inversion 
of polarity site altered the standard tetrads stacking typical of a parallel quadruplex and 
 31 
 
2 Supramolecular Structures from G-rich DNA 
generated an opposite (clockwise and anticlockwise) disposal of the two tetrads comprising 
the inversion of polarity site.  
Furthermore, in our previous study, it has been demonstrated that for the 2Q-forming 
sequences, the negative minimum at about 290 nm was diagnostic of the presence of a 
head-to-head stacking between the G-Q building block (13). Unfortunately, in this case, the 
strong positive signal at 300 nm didn’t allow us to observe it. 
The thermal stability of the species has been also explored by means of CD-melting 
experiments and results have been reported in Figure 8. The data confirmed the 
extraordinary stability of such complexes, since the thermal stability of the polymeric species 
was higher than that of G-Q building block. 
 
2.2.4 NMR 
NMR spectroscopy has a unique strength in studying DNA G-quadruplex secondary 
structures (19, 20). For this reason, the imino peaks associated with guanines in G-tetrad 
formation give rise to characteristic chemical shifts, around 10.5-12 ppm attributable to the 
exchange- protected imino protons involved in the formation of Hoogsteen Hydrogen bonds 
of G-tetrads (Fig.9). This chemical shift region is completely separated from imino chemical 
shifts from any other DNA conformations, such as duplex DNA, single-stranded DNA, or 
other secondary DNA structures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: N-1 imino protons of guanine bases and the Hoogsteen bond with O-6 carbonyl atom of the near 
guanine. 
 
In the paper previously published by the research group of Professor Piccialli, aimed at the 
study of dimeric G-quadruplexes (2Q), the 1H- NMR spectra shower well-resolved imino 
protons (11.0-12.0 ppm) and intense anomeric protons signals (5.5-6.5 ppm) visible even at 
high temperature (65°C). In our case, instead, the 1H-NMR spectrum of Qn in 1 M K+ buffer 
at 25°C was characterized by the presence of four less-defined imino and anomeric signals 
compared to those shown for 2Q; furthermore, the spectra at higher temperatures have been 
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recorded, and as noticed from the overlapping of the spectra, the imino protons disappeared 
at 65°C (Fig.10). 
 
 
 
Figure 10: imino, aromatic and anomeric protons regions of 1H-NMR spectra of the 7-mer 1.6 mM annealed 
in 1 M K+ buffer and recorded at 25,45,65 and 85°C. The insets show the imino proton regions at 10x 
magnification. 
 
The presence of this imino-protons broadened signal could be ascribed to the presence of 
the inversion of polarity site that created an asymmetric structure that destabilized the G-
Quadruplex structure: the imino-protons were more exposed to the solvent and this speeded 
up the exchange. Furthermore, side-by-side aggregation of G-quadruplex units participating 
in the Qn G-wire distribution could be responsible for the observed anomeric signal 
broadening. 
 
2.2.5 AFM analysis 
AFM spectroscopy has been used to obtain information about the morphology of the 
polymers formed by the 7-mer sequence when annealed in potassium buffer. Figure 11 and 
12 show AFM images of the obtained G-wires grown on muscovite mica. From these images 
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it is possible to noted that Qn quadruplexes interact and self-assemble on mica surfaces in 
different ways depending on their concentration in the starting solution, as previously 
reported in literature (4, 8, 21). In particular, analyzing the 1.6 mM solution (Fig.11), AFM 
images revealed the formation of rod-like shaped aggregates of different lengths (from 21 
up to 166 nm) and widths (not more than 100 nm), whereas their heights were always around 
2 nm. In particular, the rod-like shaped aggregates showed a preferential direction of 
alignment (panel B). The preferred orientation can be ascribed to the interaction between 
G-quadruplexes and the mica surface. The homogeneous values of heights recorded 
suggested the formation of self-assembled monolayers in the x,y plane owing to the 
evaporation of the buffer solution, which promoted lateral and longitudinal aggregation of G-
quadruplexes, the first one being favored by side-packing. On the other hand, analyzing the 
1.6 µM solution (Fig.12), AFM images suggested the formation of thinly distributed 
aggregates, even if the orientation was preserved. The aggregates showed the same length 
of those shown in the concentrated solution, whereas the widths were smaller, never 
exceeding 30 nm. The heights were always about 2 nm as before. This result confirmed a 
side-packing mechanism in the assembly of G-structures during evaporation of the solution 
and confirmed the hypothesis of spontaneous formation of a monolayer. Furthermore, the 
longitudinal aggregation was competitive compared with the lateral one, owing to steric 
conditions during the evaporation. 
 
 
Figure 11. AFM topography images of dried samples at 1.6 mM concentration deposited on a freshly cleaved 
mica surface: panel A shows a dense population with heights all lower than 10 nm (the scale bar is 1 µm); 
 34 
 
2 Supramolecular Structures from G-rich DNA 
panel B shows a magnified AFM image of the same sample; the colored areas underline the structures with 
heights higher than 1.488 nm (the scale bar is 200 nm); panel C shows statistics referred to image in panel B. 
 
 
Figure 12. AFM images of dried samples at 16 µM concentration deposited on a freshly cleaved mica surface: 
panel A shows topographic image of a population sparser than in Figure S7 with heights lower than 6 nm (the 
scale bar is 250 nm); panel B shows the AFM error signal deflection of the same sample, the minimum and 
maximum deflection in the measurements in the side panel show structure widths of 24 nm and 28 nm, 
compatible with a tip radius of about 10 nm (scale bar is 250 nm); panel C shows a magnified topographic 
image of panel A, measurements shows that structure is 52 nm long, 22 nm wide and 1.8 nm high (scale bar 
is 250 nm). Also in this case a tip radius of curvature of about 10 nm must be taken in account. 
 
2.3 Conclusions 
The present study demonstrates that the formation of a DNA based nanostructure consisting 
of polymer of a tetramolecular G-quadruplexes can occur when the DNA sequence CGGT3’-
3’GGC bearing two 5’CG-ends is annealed in the presence of K+ ions. The two 5’-ends can 
be obtained by simply incorporating a 3’-3’ inversion of polarity. By means of PAGE, HPLC, 
CD, NMR and AFM analyses it is possible to demonstrate that DNA polymers could be 
obtained. This findings adds further possibilities for the design of novel quadruplex-based 
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DNA functional nanostructures, and further complexity to the mechanism of folding and 
assembly of G-rich sequences.  
However, the structuring of polymeric species from G-quadruplexes remain a big challenge 
in the field of self-assembly, so further studies will be still performed in order to better control 
process of multimerization of the G-quadruplex building block. 
 
2.4 Experimental Methods 
2.4.1 DNA synthesis and Purification 
DNA sequences d(TGGGGT) and d(CGGTGGT) were chemically synthesized with an 
Expedite 8909 DNA synthesizer (PerSeptive Bio systems, USA) using a universal CPG 
support purchased from Glen Research. The syntheses were performed by adopting the 
standard β-cyanoethyl phosphoramidite chemistry at 10–15 mM scale and the products 
were purified as previously described (22). The synthesis of d(5’-CGGT-3’–3’-GGC-5’) was 
performed with the same DNA synthesizer. The inversion of polarity site within the sequence 
was achieved by initially assembling the 5’-CGGT-3’ tract by using 5’-phorphoramidites and 
then the 3’-GGC-5’ tract with standard 3’- phosphoramidites. After completion of the ODN 
sequence, the support was treated with concentrated aqueous ammonia at 55°C for 15 h. 
The combined filtrates and washings were concentrated under reduced pressure and 
purified through HPLC (JASCO PU2089 pumps equipped with the JASCO 2075 UV 
detector) with an anion exchange column (Macherey–Nagel, 1000-8/46, 4.4V 50 mm, 5 mm) 
using a linear gradient from 0 to 100% B in 30 min, flow rate =1 mLmin-1 and detection at 
260 nm (buffer A: 20 mm NaH2PO4 aq. solution pH 7.0, containing 20% (v/v) CH3CN; buffer 
B: 20 mm NaH2PO4 aq. solution pH 7.0, containing 1m NaCl and 20% (v/v) CH3CN). 
2.4.2 Annealing Procedure 
The ODN concentrations were determined in water by measuring the absorbance at 260 nm 
at 908C by using the nearest-neighbor calculated molar extinction coefficient of 5’-
CGGTGGC-3’ (e= 63100m-1cm-1). The 0.1 and 1.6 mm solutions of 1 were obtained by 
dissolving the lyophilized sample in 900 mm KCl and 100 mm KH2PO4. The samples were 
annealed by heating at 90°C for 10 min and then quickly cooling to 4°C. After the annealing 
procedure, the samples were stored at 4°C before measurements. 
2.4.3 PAGE 
Native gel electrophoresis experiments were performed on 20% polyacrylamide gels 
containing TBE (8.9 mM Tris, 8.9 mM borate, 0.2 mM EDTA, from BIORAD) and 30 mM 
KCl, at room temperature, 120 V for 2 h. The ODN samples, annealed at 1.6 mM single 
strand concentration in 1.0m K+ buffer, were diluted at 0.6 mM loading concentration just 
before the PAGE runs. Glycerol was added (10% final) to facilitate sample loading in the 
wells. The bands were finally visualized by ethidium bromide staining in a Bio-Rad 
Laboratories Gel DocTM XR+ image system. 
2.4.4 HPLC-SEC analyses and isolation of Qn species 
HPLC-SEC analyses and purifications were performed with a ReproSil 200 SEC column 
operating in the MW range of 2000–70000 Dalton (Dr. Maisch GmbH, 300V8 mm, 5 mm) 
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eluted with 90 mM KCl and 10 mM KH2PO4/CH3CN (80:20, v/v), flow rate 0.5 mLmin-1, 
detector at 260 nm. The analyses were performed at room temperature. 
2.4.5 Circular Dichroism 
CD spectra and CD melting profiles were recorded with a Jasco 715 CD spectrophotometer 
(Jasco, Tokyo, Japan) equipped with a Jasco JPT423S Peltier temperature controller in 1 
mm optical path quartz cuvettes (100 nmmin-1 scanning speed, 1 s response time). The 
spectra were recorded in triplicate at 4°C from 220 to 320 nm. CD samples were prepared 
in potassium buffer (90 mM KH2PO4 and 10 mM KCl) at 20 mM final single strand 
concentration. The buffer baseline was subtracted from each spectrum and the spectra were 
normalized to have zero at 320 nm. CD melting curves were registered at 268 nm, 1°Cmin-
1 heating rate, temperature range 5–90°C. 
2.4.6 NMR spectroscopy  
NMR data were recorded with a Varian UNITYINOVA 500 MHz spectrometer equipped with a 
broadband inverse probe with z-field gradient. The data were processed by using the iNMR 
software package (http://www.inmr.net). One-dimensional NMR spectra were acquired as 
16384 data points with a recycle delay of 1.0 s at 25, 45, 65, and 85°C and the spectra were 
apodized with a shifted sine bell squared window function. Water suppression was achieved 
by including a double pulsed-field gradient spin-echo (DPFGSE) module in the pulse 
sequence prior to acquisition. NMR samples were prepared at the concentration of 1.6 mM 
single strand in 200 mL of H2O/D2O 9:1 containing 900 mM KCl and 100 mM KH2PO4. 
2.4.7 AFM 
A XE-100 Park Systems instrument was used for the AFM imaging of Qn G-wires. Surface 
imaging was obtained in non-contact mode by using 125 mm long silicon/aluminium-coated 
cantilevers (PPPNCHR 10m; Park Systems; tip radius lower than 10 nm), with a resonance 
frequency of 200 to 400 kHz and nominal force constant of 42 Nm@1. The scan frequency 
was typically 0.5 Hz per line. When necessary, the AFM images were processed by 
flattening to remove the background slope, and the contrast and brightness were adjusted. 
Muscovite mica of about 1 cm 2 surface was used as the substrate in the AFM study. 
Muscovite mica surfaces are typically used as AFM substrates owing to their perfect 
cleavage along a <001> plane, yielding large atomically flat areas. Mica consists of layers 
of an aluminium phyllosilicate lattice ionically bonded through interstitial K+ ions. Upon 
cleavage, the K+ ions are highly mobile and are readily exchanged with divalent cation 
species at the solid–liquid interface. This exchange results in a positive overcharging of the 
mica surface, which enables the deposition of molecules that hold a net negative charge, 
such as DNA. Moreover, the positive charge distribution after cleavage enables a super-
hydrophilic surface that guarantees a lower interaction between suspended biomolecules 
during the evaporation of aqueous solvent. Mica was freshly cleaved by using adhesive tape 
prior to each deposition to establish its cleanliness. Aliquots (2 mL) of the DNA/imaging 
buffer were directly deposited by casting onto freshly cleaved muscovite mica. After 2 min, 
every sample was gently washed with deionized water and then dried by evaporation at 
room temperature under a ventilated fume hood. 
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Chapter 3 
Target Protector PNA as a new tool in the treatment of Cystic Fibrosis 
 
3.1 Introduction 
Cystic fibrosis (CF) is one of the most common serious genetic diseases (1, 2). A person 
suffering from CF produces thick, sticky mucus, which clogs the lungs (3), causes repeated 
infection and difficulty breathing. In addition to breathing problems, pancreas does not 
produce the enzymes (4) resulting in a lack of food digestion, diarrhea, malabsorption, 
growth retardation in children and poor nutritional status in adults. The progression of 
pancreatic damage with age often leads to a form of diabetes. Other events may involve the 
intestines, liver, nasal cavity and, in males, vas deferens (5). For these reasons it is a life-
threatening disorder. 
CF is due to a defect in the CFTR gene. This gene has been identified and localized on the 
Chromosome 7. The most common mutation, ΔF508, is a deletion of three nucleotides 
resulting in the loss of one phenylalanine at position 508. This gene expresses the CFTR 
protein that controls the movement of salt and water in and out of body's cells. In people 
who suffer from CF, the malfunctioning of the CFTR protein prevents the chloride ions and 
water from escaping the epithelial cells and this leads to the formation of a dense and 
dehydrated mucus that obstructs all internal ducts (especially in the lungs and the pancreas) 
(6).  
 
 
Figure 1: CFTR protein functions. 
 
A child affected by cystic fibrosis inherited a defective gene from both the father and the 
mother who are silent carriers of the mutated gene. In Italy there is one healthy carrier every 
25 people. When a mother and father are both CF carriers, each pregnancy has a 1 in 4 (or 
25%) chance for the baby to have cystic fibrosis (1). 
CF has not had cure yet, even if treatments have greatly improved life expectancy in the 
past decades. They included rehydration of the airway surface, mucolytic, anti-inflammatory 
agents, anti-infective agents; All these approaches are symptomatic, and do not directly 
target CFTR protein activity and/or the defective gene. Among all these strategies, only the 
gene therapy targeting the mutated CFTR protein has shown meaningful efficiency to 
provide hope to the patients. A CFTR potentiator (Ivacaftor) has been developed by Vertex 
Pharmaceuticals and has been recently approved for the treatment of patients carrying the 
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p.Gly 551Asp mutation (2-5% of all patients). To date, Ivacaftor in combination with 
Lumacaftor provided a benefit for patients with cystic fibrosis homozygous for the Phe508del 
CFTR (7). 
In this context, the discovery of new therapies for the treatment of cystic fibrosis has become 
a challenge for many researchers. Since many CF patients retain a residual channel activity, 
an approach could be the stabilization of the CFTR messenger RNA (mRNA), by increasing 
the amount of the protein and resulting in a net chloride channel increase (8). Thus, several 
groups have suggested miRNA-targeted therapies. 
miRNAs are small (20 to 24 nucleotides) noncoding RNAs that regulate post-transcriptional 
gene expression; miRNAs predominantly down-regulate the expression of their target genes 
by pairing with the 3’-untranslated regions (UTRs) of target mRNAs, thereby inducing mRNA 
degradation or translation inhibition (9). 
Since CF has been associated with the deregulation of specific microRNAs, many 
approaches involve the use of oligonucleotide (ON) analogues which being complementary 
to miRNAs are able to reduce or inhibit their activity (10).  
In this context, Yin and coworkers have explored the ability of a PNA sequence to selectively 
inhibit miRNA-4661-3p (11).  
The promising results reported in this kind of approach, led the group of Professor Piccialli 
to propose the use of peptide nucleic acids (PNAs) as inhibitors of a miRNA involved in the 
pathological progress of Cystic Fibrosis (12, 13).  
This approach arises from the discovery made by the research group of Professor Castaldo 
of a mutation in the 3’-UTR of CFTR responsible for the down regulation of CFTR because 
of its enhanced affinity towards a miRNA, the miR-509-3p(14). 
Starting from this finding, in these previous works, two negatively charged PNAs, 14 and 7 
bases long, conveniently modified at their termini, in order to allow their delivery and 
individuation within the cells, and complementary to the 5’-terminus of miR-509-3p, were 
proposed for the selective inhibition of the miRNA. The in vitro studies demonstrated that 
both PNAs were able to recognize the target within the cells. 
Notwithstanding the successful results, this approach gives as a side effect to prevent 
miRNA from playing other biological roles. Since they regulate multiple genes, microRNA 
inhibitors will have pleiotropic effects. 
In literature, the target protector approach has already been reported; it describes the use 
of target protector oligonucleotides for the treatment of CF. The oligonucleotides work by 
masking microRNA binding sites in the 3’UTR of the CFTR messenger with the aim to 
depress CFTR expression specifically. With target site blockers addressing this site they are 
able in adult lung cells to achieve 3-6 fold increase in luciferase activity (15). 
Starting from this idea, our approach involves the replacement of the target protector 
oligonucleotides with the PNA. Once identified the seed region of mi-509-3p in the CFTR 
3’UTR region, two PNA sequences, 13 and 7 bases long that were complementary to a 
sequence within the promoter of the CFTR gene have been synthetized.  
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Figure 2: The two approaches for the treatment of CF; on the left the anti-miRNA approach and, on the right, 
our proposed approach. 
3.2 Results and Discussion 
The first step required the synthesis and characterization of new PNA sequences, 13 and 7 
bases long, complementary to a sequence within the promoter of the CFTR gene. The 
sequences were synthesized through the Fmoc-solid phase protocol on a Rink amide resin 
and were equipped with a peptide tail composed by two glycines and two negatively charged 
serines at the C end with the aim of improving both the water solubility and the cellular 
uptake of the PNA molecules. After the synthesis, the oligomers were detached from the 
support, lyophilized and characterized by mass spectrometry; thereafter, the PNAs 
sequences were dissolved in phosphate buffered saline (PBS) and subjected to annealing 
procedure. Their ability to interact with the target sequence on the CFTR mRNA was 
assessed by means of spectroscopic techniques and molecular dynamics studies. 
Since DNA is more resistant against nucleases and does not require any chemical 
modification for handling that could alter its recognition properties, the spectroscopic studies 
were performed using the corresponding 13-mer DNA model sequence (ODN in Table 1); 
furthermore, considering the higher binding affinity of RNA strands compared to DNA 
strands towards complementary PNAs, the stability data obtained by using the ODN model 
were probably underestimated (16).  
 
Name Sequence 
3’ UTR of CFTR mRNA G-A-A-G-A-A-G-C-A-C-C-A-A-U-C-A-U-G-A- 
DNA model sequence (ODN) G-A-A-G-C-A-C-C-A-A-T-C-A 
PNA 1 (C -> N)          G-S(P)-S(P)-G-c-t-t-c-g-t-g-g-t-t-a-g-t 
PNA 2 (C -> N) G-S(P)-S(P)-G-g-g-t-t-a-g-t 
PNA 3 (C -> N) G-S(P)-S(P)-G-c-a-g-t-t-g-t-c-t-g-t-g-t 
PNA 4 (C -> N) G-S(P)-S(P)-G-t-t-g-g-a-g-t 
Table 1: Sequences of CFTR messenger RNA, DNA model sequence and PNA synthetized for the studies. 
 
3.2.1 CD and CD melting analyses 
Circular dichroism measurements are useful in the characterization of nucleic acid 
secondary structure and in the study of hybridization events (17). In fact, information about 
the secondary structure could be obtained since CD measurements are sensitive to the 
base-pair geometry in the helix (18) 
In this case, CD spectra of each component alone and of the mixture were reported in Figure 
3, and confirmed the capability of the PNA to bind the target: the dichroic profile of the 
mixture was typical of an antiparallel DNA/PNA heteroduplex, showing maxima around 220 
and 270 nm and minima at 245 nm. As expected, the CD melting analysis revealed the 
greater stability of the longer PNA1/ODN heteroduplex relative to that of the shorter one 
(PNA2/ODN), confirming, in both cases, the interaction between the molecules. In particular, 
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the Tm values of the PNA1/ODN and the PNA2/ODN were of 66°C and 35°C respectively 
(Fig.4).  
 
Figure 3: On the left, CD spectra of PNA 1 (green line), ODN (blue line) and 1/ODN mixture (1.5:1) (violet line) 
and on the right, CD spectra of PNA 2 (green line), ODN (blue line) and 2/ODN mixture (1.5:1) (violet line). 
 
 
Figure 4: CD melting profile of 1/ODN mixture (1.5:1) (violet dashed line) and 2/ODN mixture (1.5:1) (violet 
dotted line). The curves were obtained by monitoring the variation of absorbance at 266 nm for 1/ODN 
mixture and at 264 nm for 2/ODN mixture at a heating rate of 0.5 °C/min. 
 
3.2.2 UV studies 
UV experiments were performed to get information about the propensity of the PNAs to form 
heteroduplexes with the ODN sequence, by exploiting the hypochromic effect resulting from 
the formation of the PNA/ODN heteroduplexes. Both spectra were characterized by a 
maximum at around 260 nm, typical of nucleobases; but in the case of the PNA1/ODN 
complex (violet curve in Figure 5), lower values of absorbance than the arithmetic sum of 
each component alone (black curve in Figure 5) were recorded, thus confirming the 
occurrence of stacking interactions and the formation of the heteroduplex. Instead, in the 
case of the shorter PNA 2, the UV spectrum of its complex with the ODN (violet curve in 
Figure 5) recorded the same values of absorbance than the arithmetic sum of its 
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components was recorded, in agreement with the experimental lower stability of the shorter 
PNA 2/ODN heteroduplex. 
 
Figure 5: on the left, UV spectra of PNA 1 (green line), ODN (blue line), 1/ODN mixture (1.5:1) (violet line) and 
the arithmetical sum (black line); on the right, UV spectra of PNA 2 (green line), ODN (blue line), 2/ODN mixture 
(1.5:1) (violet line) and the arithmetical sum (black line). 
 
A possible explanation to this behaviour could be found in the lower number of bases 
involved in the Watson-Crick (W-C) base pairing for the 2/ODN complex relative to the total 
number of bases in the two strands (PNA + ODN). 
 
3.2.3 Molecular Dynamics  
Molecular dynamic calculations were performed to check and to obtain information about 
the structural features of the heteroduplexes PNA1/RNA and PNA2/RNA.  The structural 
analyses revealed low RMSD values and the convergence into a main structure for either 
1/RNA or 2/RNA simulations (Fig.6).  
 
 44 
 
3 Target Protector PNA in Cystic Fibrosis 
 
Figure 6. Superposition of average structures of the main represented cluster for 1/RNA (A) and 2/RNA (B), 
with relative RMSD in Å calculated on heavy atoms. Duplexes regions are represented in licorice colored by 
atom type with carbon colored by MD run (PNA 1: Blue, Run 1; Orange, Run 2; Light green, Run 3. PNA2: 
Green, Run 1; Cyan, Run 2; Magenta, Run 3) and other atoms by standard convention (Oxygen in red, Nitrogen 
in blue, Phosphate in orange and Hydrogens in white). RNA single strand flanking regions and the tetrapeptide 
Gly-SerP-SerP-Gly are represented in spheres coloured by MD run. 
 
Detailed analysis of the local base pair step parameters (twist, roll, tilt, shift, slide and rise), 
helical parameters (inclination) and the torsion angles of RNA and PNA monomers reported 
high similarity with PNA/RNA heteroduplexes structures determined by NMR (PDB ID 176D 
(19)) and by XRAY (PDB ID 5EME and 5EMF) (20), with few noticeable deviations (Table 
2). 
 
 
Table 2: Helicoidal parameters of the average structure of the more representative cluster of 1/RNA and 2/RNA 
MD simulations. Standard deviations are reported in brackets. 
 
In particular, PNA 1- and 2-containing helices were slightly unwound and less bent with 
respect to the experimentally determined structures of PNA/RNA heteroduplexes, as 
indicated by the lower twist values. On the other side, the helices appeared slightly less bent 
than both NMR and XRAY derived structures because of lower roll values. The roll 
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parameter, indeed, indicated the degree of rotation with respect to the main helical axis, 
and, therefore, higher roll values are associated to higher perturbation of the coplanarity of 
bases, inducing the bending of the helix. The analysis of torsion angles of RNA and PNA 
backbones confirmed structural features very similar to those of reference experimental 
structures. RNA strand torsion angles closely resembled those found in the reference 
PNA/RNA NMR structure and in the canonical A-RNA structure. On the other side, as 
previously reported (21), (22)(23, 24), the PNA strand showed higher flexibility, particularly 
in torsion angles α and ε, that may assume two sets of values -100° and 100° and -20° and 
180°, respectively. Taken together, these results indicated that the negatively charged 
tetrapeptide slightly affects the structural features of the heteroduplexes with respect to 
experimentally determined PNA/RNA heteroduplexes. 
 
3.2.4 Biological Assays 
Once demonstrated the ability of PNA to form a stable heteroduplex with the DNA, we 
examined its potential of being a miR-509-3p competitor in a biological context, by binding 
the seed region of the miRNA in the CFTR gene. Thus, we co-transfected different 
combinations of pLuc-CFTR-3UTR vector, (a reporter luciferase construct sensitive to the 
miR-509-3p mimic action due to the presence of the 3UTR of the CFTR gene), PNA strands, 
miR-509-3p mimic and corresponding PNA scrambled controls. The co-transfection of miR-
509-3p in the presence of the scrambled PNA 3 reduced luciferase expression leading to a 
residual activity up to 35%. The co-transfection of PNA 1 in the presence of miR-509-3p 
rescued the luciferase activity by up to 70% (Figure 8), thus indicating that PNA1 could 
counteract the inhibitory effects of miR509-3p. As expected, the addition of the PNA1 alone 
did not produce any effect on the luciferase expression, thus confirming that the binding of 
PNA1 to the 3’UTR of CFTR mRNA did not interfere with the expression of the CFTR protein. 
A different behavior was observed for the PNA2: while spectroscopic and MD data revealed 
that it was able to form a stable heteroduplex with the ODN, from a biological point of view, 
it was not able to rescue the luciferase activity. 
 
Figure 8: Effect of PNA 1 on miR-509-3p activity. A significant rescue of the luciferase expression was 
observed using 1. Contrary, any rescue was observed using the scrambled PNA 3. *P values < 0.006 
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Figure 9: Effect of PNA 2 on miR-509-3p activity. No significant rescue of the luciferase expression was 
observed using 2. And as expected, any rescue was observed using the scrambled PNA 4. 
3.3 Conclusions 
In this work, we presented the use of PNA sequences as target protector agent. The 
chemical features of PNA make it a versatile tool in the field of gene modulation and, to date, 
several works have witnessed its potency in this context. However, beyond the classical and 
consolidated application as antigene, antisense and anti-miRNA agent, another interesting 
and less explored field can benefit from its properties, the miRNA target protectors, with the 
aim to increase the expression of CFTR in CF. The negatively charged PNAs 1 and 2, 
conveniently modified at their C-ends and fully complementary to the 3’UTR region of the 
CFTR mRNA recognized by the seed region of miR-509-3p, were synthesized and 
characterized. To demonstrate the sequence dependent activity of 1 and 2, two other PNAs 
(3 and 4, Table 1), containing scrambled sequences of 1 and 2 respectively, were designed 
and synthesized. A combination of spectroscopic techniques was firstly used to explore the 
capability of our PNA to bind the RNA target and the successful findings obtained were then 
confirmed by the biological assays. Furthermore, this type of approach has the advantage 
of being relatively mutation-independent. For this reason, it would be sufficient to increase 
the expression of a protein, even if mutated, to exceed the threshold of minimal activity 
needed to obtain an optimal clinical phenotype. 
 
3.4 Materials and Methods 
3.4.1. General Methods 
All reagents and solvents were obtained from commercial sources and used without further 
purification. Phosphoramidites for DNA syntheses were purchased from Glen Research 
(Sterling, VA, USA). The ODNs were assembled by using the PerSeptive Biosystems 
Expedite DNA/RNA 8909 synthesizer using phosphoramidite chemistry. Peptide nucleic 
acid monomers were purchased from Link technologies (Bellshill, Lanarkshire, UK). Fmoc-
L-Ser[PO(OBzl)OH]-OH was purchased from Iris Biotech GmbH (Marktredwitz, Germany). 
 47 
 
3 Target Protector PNA in Cystic Fibrosis 
Fmoc-Gly-OH and the MBHA resin (1% divinylbenzene, 200–400 mesh, 0.5 mmol/g loading) 
were purchased from Sigma-Aldrich (Saint Louis, MO, USA). The reactions on solid phase 
were performed using ISOLUTE®single fritted reservoirs (SG), 20 µm PE (polyethylene), 
equipped with tube caps and luer tip caps Biotage (Uppsala, Sweden) which were shaken 
in a Multi-reax vibrating shaker Heidolph (Schwabach, Germany). High performance liquid 
chromatography (HPLC) analyses and purifications were carried out on a Jasco UP-2075 
Plus pump equipped with a Jasco (Easton, MD, USA) UV-2075 Plus UV detector using a 
4.8 × 150 mm C-18 reverse-phase column (particle size 5 µm) eluted with a linear gradient 
of CH3CN containing 0.1% (v/v) trifluoroacetic acid (TFA) in H2O containing 0.1% (v/v) TFA 
(from 0 to 100% in 45 min, flow 1.2 mL/min). UV spectra were recorded on a Jasco V-530 
spectrophotometer (Jasco). CD spectra were performed on a Jasco 1500 
spectropolarimeter (Jasco) equipped with a Jasco PTC-348 WI Peltier-type temperature 
controller in a 0.1 cm path length cuvette. ESI-MS experiments were performed on an 
Applied Biosystems (Warrington, Cheshire, UK) 4000 QTRAP mass spectrometer in positive 
ion electrospray mode, dissolving the compounds in H2O containing 0.1% (v/v) formic acid.  
3.4.2. DNA Synthesis and Analysis  
The oligonucleotide 5’GAAGCACCAATCA3’ was synthesized using solid phase β-cyanoethyl 
phosphoramidite chemistry. After the synthesis, the oligomers were detached from the 
support and deprotected by treatment with concentrated aqueous ammonia at 55◦ C for 12 
h. The combined filtrates and washings were concentrated under reduced pressure, 
redissolved in H2O, and analyzed and purified by HPLC on a Macherey Nagel (Düren, 
Germany) Nucleogel SAX column 1000-8/46 using buffer A: 20 mM NaH2PO4 aqueous 
solution, pH 7.0, containing 20% (v/v) CH3CN; buffer B: 1 M NaCl, 20 mM NaH2PO4 aqueous 
solution, pH 7.0, containing 20% (v/v) CH3CN; a linear gradient from 0% to 100% B in 30 
min and flow rate 1.2 mL/min were used. The oligomers were collected and successively 
desalted by Sep-Pak cartridges (C18). The isolated oligomers were >99% pure (NMR). The 
ODN concentration was determined spectrophotometrically at λ = 260 nm and 90◦ C, using 
the molar extinction coefficient ε = 200.9 cm−1 ·mM−1 calculated by the nearest neighbor 
mode. 
3.4.3. PNA Synthesis and Analysis  
PNA sequences were synthesized using the Fmoc-solid-phase strategy. Fifty milligrams of 
MBHA resin (0.5 mmol/g), after swelling in CH2Cl2 for 30 min and DMF washings, were 
treated with a solution of 20% piperidine in DMF for 10 min. After washings in DMF (×5), the 
resin was reacted with Fmoc-Gly (5 eq. in NMP 0.2 M), 1-[Bis(dimethylamino)methylene]-
1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) (5 eq. in DMF 0.2 M) 
and N,N-Diisopropylethylamine (DIPEA) (5 eq.)/lutidine (7.5 eq.) for 45 min at room 
temperature. Couplings of Fmoc-L-Ser[PO(OBzl)OH]-OH were achieved using the following 
conditions: Fmoc-Ser monomer (8 eq. in NMP 0.2 M), HATU (8 eq. in DMF 0.4 M), and 
DIPEA (8 eq.)/lutidine (12 eq.) for 15 h at room temperature. After the serine couplings, a 
further glycine residue was attached on the N-terminal of the serine tract following the 
previously described coupling with the glycine monomer. PNA monomers were reacted 
using the following conditions: monomer building block (10 eq. in NMP 0.2 M), HATU (10 
eq. in DMF 0.2 M), and DIPEA (10 eq.)/lutidine (15 eq.), 45 min at room temperature. After 
each coupling step, capping with Ac2O in the presence of pyridine was performed for 20 min 
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at r.t. Fmoc group was removed by a treatment with a 5% 1,8-Diazabicyclo[5,4,0]undec-7-
ene (DBU) in DMF solution (5 min). In the case of Fmoc-Ser amino acids, the basic treatment 
was prolonged (20 min). At the end of synthetic cycles, the PNAs were cleaved from the 
solid support by treatment with TFA/anisole/ethanedithiol (9:1:1; v/v/v) for 4 h and the 
products were precipitated with cold diethyl ether. The precipitates were recovered by 
centrifugation, washed twice with diethyl ether, dissolved in water, and finally lyophilized. 
PNAs 3 and 4, chosen as the negative control and bearing the same functionalization of 
PNAs 1 and 2, were synthesized using the same standard Fmoc-solid-phase strategy. The 
PNAs were obtained with a 48–50% overall yield (94–95% medium yield for each coupling 
as estimated by Fmoc spectrophotometric measurements). The crude sample was purified 
by semipreparative reverse phase HPLC (see General methods). The collected fractions 
were lyophilized and the final pure product was characterized by ESI-MS (positive mode): 
ESI-MS (m/z) calcd. for PNAs 1 and 3 4003.4; found [M+ 3H]3+ 1335.5, [M+ 4H]4+ 1002.0; PNAs 
2 and 4 2411.8; found [M+ 2H]2+ 1206.9, [M+ 3H]3+ 805.0. The amount of each PNA sample 
dissolved in pure water was estimated by quantitative UV at 90◦ C using the following molar 
extinction coefficients: PNAs 1 and 3 ε = 126.5 mL·µmol−1 ·cm−1; PNAs 2 and 4 ε = 75.2 
mL·µmol−1 ·cm−1 and DNA ε = 134.2 mL·µmol−1 ·cm−1.  
 
 
3.4.4. Preparation of DNA/PNA Heteroduplexes (Annealing Procedure)  
The PNA/ODN heteroduplexes (1.5:1) were obtained by dissolving the mixture of the 
samples at the concentration of 2.0 × 10−5 M in 100 mM PBS and by heating the solution to 
90◦ C for 5 min and then slowly cooling to room temperature over 12 h.  
3.4.5. UV 
The UV spectra were recorded with a Jasco V-530 UV spectrophotometer, in 100 mM PBS 
buffer at the concentration of 20 µM. They were recorded at 20 ◦C (λ = 220–310 nm, 400 
nm/min scanning speed, 2.0 nm bandwidth).  
3.4.6. CD and CD Melting Studies  
The CD spectra were recorded with a Jasco 1500 spectropolarimeter equipped with a 
Peltier-type temperature controller (PTC-348 WI) in a 0.1 cm cuvette, in 100 mM PBS buffer 
at the concentration of 20 µM. They were recorded at 5 ◦C (λ = 220–310 nm, 200 nm/min 
scanning speed, 2.0 nm bandwidth) and averaged over three repetitions. A buffer baseline 
was subtracted from the CD spectra and the spectra were normalized to have zero at 320 
nm. Thermal denaturation experiments were also carried out in the temperature range of 5–
90 ◦C by monitoring the CD values at 266 nm for PNA 1/ODN and at 264 nm for PNA 2/ODN 
at a heating rate of 1.0 ◦C/min. 
3.4.7. Molecular Dynamics (MD) Simulations  
The initial structures were built following the same procedure described in (13), starting from 
the NMR structure of the RNA(GAGUUC)/PNA(GAACTC) duplex (PDB-ID 176D) (18). The 
correct sequence was obtained by mutating the bases using the X3DNA software (25). Each 
heteroduplex was built including three flanking bases on both the 30 and 50 ends of the 
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RNA segment. Thermalization of the duplex and production of MD trajectories were obtained 
using Amber 15 suite. The leap module of Ambertools 15 was used to perform the 
parameterization of the systems, using the ff14SB force field (AMBER99SB and 
frcmod.ff14SB for peptide + ff99bsc0_chiOL3 for RNA) (26–28), and the Sanders et al. 
parameters for PNA (24), whereas the parameters for serine phosphate were taken from 
(24). TIP3P water molecules were added with at least a minimum spacing of 14.0 Å between 
the edge of the box and the molecules. Na+ counterions were added to neutralize the 
system. The system was geometrically minimized in three steps: (i) optimization of hydrogen 
atoms with 2000 steps of steepest descent algorithm and 8000 steps of conjugate gradient 
algorithm, (ii) optimization of water molecules and counterions with 2000 steps of steepest 
descent and 18,000 steps of conjugate gradient, and (iii) optimization of the whole system 
with 2000 steps of steepest descent and 8000 steps of conjugate gradient. The equilibration 
of the system was performed using the protocol described in (25). Briefly: (i) the system was 
thermalized in 240 ps, raising the temperature from 10 K to 298 K with a time step of 1 fs, 
and applying inter and intra-strand constraints of 20 kcal·mol−1 ·Å−2 in order to preserve, 
respectively, the W-C base pairs and the torsional angles of the RNA sugar; ii) the 
constraints were gradually removed from 20 kcal·mol−1 ·Å−2 to 0.1 kcal·mol−1 ·Å−2 in 240 ps 
at constant pressure (1 bar) and temperature (298 K). Finally, an equilibration step of 500 
ps was run without constrains. Production runs were performed using a time step of 2 fs. 
The SHAKE algorithm was used for all hydrogen atoms in conjunction with periodic 
boundary conditions at constant pressure and temperature. Particle mesh Ewald was used 
for the treatment of long range electrostatic interactions, and a cut-off of 9 Å was used for 
non-bonded interactions. Each system was studied by means of 300 ns MD simulation runs 
in triplicate with random seeding for the initial velocities. To investigate more deeply the 
stability of the PNA 1/RNA system, we extended one run to 600 ns, for a total of 1200 ns for 
the PNA 1/RNA and 900 ns for the PNA 2/RNA. The analysis of the structure was carried 
out using the software Curves+ (29). The visualization of the trajectories and related 
snapshots were performed with Pymol andVMD, while the trajectory post-processing 
analysis was performed using Ambertools15. Cluster analysis was performed through a 
hierarchical agglomerative (bottom-up) approach using a root-mean-square (RMS) metric 
comparing the heavy atoms in the central duplex base-pairs. Correlation analysis was 
performed calculating the Pearson correlation coefficient on torsion angles sampled each 
0.01 ns.  
3.4.8. Cell Line, Construct, and Transfections  
A549 human lung carcinoma cells were purchased from ATCC (Manassas, VA, USA). The 
cells were maintained in Dulbecco’s modified Eagle’s medium (Gibco Invitrogen, North 
Andover, MA, USA) with 10% heat inactivated fetal bovine serum (HyClone Laboratories, 
South Logan, UT, USA) without the addition of antibiotics. A Luciferase construct bearing 
the 30UTR of the CFTR gene was used as the miR-509-3p sensitive reporter system. The 
transfection of the A549 cells with miRNA-mimics (Qiagen, Hilden, Germany) or PNAs was 
performed with the Attractene Transfection Reagent (Qiagen). Briefly, the cells seeded in 
96-well plates were cotransfected with the luciferase reporter construct, miR-509-3p mimic 
and the PNAs. The luciferase activity level was measured 24 h after transfection using the 
Dual-Glo Luciferase Assay System (Promega Corporation, Madison, WI, USA). The EnSpire 
Multimode Plate Reader (Perkim Elmer, Waltham, MA, USA) was used for the luminescence 
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assay using 96-multiwell black plates. The relative reporter activity was obtained by 
normalization to the Renilla luciferase activity. 
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Chapter 4 
Synthesis and Label Free Characterization of a Bimolecular PNA Homo Quadruplex 
for the construction of new K+ sensing probes 
 
4.1 Introduction 
One of the most interesting features of nucleic acids forming G-quadruplexes is the high 
polymorphism (1, 2). In fact, G-quadruplexes can give rise to a number of architectures, that 
depend on alternate strand orientations, loop connectivity, and syn-anti distribution of 
guanine bases around G-tetrads (3); this polymorphism makes them versatile scaffolds for 
creating new nanomaterials such as mechanical devices, templates, and biosensors (4,5) . 
First of all, G-quadruplexes demonstrate a potentially high conductance (6) making them 
appropriate for applications in electronic nanodevices.  Furthermore, the use of 
oligonucleotides for the assembly of inorganic nanocrystals has already been reported: in 
this case the hybridization properties of oligonucleotides led to the assembly of gold 
nanoparticles at distances given by the length of the oligonucleotides and led also to the 
formation of three-dimensional networks (7, 8). 
Recently, it has been demonstrated that suitable G-rich ONs can be considered versatile 
scaffolds for the construction of oligonucleotide-based analytical sensing platforms (9). For 
example, as reported in literature, by connecting AuNPs (as probes) and suitable G-rich 
fragments (as the recognition element) is possible to obtain a rapid, simple, high sensitive 
and excellent selective sensor for the determination of K+, exploiting the conformation 
change from the “random coil” to a compact rigid G-quadruplex formed by the aggregation 
of the nanoparticles in solution (10). 
 
However, the ability to control the assembly of nanomaterials from stable and well-defined 
building blocks represents a key step for the exploitation of the technological potential of 
these materials. 
Several studies demonstrated that the formation of four-stranded (or tetramolecular) G-
quadruplexes is slow and requires high oligonucleotide concentration (11). These 
unfavourable kinetic parameters could be disadvantageous in view of their potential use in 
the field of therapeutic but also of nanotechnology. The synthesis of modified quadruplexes 
could overcome these problems, and could help researcher in developing new building 
blocks with improved chemical-physical properties to be used in biotechnology.  
For all these reasons, the research group of Professor Piccialli, some years ago, proposed 
the use of tetra-end linker (TEL) oligonucleotides. These modified oligonucleotides form very 
stable TEL-quadruplex structures (Fig.1). 
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Figure 1: Schematic representation of unfolded (left) and folded (right) TEL-ODNs. 
 
These new kind of quadruplex is formed by a cluster of four d(TG4T) hexanucleotides linked 
together by their 3’-ends (or 5’-ends) through a tetra-branched linker. Subsequently, the new 
structure has been proven to possess a remarkable thermal stability compared to its natural 
counterpart (12–14). Furthermore, TEL-quadruplexes have been shown to possess a high 
antiviral (HIV) activity acting as an aptamer that binds selectively the HIV-1 glycoprotein 
gp120 (15–17).  
Since ODNs are susceptible to nucleases, and so unstable in biological fluids, their use has 
been often limited. For this reason, researchers realized the necessity for inclusion of 
chemical modifications to develop ODNs with improved features. In this context, one of the 
most promising ON analogue is Peptide Nucleic Acid (PNA). The first report concerning the 
design and properties of PNA was published in 1991 by Nielsen (18). PNA is a synthetic 
DNA mimic, in which the phosphodiester backbone of DNA/RNA is replaced with a 
polyamide–(2-aminoethyl) glycine–skeleton to which nucleobases are attached via a 
methylene carbonyl linker. By strict chemical means, PNA, is neither a peptide nor a nucleic 
acid, since its backbone is achiral uncharged polyamide. However, this atypical backbone 
gives PNA most appreciated advantages over other DNA analogues like phosphorothioates 
etc. PNA oligonucleotides are not recognized by proteases or nucleases and are therefore 
extremely stable in biological fluids (19)(20).  
To date, the ability of PNA to form stable G-quadruplexes hasn’t been so much investigated 
and, at the best of our knowledge, only tetramolecular PNA G-quadruplexes have been so 
far reported, despite their unfavourable kinetic and thermodynamic parameters (21). 
In this context, exploiting our experience in the synthesis of branched linkers, the aim of my 
research work was to synthetize an unprecedented non-DNA bifunctional linker 
functionalized with two PNA strands (bis-end-linker PNA or bel-PNA), and to evaluate its 
ability to form quadruplexes.  
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Figure 2: Structure of the bel-PNA. 
 
Thanks to CD, CD melting and SERS experiments, it was proved that, in presence of K+, 
the bel-PNA could form a bimolecular PNA G-quadruplex structure.   
The present study aimed at the design of a new PNA G-Q based sensor: in fact, once 
demonstrated the ability of the bel-PNA to form G-quadruplexes, further studies will be 
devoted to the realization of nanoparticles decorated with the bel-PNA to obtain lattice 
through quadruplexes connections. 
 
4.2 Results and Discussion 
My research work has been addressed on such targets: 
1) Synthesis of the non-nucleotidic linker; 
2) Functionalization of the linker with PNA strands to form the bel-PNA; 
3) Evaluation of the ability of the bel-PNA to form a PNA-based quadruplex. 
 
4.2.1 Synthesis of the non-nucleotidic linker. 
The first step for the preparation of the target compound contemplated the synthesis of the 
non-nucleotidic linker 8. 
The key reaction step was the selective Fmoc protection of the primary amino functions of 
1. In literature was reported that the selective Fmoc NH2 protection in the presence of OH 
groups could be performed by using Fmoc-N-hydroxy succinimide ester or Fmoc-Cl 
reagents (22), but these procedures allowed us to obtain the target bis-Fmoc derivative 2 
only in low yield, together with other variously protected by-products. The inability of 
modulating the nucleophilicity of the functional groups in the compound 1 towards Fmoc 
reagents forced us to explore an alternative synthetic route for the preparation of compound 
2, exploiting the protection of the OH group during the synthetic steps. Starting with the full 
protection of the three functional groups in 1 with an excess of CF3COOEt, we obtained the 
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tri-protected derivative 3 in 97% yield. At this stage, we explored the selective deprotection 
of the OH group. Pleasingly, the treatment of the compound 3 with methanol afforded the 
derivative 4 by selective methanolysis of the trifluoroacetic ester. The alcohol 4 was then 
silylated, affording the derivative 5 in 62% yield. The quantitative deprotection of both amino 
groups in 5 was accomplished with saturated NH3 in MeOH, to give compound 6 that was 
successfully transformed in its bis-Fmoc derivative 7 in 90% yield by reaction with Fmoc-Cl. 
Next, compound 7 was desilylated by treatment with the 3HF*TEA complex and the free OH 
group of compounds 2 reacted with (iPr)2NP(OCE)Cl to afford the phosphoramidite 
derivative 8. 
 
 
Scheme 1. i) Fmoc-N-hydroxy sucinimide ester, Py, r.t., 16 h, or Fmoc-Cl, NaHCO3(aq), CH2Cl2, r.t., 16 h; ii) 1) 
CF3COOEt, DCM, r.t., 1 h, iii) MeOH, r.t., 30 min; iv) TBDMSCl, Hym, DMF, r.t., 16 h; v) sat. NH3 in MeOH, 
r.t., 16 h; vi) Fmoc-Cl, Py, r.t., 16 h; vii) 3HF*TEA, THF, r.t. 16 h; viii) 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite, DIPEA, CH2Cl2,THF, r.t., 1 h. 
 
4.2.2 Functionalization of the linker with PNA strands to form the bel-PNA. 
Thereafter, solid support 10, after reaction with 8 in the presence of 1-H-tetrazole and 
oxidation with tBuOOH, gave the phosphoramidate containing support 14. Cleavage of both 
Fmoc protecting groups on the functionalized resin 14 in basic solution allowed the 
construction of PNA strands using the standard protocols. At the end of the synthetic cycles, 
treatment of solid support 17 with concentrated NH4OH(aq) gave the support 18 from which 
the BEL-PNA 19 was detached.  
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Scheme 2. Reagents: (i) piperidine/DMF, r.t., 10 min; (ii) 7, 1-H-tetrazole, DCM, THF, r.t., 2 h; (iii) tBuOOH, 
THF, r.t., 30 min; (iv) Ac2O/Py, r.t., 20 min; (v) 11, HATU, DIPEA, lutidine, DMF, r.t., 30 min; (vi) 12, HATU, 
DIPEA, lutidine, DMF, r.t., 30 min; (vii) conc. aq NH4OH, MeOH, r.t., 2 h; (viii) m-cresole, TFA, r.t., 4 h. 
 
The obtainment of pure compound 19 was assessed by ESI-MS analyses. Puriﬁed sample 
was dissolved in K+ buffer and subjected to the annealing procedure. The propensity of 19 
to fold into the target bimolecular PNA quadruplex was then supported by means of 
spectroscopic techniques. 
 
4.2.3 Evaluation of the ability of the bel-PNA to form a PNA-based quadruplex. 
To investigate whether the bel-PNA adopted a quadruplex structure and, in case, to 
determine its nature and stability, CD studies, including CD thermal denaturation 
experiments, were carried out (23). The sample was analysed K+ buffer after the annealing 
procedure. The bel-PNA showed a CD profiles characterized by positive and negative bands 
centred around 283 and 260 nm, respectively, which are indicative of a bimolecular 
antiparallel stranded G-quadruplex structure. Upon the basis of these findings, it was 
reasonable to hypothesize that the antiparallel orientation of PNA strands could be due to 
the steric hindrance and charge repulsion of the negatively charged phosphate linker 
moieties. Furthermore, the apparent melting temperature of the PNA-based bimolecular 
quadruplex was to be estimated at around 25°C (Fig.3). 
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Figure 3: (left) CD spectra of BEL-PNA 19 (2.0×10−5M) dissolved in pure water (solid line) or annealed in 0.1 
M K+ buffer (dotted line), pH 7; (right) CD melting at 283 nm of 19 dissolved in K+ buffer. 
 
It was to be noted that the backbone of PNAs is inherently achiral, so PNA G-Qs show a 
weak CD spectrum in comparison to their DNA analogues, as previously demonstrated by 
Balasumananian (21). The formation of such CD-unfriendly complexes could be monitored 
by using other spectroscopic techniques. 
Among all, Surface-enhanced Raman scattering (SERS) has recently emerged as a unique 
technique to be used for the structural analysis of biomolecules. Since its discovery in 1977, 
SERS has received a huge interest from researchers because of its high sensitivity and the 
minimal required sample volume, making it an ideal tool for the investigation of precious 
biological samples (24). The high sensitivity of this technique derives from the strong 
enhancement of the Raman cross section when the analyte is close to metallic 
nanostructures. The metallic surface (typically silver or gold) is usually in the form of a thin 
layer of metallic ﬁlm or a suspension of aqueous metallic colloidal nanoparticles. Several 
studies demonstrated the effectiveness of this technique for the detection of DNA bases or 
short DNA sequences (25).  
Starting from these findings, recently, the research group of Professor Piccialli proposed, for 
the first time, the use of the SERS technique for having an insight of the formation of G-
quadruplexes in solution (26). Furthermore, they also evaluate the stability of different kind 
of quadruplexes. In the proposed model, they also suggested that quadruplexes adopted a 
perpendicular or “standing-up“orientation with respect to the silver colloidal substrate, 
therefore exposing the guanine tetrad to the metallic surface. In doing so, this produced a 
favorable conﬁguration for investigating the intrastrand bonding.  
In this context, the aim of the work was to extend the applicability of this label-free technique 
to ascertain the formation of the bimolecular PNA-based quadruplex. SERS analysis of bel-
PNA 19 annealed in K+ buffer was performed by acquiring the signals in 100 randomly 
selected points. Figure 5 shows the average SERS signal for bel-PNA molecules in the K+ 
buffer. To better highlight the SERS features a forth order baseline was removed and the 
spectrum was normalized to the height of the prominent peak at 1572 cm-1. On the other 
hand, Table 1 summarizes the main SERS bands observed and their assignment.SERS 
spectra of PNA molecules (single strands) were firstly reported by Colaianni et al. (28); in 
this case, the spectra were mainly characterized by single nucleobase contributions as well 
as Amide I band due to the PNA backbone. Differently, our bel-PNA 19 in K+ annealed SERS 
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signals are dominated in the 1300-1600 cm–1 region by spectral features clearly due to 
guanine residues, also exhibiting some clear similarities with the spectral features observed 
in both spontaneous Raman scattering of telomeric DNA quadruplexes (29) and in SERS 
spectra of guanine-rich DNA sequences (26). Notably, the SERS spectrum shows a strong 
band at 1484 cm–1 easily assignable to the C8=N7-H2 deformation of the guanine tetrad, 
being therefore diagnostic of the Hoogsteen hydrogen bonding of the G.G pairs (28, 30). To 
the best of our knowledge, this outcome constitutes the first SERS-based evidence of PNA-
quadruplex formation. This also confirms the outcome provided by CD-measurements, 
which reveals the arrangement of BEL-PNA 19 K+ annealed in an antiparallel folded 
quadruplex structure. The other intense SERS peak at 1572 cm–1 can be identified with the 
C2=N3 guanine band appearing in the spontaneous Raman spectrum of quadruplexes 
around 1580 cm–1. The ~ 8 cm–1 shift of this band for the SERS case has been previously 
observed by Pagba et al. (31) in the analysis of quadruplex-folded DNA and is likely due to 
the specific surface-induced selection rules of SERS. The band around 1220 cm–1 can be 
assigned to PO2– bonds (32), which are present in the bel linker. Numerous other bands of 
the spectrum in Figure 5 are clearly due to the peptide components of the molecule and to 
single unpaired components. For instance, the peak at 1165 cm–1 is likely due to a 
combination of ν(C-N) and δ(C-H) vibrations with some contributions of unpaired thymine 
residues (33), while the band at 791 cm–1 is certainly a ring mode from the moieties (28). 
Moreover, many protein-related Raman bands can be observed in the Amide III (1200-1310 
cm–1), Amide II (1540-1560 cm–1) and Amide I (1610-1700 cm–1) regions, the latter band 
mainly involving the C=O vibration. In particular, the Amide I band probably masks the 
presence of guanosine N1H bands which, being sensitive of the N1H environment, is usually 
a valuable indicator of the guanine interbase interaction strength. Importantly, a significant 
number of the acquired signals (more than 80%) exhibited a quite reproducible spectral 
pattern, the relative height of each feature being constant within 15% of its mean value. 
These spectra were dominated by features due to guanine residues, with only some 
contributions from the PNA backbone. The remaining spectra exhibited numerous bands 
associated with the CH vibration bands in the region 1350–1650 cm–1, whose partial 
overlapping gave rise to a broad background in the same region. As it is well known, 
enhanced bands in SERS spectra are generally due to vibrational modes occurring in 
molecular moieties in close contact with the silver colloids. Therefore, the substantial 
reproducibility of spectra could be read in terms of a tendency of molecules to assume a 
well-defined orientation on the SERS substrate (Fig.4). A similar propensity to be ordered, 
mainly ruled by the electrostatic interaction of charged groups with the colloid surface, was 
previously observed by our group for DNA-based quadruplexes on Ag-colloids (26) and by 
Briones et al. for PNA strands on gold colloids (27). The reproducibility of SERS signals, 
together with the favourable exposure of guanines in PNA strands to the SERS substrate, 
revealed in most of SERS spectra, allowed us to get precious information on their structural 
arrangement.  
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Figure 4: Schematic representation for the interaction between PNA-based quadruplex and the silver colloidal 
microparticle. G-tetrads are reported in yellow.  
 
 
Figure 5: Average SERS signal from bel-PNA molecules in a K+ buffer. This spectrum exhibits the typical band 
around 1484 cm–1 diagnostic of quadruplex formation.  
 
Observed position (cm-1) Assignment 
785 Guanine ring  
966 (C-C) 
1160 ν(C-N) + δ(C-H), T 
1220 PO2- 
1300 Amide III 
1484 C8=N7-H2 
1542 Amide II 
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1572 C2=N3 of Guanine 
1630 Amide III 
1650 Amide III, (CO2), 
(C6O6)   
Table 1: Assignment of the prominent SERS features observed in this work. 
 
4.3 Conclusions 
The results, described in this work, confirm the potential of the bel-PNA, a new type of ON 
analogue, to form a bimolecular PNA-based quadruplex. In particular, it has been 
demonstrated that by tethering two G-rich PNA strands to the two ends of a suitable 
bifunctional linker it is possible to obtain bimolecular PNA homo quadruplexes after 
annealing in K+-containing buffers. Moreover, the formation of such CD-unfriendly 
complexes can be monitored, even at low concentrations, by using the SERS technique. 
Once demonstrated the ability of bel-PNA to fold into a new Bimolecular G-Q structure, the 
next step will be the functionalization of nanoparticles with the aim to obtain new sensing 
probes. 
Given the importance of DNA G-quadruplexes in medicine and nanotechnology, the 
obtainment of G-quadruplex analogues provided with enhanced enzymatic stability, and 
their monitoring by highly sensitive label-free techniques, are of the highest importance.  
 
4.4 Experimental section 
All reagents and solvents were obtained from commercial sources and used without further 
purification. MBHA resin (1% divinylbenzene, 200–400 mesh, 0.5 mmol/g loading) was 
purchased from Sigma-Aldrich. The reactions on solid phasewere performed using 
ISOLUTE® single fritted reservoirs (SG), 20 μm PE, equipped with tube caps and luer tip 
caps (Biotage) which were shaken in a Multi-reax vibrating shaker (Heidolph). High 
performance liquid chromatography (HPLC) analyses and purifications were carried out on 
a Jasco UP-2075 Plus pump equipped with a Jasco UV-2075 Plus UV detector using a 4.8 
× 150 mm C-18 reverse-phase column (particle size 5 μm) eluted with a linear gradient of 
CH3CN containing 0.1% (v/v) TFA in H2O containing 0.1% (v/v) TFA (from 0 to 100% in 45 
min, flow 1.2mL/min). UV spectra were recorded on a Jasco V-530 spectrophotometer. CD 
spectra were performed on a Jasco 1500 spectropolarimeter in a 0.1 cm path length cuvette. 
1H NMR experiments were performed using Varian Mercury Plus 400MHz and Varian 
UNITYINOVA 500MHz spectrometers in CD3OD, D2O, and acetone-d6 solvents. Chemical 
shifts are reported in parts per million (δ) relative to residual solvents signals – CD2HOD 
3.31, (CD3)(CD2H)CO 2.09 – and assigned by H\\H COSY experiments. 31P NMR 
experiments were performed on a Varian UNITYINOVA 500 MHz spectrometer using 85% 
H3PO4 as an external standard (0 ppm). Data were processed using the Varian VNMR 
software package. The abbreviations s, d, dd, m, bs, bd, bt represent singlet, doublet, 
doublet of doublets, multiplet, broad singlet, broad doublet and broad triplet, respectively. 
ESI-MS experiments were performed on a AB Sciex 4000 QTRAP mass spectrometer in 
positive ion electrospray mode. Column chromatography was performed on silica gel 60 
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(70–230 mesh ASTM, Merck) and analytical TLC analyses were performed on F254 silica gel 
plates (0.2 mm thick, Merck) with TLC spots being detected under UV light (λ = 254 nm).  
4.4.1. Synthesis of Fmoc protected bel-linker 8 
2.2.1. N,N’-(2-hydroxypropane-1.3-diyl)bis(2,2,2-trifluoroacetamide) (4) To an ice-cooled 
solution of 1.3-diamino-2-propanol 1 (0.10 g, 1.1 mmol) in CH2Cl2 (1 mL), CF3COOEt (0.6 
mL, 5.0 mmol) was added dropwise. The mixture was stirred at 0 °C for 60 min (TLC 
monitoring: CH2Cl2/CH3OH = 95:5) and then quenched with CH3OH at r.t. for 30 min. 
Volatiles were removed by rotary evaporation, thus obtaining 4 (0.302 g, 97% yield) as an 
amorphous solid that was used for the next reaction step without purification. 1H NMR (400 
MHz, CD3OD) δ 3.92–3.84 (m, 1H, CH), 3.37 (dd, J =4.7, 13.7 Hz, 2H, 2 × Ha), 3.28 (dd, 
J=7.2, 13.7 Hz, 2H, 2 × Hb). ESI-MS (m/z) calcd. for C7H8F6N2NaO3 [M + Na]+ 305; found 
305. 
4.4.2 N,N’-(2-((tert-butyldimethylsilyl)oxy)propane-1.3-diyl)bis(2,2,2- trifluoroacetamide) (5)  
tert-butyldimethylsilyl chloride (0.96 g, 0.6 mmol) and imidazole (0.06 g, 1.0 mmol) were 
dissolved in dry DMF and the solution cooled at 0 °C in an ice-bath. Compound 4 (0.150 g, 
0.53 mmol), dissolved in dry DMF (2 mL), was added dropwise and the mixture was stirred 
for 24 h (TLC monitoring: CH2Cl2/CH3OH = 95:5). The reaction was quenched by adding 
CH3OH and the mixture was diluted with AcOEt (30 mL) and washed with Brine (3 × 30 mL). 
The organic phase was dried over Na2SO4 and evaporated. The crude was purified over a 
silica gel column eluted with increasing amounts of CH3OH in CH2Cl2 (up to 3%) giving pure 
5 (0.13 g, 62% yield) as a white foam. 1H NMR (400 MHz, CD3OD) δ 4.06–3.98 (m, 1H, CH), 
3.38–3.26 (m, 4H, 2 × CH2), 0.89 (s, 9H, tBu), 0.089 (s, 6H, 2 × CH3). ESI-MS (m/z) calcd. 
For C13H22F6N2NaO3Si [M + Na]+ 419; found 419. 
4.4.3. 2-((tert-butyldimethylsilyl)oxy)propane-1.3-diamine (6) 
Compound 5 (0.13 g, 0.33mmol) was dissolved in sat. NH3 in CH3OH (1 mL) and kept at r.t. 
for 16 h (TLC monitoring: CH2Cl2/CH3OH/ NH3(aq)=7:3:0.2). The solvents were removed 
under reduced pressure and the crude was purified over a silica gel column eluted with 
increasing amounts of CH3OH in CH2Cl2 (up to 30%), giving pure 6 (0.07 g, 99% yield) as 
an oil. 1H NMR (400 MHz, CD3OD) δ 4.22–4.15 (m, 1H, CH), 3.12–3.02 (m, 4H, 2 × CH2), 
0.94 (s, 9H, tBu), 0.18 (s, 6H, 2 × CH3). ESI-MS (m/z) calcd. for C9H25N2OSi [M + Na]+ 205; 
found 205. 
4.4.4. bis((9H–fluoren-9-yl)methyl) (2-((tert-butyldimethylsilyl)oxy)propane- 1.3-
diyl)dicarbamate (7) 
To a solution of 6 (0.05 g, 0.25mmol) in dry pyridine (5mL), Fmoc-Cl (0.14 g, 0.54mmol) was 
added and the mixture was shaken at r.t for 16 h (TLC monitoring: CHCl3/CH3OH = 95:5). 
The reaction was quenched by addition of CH3OH, solvents were removed under reduced 
pressure and the crude purified over a silica gel column eluted with increasing amounts of 
CH3OH in CHCl3 (up to 2%), affording pure 7 (0.11 g, 90% yield) as an amorphous white 
solid. 1H NMR (400 MHz, CD3OD) δ 7.76–7.19 (complex signal, 16H, arom. Fmoc), 4.30 (d, 
J = 6.6 Hz, 4H, 2 × CH2 Fmoc), 4.13 (t, J = 6.5 Hz, 2H, 2 × CH Fmoc), 3.05 (d, J = 5.5 Hz, 
4H, 2 × CH2), 0.82 (s, 9H, tBu), 0.00 (s, 6H, 2 × CH3). ESI-MS (m/z) calcd. for 
C39H44N2NaO5Si [M + Na]+ 671; found 671. 
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4.4.5. bis((9H–fluoren-9-yl)methyl) (2-hydroxypropane-1.3-diyl) dicarbamate (2) 
Compound 7 (0.08 g, 0.12 mmol) was dissolved in THF (8 mL) and treated with TEA*3HF 
(196 μL, 1.2 mmol) at r.t. for 16 h (TLC monitoring: CHCl3/CH3OH, 95:5). Volatiles were 
removed under reduced pressure and the crude purified over a silica gel column eluted with 
increasing amounts of CH3OH in CHCl3 (up to 5%), giving pure 2 (0.06 g, 90% yield) as an 
amorphous white solid. 1H NMR (400 MHz, CD3OD) δ 7.90–7.20 (complex signal, 16H, 
arom. Fmoc), 4.35 (bd, 4H, 2 × CH2 Fmoc), 4.23 (bt, 2H, 2 × CH Fmoc), 3.73–3.61 (m, 1H, 
CH), 3.05–3.23 (complex signal, 4H, 2 × CH2). ESI-MS (m/z) calcd. For C33H31N2O5 [M + 
H]+ 535; found 535. 
4.4.6. bis((9H-fluoren-9-yl)methyl)(2-(((2-cyanoethoxy)(diisopropylamino) 
phosphino)oxy)propane-1.3-diyl)dicarbamate (8) 
2 (0.06 g, 0.11 mmol) was dissolved in a 1:1 (v/v) mixture of dry CH2Cl2/THF (3 mL), DIPEA 
was added (60 μL, 0.33 mmol) followed by addition of 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (40 μL, 0.18mmol). The mixture was stirred for 1 h at r.t. 
(TLC monitoring: n-hexane/AcOEt/DIPEA = 6:4:0.1) then diluted with AcOEt (30 mL) and 
washed with brine (4 × 30 mL). The organic phase was dried over Na2SO4 and evaporated 
under reduced pressure. The crude was purified over a silica gel column eluted with 
increasing amounts of AcOEt in n-hexane (up to 40%), giving pure 8 (0.048 g, 59% yield) 
as a white foam. 1H NMR (500MHz, acetone-d6) δ 7.86–7.25 (complex signal, 16H, arom. 
Fmoc), 4.36 (d, J = 8.6 Hz, 2H, CH2 Fmoc), 4.33 (d, J = 8.6 Hz, 2H, CH2 Fmoc), 4.26–4.17 
(m, 2H, 2 × CH Fmoc), 4.01–3.93 (m, 1H, CHO), 3.90–3.70 (complex signal, 2H, CH2O), 
3.67–3.59 (m, 1H, CHN), 3.36–3.28 (m, 4H, 2 × CH2N), 2.71–2.65 (m, 2H, CH2CN), 1.18– 
1.13 (two overlapped doublets, J = 6.5 and 6.6 Hz, 12H, 4 × CH3). 31P NMR (202 MHz, 
acetone-d6) δ 149.5 (s). ESI-MS (m/z) calcd. For C42H47N4NaO6P [M + Na]+ 757; found 757. 
4.4.7. Synthesis of bel-PNA 19 
bel-PNA 19 was synthesized using the Fmoc-solid-phase strategy. In particular, 50mg of 
MBHA resin 9 (0.5mmol/g), after swelling in CH2Cl2 for 30min and DMF washings, was 
treated with a solution of 20% piperidine in DMF for 10 min, giving solid support 10. After 
washings with DMF, the resin 10 was swelled in a 1:1 solution of CH2Cl2/THF (1 mL) and 
reacted with compound 8 (74 mg, 0.1 mmol) in the presence of 1-H-tetrazole (13mg, 
0.19mmol) for 2 h at r.t., affording, after washings with a 1:1 solution of CH2Cl2/THF, the 
solid support 13. The last was swelled in THF (1 mL) and treated with tBuOOH (5.5 M in 
decane, 50 μL, 0.25 mmol) for 30 min at r.t. giving, after washings with THF and then CH2Cl2, 
the solid support 14. The resin 14 was swelled in CH2Cl2 for 30 min, washed with DMF and 
treated with a solution of 20% piperidine in DMF for 10 min, thus obtaining solid support 15. 
The eluate was collected, and the coupling yield was estimated by Fmoc spectrophotometric 
measurements (98%). PNA chains were assembled by reacting PNA monomers (11 or 12, 
5 equiv.) in the presence of HATU (5 equiv), DIPEA (5 equiv) and lutidine (6 equiv.), for 30 
min at r.t. After each coupling step, capping with Ac2O in the presence of pyridine was 
performed by shaking the corresponding support with the reagents mixture for 20 min at r.t. 
At the end of synthetic cycles, cyanoethyl groups were removed suspending the resin 17 in 
conc. NH4OH(aq) for 2 h at r.t., affording solid support 18. Next, the synthesized bel-PNA 
was cleaved off suspending the resin 18 in a TFA/m-cresol (4:1, v/v) solution for 4 h at r.t. 
and precipitated with cold diethyl ether. The precipitates were recovered by centrifugation, 
washed twice with diethyl ether, dissolved in water and finally lyophilized. bel-PNA 19 was 
obtained with a 48–50% overall yield (94% average yield for each coupling). The crude 
sample was purified by semipreparative RP-HPLC. The collected fractions were lyophilized, 
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and the final pure product was characterized by ESI-MS (positive mode): ESI-MS (m/z) 
calcd. for C91H123N53O29P [M + H]+ 2453; found 2453. 
4.4.8. Obtainment of quadruplexes (annealing) 
The target dimeric PNA G-Q was obtained by dissolving the bel-PNA 19 at the concentration 
of 2.0 × 10−5 M in 100 mM K+ buffer (KH2PO4 10 mM, KCl 90 mM, pH 7.0) and by heating 
the solution at 90 °C for 10 min and then slow cooling to room temperature over 3 h. The 
solution was equilibrated at 4 °C for 72 h before characterizations. 
4.4.9. UV and CD studies 
The concentration of 19, dissolved in pure water, was determined by UV measurements at 
260 nm at 90 °C using the nearest-neighbor calculated molar extinction coefficient of the 
gggt PNA strand multiplied by 2 (the number of PNA strands linked to bel) (calculated ε = 
43.9 mL cm−1 μmol−1). The CD spectra were recorded both in pure water and in the 100 mM 
K+ buffer at final single strand concentration of 20 μM. The spectra were recorded at 5 °C 
(λ=220–310 nm, 200 nm/min scanning speed, 2.0 nm bandwidth) and averaged over 50 
repetitions. A buffer baseline was subtracted from the CD spectra and the spectra were 
normalized to have zero at 320 nm. Thermal denaturation experiments on 19 were also 
carried out in the temperature range of 5–90 °C by monitoring CD values at 282 nm at a 
heating rate of 1.0 °C/min. 
4.4.10 SERS studies 
Ag colloids were used as the SERS substrate; briefly, AgNO3 (90 mg) was dissolved in 500 
mL of H2O and brought to the boil. Next, a sodium citrate solution (1%w/w) was added under 
vigorous stirring and then the resulting mixture was kept boiling for 1 h. All chemicals were 
purchased from Sigma- Aldrich. Before use, the silver solution was appropriately diluted with 
distilled water. SERS spectra were recorded using the WiTec Alpha 300 system, a confocal 
Raman system endowed with a Raman probe at 532 nm focused on the sample through a 
Nikon 60× dry objective (NA = 0.8 and WD = 300 μm). The back-scattered light from the 
sample, after proper filtering to remove the pump radiation, was sent to a high throughput 
spectrometer equipped with two diffraction gratings with 600 and 1800 gmm−1, providing a 
resolution, respectively, of 3.6 and 1.5 cm−1. Photons were detected by a back-illuminated 
Andor CCD camera (DV401A-BV-352, 1024 × 400 pixels) operating at −60 °C. The confocal 
conditions were imposed by the 25 μm core (acting as a pin-hole) of the multimode fibre 
delivering the signal to the spectrometer. SERS analysis was performed on samples at a 
concentration of 20 μM. For the measurements, a proper diluted aliquot of the silver colloid 
solution was added to the sample and the analyte was allowed to bind for 2 h at room 
temperature prior to spectrum acquisition. To avoid any photochemical-induced effect, the 
Raman probe power impinging on the sample was limited to 50 μW while the integration 
time was 5 s. Under this condition, SERS spectra were comparatively stable and the signal-
to-noise ratio was higher than 100 on the single acquisition. 
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Chapter 5 
Concluding Remarks and Future Perspectives 
 
The present thesis has been devoted to exploring the most promising and fascinating 
applications of nucleic acids. Hereafter, the most important results of my research. 
The first part of my research was focused on the use of oligonucleotides in 
supramolecular chemistry. In this context, I synthetized and characterized a novel G-
rich ODN sequence for the development of long G-wires; The basic idea has been to 
create a stable monomeric G-quadruplex having two 5’-CG ends able to polymerize 
using its two 5’-sticky ends and thus to obtain long g-wires like poly-(Q)n exploiting the 
5’-5’ π-stacking between G(:C) G(:C) G(:C) G(:C) octads formed by 5’-CG ends. So, 
the 7-mer d(5’-CGG-3’-3’-TGGC-5’) containing a 3’-3’ phosphodiester bond that reverse 
the polarity in the strand thus creating two 5’-ends, has been synthetized. Particularly, 
once annealed our sample in potassium buffer, it has been possible to visualize, 
according to their different electrophoretic mobility, a distribution of objects, starting 
from the monomeric G-quadruplex species (fastest species) through to an indistinct 
mixture of higher order objects (slowest species). The SEC-HPLC analysis has been 
particularly interesting: the obtained chromatograms have allowed us to identify, by 
analysing the retention times, all the multimers formed by the examined species and 
to isolate those objects. In addition, by varying the experimental conditions, it was 
possible to demonstrate that the pattern of the peaks was concentration/temperature-
dependent. Furthermore, circular dichroism and NMR spectroscopies have contributed 
to further characterizing these higher order structures, while AFM analysis has allowed 
to visualize these structures and define their dimensions. 
An interesting development of this work could be aimed at the study of the interaction 
of these higher order structures with ligands in order to obtain further information about 
the self-assembly process, in particular by studying the effect of such molecules on the 
multimerization.  
 
The second part of my research was focused on the use of the most intriguing 
oligonucleotide analogue, the Peptide Nucleic Acid, and, in particular I synthetized and 
characterized four PNA sequences to be used in a novel approach for the treatment of 
Cystic Fibrosis (target protector strategy), in which the basic idea was to mask the 
miRNA binding region of 3'UTR region of the CFTR gene by the action of miRNA, with 
the effect to increase the production of CFTR protein. In this context, we have 
synthesized and characterized 2 PNA sequences (and related scrumble sequences 
used as a negative control) and through spectroscopic studies, such as circular 
dichroism and UV, their ability to form structures hybrids with the target has been 
evaluated: from such experiments it emerged that both PNA sequences are able to 
form anti-parallel heteroduplex with the target, whose thermal stability has been 
evaluated through CD melting analysis. Such results have been supported by 
molecular dynamics studies. Finally, preliminary biological assays performed on the 
luciferase construct have highlighted that the action of the PNA is able to significantly 
restore luciferase activity.  
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As future perspective, we hope to complete all the set of biological assays with the aim 
to fully understand all the mechanisms that control this kind of approach. 
 
Encouraged by the positive results obtained from the use of PNA in a biological context 
the third part of my research has been focused on the use of PNAs from a 
nanotechnological point of view; so my work was focused on the synthesis and 
characterization of a short sequence of PNA conjugated to a novel bifunctional linker 
aimed at the obtainment of PNA-based quadruplex. In this context, the goal of my work 
was to continue investigating the infinite potential of PNA by evaluating its ability to 
form new G-quadruplex structures, useful for the construction of new nanomaterials. 
Exploiting as the starting point the expertise of the research group of Prof. Piccialli in 
the synthesis of branched linkers, the approach has provided first the synthesis of a 
new type of linker, and, secondly, its functionalization by guanine-rich PNA sequences. 
Thus, the obtained molecule, named bis-end-linked PNA, (or bel-PNA), was then 
suspended in potassium buffer and the ability to form a G-quadruplex structure was 
evaluated by spectroscopic studies. In particular, through the preliminary circular 
dichroism analysis, it was possible to demonstrate that the bel-PNA gave rise to a G-
quadruplex structure; however, since the PNA is an achiral molecule, CD analysis 
requires the support of another type of technique. In this context, SERS spectroscopy 
has been included, and has proved to be an indispensable instrument for the structural 
characterization of CD-unfriendly type of molecule. 
An interesting development of this work could be aimed at the functionalization of 
nanoparticles with the aim to obtain new sensing probes with enhanced enzymatic 
stability to be used in the field of nano-biotechnology.  
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Abstract: Cystic Fibrosis (CF) is one of the most common life shortening conditions in Caucasians.
CF is caused by mutations in the CF Transmembrane Conductance Regulator (CFTR) gene which
result in reduced or altered CFTR functionality. Several microRNAs (miRNAs) downregulate the
expression of CFTR, thus causing or exacerbating the symptoms of CF. In this context, the design of
anti-miRNA agents represents a valid functional tool, but its translation to the clinic might lead to
unpredictable side effects because of the interference with the expression of other genes regulated by
the same miRNAs. Herein, for the first time, is proposed the use of peptide nucleic acids (PNAs) to
protect specific sequences in the 3’UTR (untranslated region) of the CFTR messenger RNA (mRNA)
by action of miRNAs. Two PNAs (7 and 13 bases long) carrying the tetrapeptide Gly-SerP-SerP-Gly
at their C-end, fully complementary to the 3’UTR sequence recognized by miR-509-3p, have been
synthesized and the structural features of target PNA/RNA heteroduplexes have been investigated
by spectroscopic and molecular dynamics studies. The co-transfection of the pLuc-CFTR-3´UTR
vector with different combinations of PNAs, miR-509-3p, and controls in A549 cells demonstrated the
ability of the longer PNA to rescue the luciferase activity by up to 70% of the control, thus supporting
the use of suitable PNAs to counteract the reduction in the CFTR expression.
Keywords: cystic fibrosis; CFTR; miRNA; miRNA target protectors; miR-509-3p; peptide nucleic
acid; PNA
1. Introduction
One in every 3000 newborn Caucasians is affected by Cystic Fibrosis (CF), an autosomal recessive
genetic disorder caused by mutations in a gene that encodes the cystic fibrosis transmembrane
conductance regulator (CFTR) protein, a chloride-conducting transmembrane channel expressed
in most epithelial and blood cells. Individuals who have inherited two mutated copies of the CFTR
gene produce an altered CFTR protein (with decreased or absent CFTR chloride channel activity) that
inhibits the flow of water and chloride ions across the cellular membranes and triggers the onset of
clinical phenotypes characterized by an altered sweat test, pancreatic insufficiency, and pulmonary
infections that gradually lead to respiratory insufficiency [1,2]. CF patients with at least one mutation
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that retains a residual channel activity could be treated with a strategy that aims to stabilize the
CFTR messenger RNA (mRNA), thus increasing the amount of the protein and resulting in a net
chloride flux increase [3]. Recently, it has been demonstrated that microRNAs (miRNAs) are also
involved in the negative regulation of CFTR expression and consequently in the development and
manifestations of CF lung disease [4–10]. MicroRNAs are evolutionarily conserved single-stranded
non-coding RNAs, 18–25 nucleotides in length, that regulate the expression of specific genes at a
post-transcriptional level, inhibiting the protein production [11–13]. In this context, the anti-miRNA
strategy represents a valid tool within basic research and clinical applications. Indeed, our group used
Peptide Nucleic Acids (PNAs) as anti-miRNA agents [14,15]. PNAs are mimics of DNA in which the
sugar-phosphate backbone of the nucleic acid is replaced by a synthetic achiral peptide backbone.
They emerged as one of the most promising candidates for gene therapeutics in antisense strategies
and anti-miRNA approaches, showing a high affinity towards nucleic acid targets and generating
very stable heteroduplex complexes. Moreover, PNAs and their complexes are not recognized by
nucleases [16–25]. In a previous study, using an in vitro system based on the luciferase reporter system,
we demonstrated that PNAs can inhibit miRNA activity and rescue the CFTR expression [14,15].
Although effective, the anti-miRNA approach suffers from a main limitation, i.e., it may interfere with
other miRNA targets leading to unpredictable side effects. To overcome this problem and to counteract
the effects of miRNAs binding to the CFTR mRNA [26], we propose the use of PNAs as miRNAs
target protectors (TPs). This approach differs from the anti-miRNAs one because the PNAs block the
miRNAs activity only for the specific gene of interest by competing with the miRNAs for the target
mRNA. In the case of CF, the increased expression of the CFTR protein could lead to clinical benefit
for all patients who retain residual activity of the CFTR channel. Furthermore, it has been shown that
the expression of CFTR decreases during the development from embryo to adulthood. Therefore, an
increase of the CFTR protein, and consequently of the flow of chloride through the membranes, could
help those patients with at least one mutation that maintains some residual activity of the protein.
In this study, we have synthesized and investigated, based on their ability to protect the CFTR mRNA,
two PNA strands of different lengths (1 and 2, thirteen and seven bases in length, respectively, Table 1)
that are fully complementary to the mRNA sequence recognized by the seed region of mir-509-3p.
In addition, two other PNAs sharing the same base composition as 1 and 2, but in random order (3 and
4, respectively, Table 1), have been designed and synthesized to confirm the sequence dependent
activity of 1 and 2. The negatively charged tetra-peptide Gly-SerP-SerP-Gly was installed at the C-end
of all PNAs to improve their water solubility. The ability of 1 and 2 to recognize the mRNA was
investigated by Circular Dichroism (CD) and UV studies on the corresponding PNA/DNA models
and molecular modelling studies were performed to further confirm the structure and stability of the
target PNA/mRNA complexes. We show that 1 proved effective in rescuing the luciferase expression
by up to 70% of control in A549 cell culture model.
2. Results
2.1. Synthesis of PNAs 1–4
PNAs 1–4 (Table 1) were synthesized using the standard Fmoc-solid phase strategy on a
4-methylbenzhydrylamine (MBHA) resin. In the synthetic approach, the peptide tract was assembled
at first, followed by the construction of the PNA portion. After the synthesis, the oligomers were
detached from the support and lyophilized. The purification and analysis of the crude products were
carried out using HPLC as outlined in the Materials and Methods. The electrospray mass spectrometry
(ESI-MS) analyses confirmed the structure of the synthesized PNAs (Table 1).
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Table 1. Sequences of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) messenger
RNA (mRNA) and of peptide nucleic acids (PNAs) 1–4. UTR = untranslated region.
Name Sequence 1,2
3’UTR of CFTR mRNA (RNA) G-A-A-G-A-A-G-C-A-C-C-A-A-U-C-A-U-G-A
DNA model sequence (ODN) G-A-A-G-C-A-C-C-A-A-T-C-A
PNA 1 (C→ N) G-S(P)-S(P)-G–c-t-t-c-g-t-g-g-t-t-a-g-t
PNA 2 (C→ N) G-S(P)-S(P)-G–g-g-t-t-a-g-t
PNA 3 (C→ N) G-S(P)-S(P)-G–c-a-g-t-t-g-t-c-t-g-t-g-t
PNA 4 (C→ N) G-S(P)-S(P)-G–t-t-g-g-a-g-t
1 The tetrapeptide tail at PNAs C-end is written in italics. 2 Target of miR-509-3p seed region is in red.
2.2. Circular Dichroism (CD) and CD Melting Analyses
To assess the interaction between the new PNAs and the target sequence on the CFTR mRNA
strand and the stability of the resulting PNA/RNA heteroduplexes, we used CD and CD melting
analyses. However, because DNA is more resistant against nucleases and does not require any
chemical modification for handling that could alter its recognition properties, the spectroscopic
studies were performed using the corresponding 13-mer DNA model sequence (ODN in Table 1).
Furthermore, considering the higher binding affinity of RNA strands relative to DNA strands
towards complementary PNAs [27], the stability data obtained using the ODN model are probably
underestimated. The formation of PNA/ODN heteroduplexes for 1 and 2 was assessed by recording
the CD spectra of PNAs/ODN mixtures (1.5:1) in comparison with the CD spectra of PNAs and ODN
alone. Each spectrum was recorded in phosphate buffered saline (PBS) buffer at 5 ◦C after the annealing
procedure. Different from the CD spectra of PNAs and ODN alone, the spectra of both PNA/ODN
mixtures showed the typical CD profile of antiparallel PNA/DNA heteroduplexes [28], characterized
by maxima around 260 nm and 220 nm, and minima around 245 nm and 200 nm, thus confirming
the formation of the target heteroduplexes 1/ODN and 2/ODN (Figure 1). The CD melting curves
of both complexes are shown in Figure 2 and confirm, as expected, the greater stability of the longer
1/ODN heteroduplex relative to that of the shorter one (Tm values of 66 ◦C and 35 ◦C, respectively).
Molecules 2017, 22, 1144  3 of 16 
 
Table 1. Sequences of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) 
messenger RNA (mRNA) and of peptide nucleic acids (PNAs) 1–4. UTR = untranslated region. 
Name Sequence 1,2 
3’UTR of CFTR mRNA (RNA) G-A-A-G-A-A-G-C-A-C-C-A-A-U-C-A-U-G-A 
DNA model sequence (ODN) G-A-A-G-C-A-C-C-A-A-T-C-A 
PNA 1 (C → N) G-S(P)-S(P)-G–c-t-t-c-g-t-g-g-t-t-a-g-t 
PNA 2 (C → N) G-S(P)-S(P)-G–g-g-t-t-a g t 
PNA 3 (C → N) G-S(P)-S(P)-G–c-a-g-t-t-g-t-c-t-g-t-g-t 
PNA 4 (C → N) G-S(P)-S(P)- –t-t- -g-a-g-t 
1 The tetrapeptide tail at PNAs C-end is written in italics. 2 Target of miR-509-3p seed region is in red. 
2.2. Circular Dichroism (CD) and CD Melting Analyses 
To assess the interaction between the new PNAs and the target sequence on the CFTR mRNA 
strand and the stability of the resulting PNA/RNA heteroduplexes, we used CD and CD elting 
analyses. However, because DNA is more resistant against nucleases and does not require any 
chemical modification for handling that could alter its recognition properties, the spectroscopic 
studies were performed using the corresponding 13-mer DNA m del sequence (ODN in Table 1). 
Furthermore, considering the higher bindi g affinity of RNA strands relative to DNA strands 
towards complementary PNAs [27], the stability data obtained u ing the ODN model are probably 
underestimated. Th  formation of PNA/ODN heteroduplexes for 1 and 2 was assess d by recording 
the CD spectra of PNAs/ODN mixtures (1.5:1) in comparison with the CD spectra of PNAs and ODN 
alone. Each spectrum was recorded in phosphate buffered saline (PBS) buffer at 5 °C after the 
annealing proc dure. Different from the CD spectra of PNAs and ODN lone, the spectra of both 
PNA/ODN mixtures sh wed the ty i al CD profile of antiparallel PNA/DNA heteroduplexes [28], 
characterized by maxima around 260 nm and 220 nm, and minima around 245 nm and 200 nm, thus 
confirming the formation of the target hetero uplexes 1/ODN and 2/ODN (Figure 1). The CD melting 
curves of both complexes are shown in Figure 2 and confirm, as expected, the greater stability of the 
longer 1/ODN heteroduplex relative to that of the shorter one (Tm values of 66 °C and  
35 °C, respectively).  
(a) (b) 
Figure 1. Circular dichroism (CD) spectra of: (a) PNA 1 (green), ODN (blue), and 1.5:1 1/ODN mixture 
(magenta); (b) PNA 2 (green), ODN (blue), and 1.5:1 1/ODN mixture (magenta). ODN is the DNA 
model sequence. 
Figure 1. Circular dichroism (CD) spectra of: (a) PNA 1 (green), ODN (blue), and 1.5:1 1/ODN mixture
(magenta); (b) PNA 2 (green), ODN (blue), and 1.5:1 1/ODN mixture (magenta). ODN is the DNA
model sequence.
Molecules 2017, 22, 1144 4 of 16Molecules 2017, 22, 1144  4 of 16 
 
 
Figure 2. CD melting profiles of 1.5:1 PNA/ODN mixtures of 1 (solid line) and 2 (dashed line). The 
curves were obtained by monitoring the absorbance at 266 or 264 nm, respectively, for 1/ODN or 
2/ODN, at a heating rate of 0.5 °C/min. 
2.3. UV Studies 
The formation of PNAs/ODN heteroduplexes was also monitored by UV spectroscopy by 
exploiting the hypochromic effect resulting from the formation of the heteroduplexes. The UV 
spectrum of each component alone and those of the mixtures are reported in Figure 3. All spectra 
were characterized by a maximum at around 260 nm, typical of nucleobases. The UV spectrum of the 
1/ODN complex (magenta curve in Figure 3a) showed lower values of absorbance than the arithmetic 
sum of each component alone (black curve in Figure 3a), thus confirming the occurrence of stacking 
interactions and the formation of the heteroduplex. In the case of the shorter PNA 2, the UV spectrum 
of its complex with the ODN (violet curve in Figure 3b) showed almost the same values of absorbance 
as the arithmetic sum of its components, in agreement with the experimental lower stability of the 
shorter 2/ODN heteroduplex.  
  
(a) (b) 
Figure 3. UV spectra of: (a) PNA 1 (green), ODN (blue), 1.5:1 1/ODN mixture (magenta), and the 
arithmetical sum of 1 and ODN (black); (b) PNA 1 (green), ODN (blue), 1.5:1 1/ODN mixture 
(magenta), and the arithmetical sum of 1 and ODN (black). 
2.4. Molecular Modelling Studies 
Molecular dynamics was used to check the structural features of the heteroduplexes 1/RNA and 
2/RNA (Supplementary Materials, Table S1). The heteroduplexes were built starting from the NMR 
structure of the RNA(GAGUUC)/PNA(GAACTC) duplex (PDB-ID 176D) [29] as described in the 
Material and Methods section. The heteroduplexes were analyzed by means of three independent 
runs of molecular dynamics, for a total simulation time of 1200 ns for 1/RNA system and of 900 ns 
for 2/RNA. The chemical-physical properties of the systems, such as temperature, pressure, volume, 
density, and energy were fairly constant during the whole simulation for all the systems (data not 
shown). All the simulations were characterized by low root-mean-square deviation (RMSD) values 
Figure 2. CD melting profiles of 1.5:1 PNA/ODN mixtures of 1 (solid line) and 2 (dashed line). The
curves were obtained by monitoring the absorbance at 266 or 264 nm, respectively, for 1/ODN or
2/ODN, at a heating rate of 0.5 ◦C/min.
2.3. UV Studies
The formation of PNAs/ODN heteroduplexes was also monitored by UV spectroscopy by
exploiting the hypochromic effect resulting from the formation of the heteroduplexes. The UV
spectrum of each component alone and those of the mixtures are reported in Figure 3. All spectra
were characterized by a maximum at around 260 nm, typical of nucleobases. The UV spectrum of the
1/ODN complex (magenta curve in Figure 3a) showed lower val es of ab orbanc than th a ithmetic
sum of each component alone (black curve in Figure 3a), thus confirming the occurrence of stacking
interactions and the formation of the heteroduplex. In the case of the shorter PNA 2, the UV spectrum
of its complex with the ODN (violet curve in Figure 3b) showed almost the same values of absorbance
as the arithmetic sum of its components, in agreement with the experimental lower stability of the
shorter 2/ODN heteroduplex.
Molecules 2017, 22, 1144  4 of 16 
 
 
Figure 2. CD melting profiles of 1.5:1 PNA/ODN mixtures of 1 (solid li e)      
curves wer  obtained by monitoring the absorbance at 266 or   , f r 1/   
2/ODN, at  heating rate of 0.5 °C/min. 
2.3  UV Studies 
The formation of PNAs/ODN heteroduplexes was also monitored by    
exploiting the hypochromic effect resulting fro  t  i   t  heteroduplexes.   
spectrum of each component alone and those of the ixtures r  t  i  i  . ll t  
were characterized by a maximum at around 260 n , typical f l s s.   s tr  f t  
1/ODN complex (magenta curve in Figure 3a) showed lower values of absorba ce t  t e rit etic 
sum of each compo ent alone (black curve in Figure 3a), thus confir ing the occ rrence of stacking 
int ractions and the formation of the het roduplex. In the case of the shorter P  2, th  spectru  
of its complex with the ODN (violet curve in Figure 3b) showed al o t the sa e values of absorbance 
as the arithmetic sum of its components, in agree ent ith the experi ental lo er stability f the 
shorter 2/ODN heteroduplex.  
  
(a) (b) 
Figure 3. UV spectra of: (a) PNA 1 (green), ODN (blue), 1.5:1 1/ODN mixture (magenta), and the 
arithmetical sum of 1 and ODN (black); (b) PNA 1 (green), ODN (blue), 1.5:1 1/ODN mixture 
(magenta), and the arithmetical sum of 1 and ODN (black). 
2.4. Molecular Modelling Studies 
Molecular dynamics was used to check the structural features of the heteroduplexes 1/RNA and 
2/RNA (Supplementary Materials, Table S1). The heteroduplexes were built starting from the NMR 
structure of the RNA(GAGUUC)/PNA(GAACTC) duplex (PDB-ID 176D) [29] as described in the 
Material and Methods section. The heteroduplexes were analyzed by means of three independent 
runs of molecular dynamics, for a total simulation time of 1200 ns for 1/RNA system and of 900 ns 
fo  2/RNA. The chemical-physical properties of the syst ms, such as temperature, pressure, volume, 
density, and energy were fairly constant during the whole simulation for ll the systems (data not 
shown). Al  the simulations were characterized by low root-mean-square deviation (RMSD) values 
Figure 3. UV spectra of: (a) PNA 1 (green), ODN (blue), 1.5:1 1/ODN mixture (magenta), and
the arithmetical sum of 1 and ODN (black); (b) PNA 1 (gr en), ODN (blue), . : i t
(magenta), and the arithmetical sum of 1 and O (black).
2.4. Molecular Modelling Studies
Molecular dynamics was used to check the struct r l f plexes 1/
2/RNA (Supplementary Materials, Table S1). The heteroduplexes were built st rti
structure of the RNA(GAGUUC)/PNA(G ACTC) duplex (PDB-ID 176D) [29] as t
Material and Methods section. The heteroduplexes were analyzed by s
runs of molecular dynamics, for a total simulation ti e of t
Molecules 2017, 22, 1144 5 of 16
for 2/RNA. The chemical-physical properties of the systems, such as temperature, pressure, volume,
density, and energy were fairly constant during the whole simulation for all the systems (data not
shown). All the simulations were characterized by low root-mean-square deviation (RMSD) values
and low fluctuations in the central duplex region (Supplementary Materials, Figure S1), thus indicating
the presence of a stable structure. To evaluate the convergence between the independent runs of
each system, a hierarchical clusterization of the molecular dynamics (MD) run was performed using
Ambertools 15 [30]. The clusterization yielded in both cases one main cluster, accounting for more
than 77% of frames for each run of PNA 1 and for more than 90% for PNA 2 runs (Supplementary
Materials, Table S2 for details). Superposition of the average structure of the main cluster of each run
showed very low RMSD values, thus indicating the convergence of the run to the same main structure
(Figure 4; Supplementary Materials, Tables S3 and S4).
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To characterize the structural properties of the 1/RNA and 2/RNA heteroduplexes, local base
pair step parameters (twist, roll, tilt, shift, slide, and rise), helical parameters (inclination), and the
torsion angles of RNA and PNA monomers were calculated with the program Curves+ [31]. To limit
the influence of the sterically less restricted terminal base pairs, the analysis was limited to the central
11 and 5 base pairs for the heteroduplexes formed by 1 and 2, respectively. The results are reported
in Tables 2 and 3. All the heteroduplexes showed high similarity with the PNA/RNA heteroduplex
experimental structures determined by NMR (PDB ID 176D [29]) and by XRAY (PDB ID 5EME and
5EMF) [32], with few noticeable deviations. In particular, 1/RNA and 2/RNA heteroduplexes showed
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lower values of twist and roll with respect to the experimentally determined structures, assuming
values similar to those reported in previous MD studies [33].
Table 2. Helicoidal parameters of the average structure of the more representative cluster of 1/RNA
and 2/RNA MD simulations. Standard deviations are reported in brackets.
Name Shift Slide Rise Tilt Roll Twist
1/RNA −0.7 (0.2) −1.9 (0.2) 3.3 (0.2) 1.0 (1.4) 2.4 (1.9) 23.6 (1.7)
2/RNA −0.9 (0.3) −1.7 (0.2) 3.3 (0.1) 1.3 (1.5) 3.9 (1.9) 22.6 (1.3)
PNA/RNA (NMR) 1 0.3 (0.3) −1.4 (0.6) 3.2 (0.4) −2.8 (1.3) 4.6 (4.3) 29.4 (3.8)
PNA/RNA (MD) 2 - - - - - 24
PNA/RNA (X-RAY) 3 −0.8 (0.4) −2.1 (0.3) 3.3 (0.1) 0.1 (1.3) 6.9 (3.5) 25.0 (1.6)
A-RNA 4 - - 2.8 - - 32.7
1 Calculated on the average structure of PDB 176D, from [29]; 2 from [33]; 3 calculated on the average structure of
PDBs 5EME and 5EMF, from [32]; 4 from [34].
The analysis of RNA torsion angles (Table 3) confirmed their close similarity with respect to
the reference NMR PNA/RNA heteroduplex [29] and a strict consistence with the canonical A-RNA
structure [34]. PNA angles, on the contrary, as previously reported [15,35–38], showed higher deviation
and flexibility, particularly pronounced in the case of α and ε torsion angles, assuming values around
−100◦ and 180◦, respectively, in both PNA/RNA heteroduplexes (Supplementary Materials, Figure S1).
Table 3. Average torsion angle values of the average structure of the more representative cluster of
1/RNA and 2/RNA MD simulations. Standard deviations are reported in brackets. The torsion angle
definition is given in Figure 5.
Torsional PNA Angles
Name α β γ δ ε ω χ1 χ2 χ3
1/RNA –120(46.0)
78
(10.6)
71
(2.5)
95
(1.8)
–177
(42.9)
–146
(10.0)
–2
(1.2)
–164
(2.2)
84
(2.8)
2/RNA –136(43.2)
76
(4.1)
79
(3.9)
96
(2.0)
–162
(56.6)
–172
(10.6)
–3
(1.6)
–152
(18.0)
77
(12.6)
PNA/RNA
(NMR) 1
160
(10.1)
68
(2.4)
81
(5.0)
59
(16.1)
–104
(6.7)
–177
(3.2)
12
(3.3)
–118
(8.6)
49
(10.2)
PNA/RNA
(XRAY) 2
–177
(83.5)
68
(8.8)
71
(7.5)
95
(5.2)
–123
(81.0)
–178
(10.5)
5
(5.1)
–173
(4.0)
82
(6.6)
Torsional RNA Angles
Name α β γ δ ε ζ χ
1/RNA –77(1.5)
172
(1.7)
68
(1.5)
79
(0.9)
–162
(2.7)
–72
(2.9)
–160
(3.1)
2/RNA –78(1.6)
173
(1.9)
67
(1.6)
79
(1.3)
–164
(2.7)
–73
(2.4)
–156
(2.8)
PNA/RNA
(NMR) 1
–68
(6.7)
171
(13.8)
58
(1.2)
79
(3.6)
–149
(23.8)
–73
(11.6)
–168
(4.4)
PNA/RNA
(X-RAY) 2
–80
(4.9)
177
(5.4)
63
(4.9)
79
(6.2)
–158
(5.5)
–71
(6.6)
–164
(4.9)
A-RNA 3
–79
(43.5)
172
(19.9)
64
(34.7)
80
(9.53)
–152
(17.6)
–76
(24.7)
–162
(9.76)
1 Calculated on the average structure of PDB 176D, from Ref. [29]; 2 calculated on the average structure of PDBs
5EME and 5EMF, from Ref. [32]; 3 from Ref. [34].
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Interestingly, the analysis of the correlation between the torsion angle ε of the residue i and the
torsion α(i+1) of the subsequent base, showed the lack of consistent correlation between εi and α(i+1).
Moreover, to further explore structural features of PNAs/RNA heteroduplexes, we also evaluated
the correlation between the pseudo-torsion angle νi, defined as the angle between C8′-N4′-C′-O1′
(Figure 5, red circles), and the torsion angle α(i+1) of the subsequent base, as a pointer of the orientation
of the backbone carbonyl with respect to the strand terminus. The high Pearson correlation coefficients
calculated revealed that there is a strong anti-correlation between the pseudo torsion angle νi and
α(i+1) of the subsequent base, thus revealing a prevalent orientation of the carbonyl group toward the
N-terminus (Supplementary Materials, Table S5). A detailed discussion of the torsion angle behavior
is given in Supplementary Materials (Text S1).
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2.5. Biological Activity
Next, we tested the ability of PNAs 1 and 2 to block the i hibitor activity of miR-509-3p in
a biol gical context. For this p rpose, we tested the ability of the two PNA strands to rescue t e
reduction of luciferase activity induced by the transfection of miR-509-3p in A549 cells. Thus, we
co-transfected different combinations of pLuc-CFTR-3′UTR (untranslated region) vector (a reporter
luciferase construct sensitive to the miR-509-3p mimic action due to the presence of the 3′UTR of
the CFTR gene), PNA strands, miR-509-3p mimic, and corresponding PNA scrambled co trols. The
co-transfection of miR-509-3p in the presence of the scrambled PNA 3 reduced luciferase expression
leading to a residual activit up to 35%. The co-transfection of PNA 1 in the presence of miR-509-3p
rescued the luciferase activity by up to 70% (Figure 6a). On the contrary, the addition of 1 alone
did not produce any effect on the luciferase expression, thus indicating that 1 counteracts the
inhibitory effects of miR509-3p by selectively competing for its binding on the 3′UTR of CFTR mRNA.
Conversely, despite the spectroscopic and molecular dynamics evidence, the co-transfection of 2 in
similar experimental conditions did not rescue the luciferase activity (Figure 6b).
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3. Discussion
CFTR gene regulation by miRNAs plays an important role in lowering CFTR levels in CF
patients. Therefore, much effort has been made to modulate miRNA control on CFTR. In a recent
paper, we demonstrated that the activity of miR-509-3p miRNA, one of the miRNAs involved
in the post-transcriptional regulation of the CFTR gene, could be inhibited using 14 or 7 bases
long PNAs [14,15]. However, this type of strategy, as evidenced by some authors [26,39], has
enormous off-target effects, because every miRNA regulates hundreds or thousands of mRNA targets.
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Alternatively, the use of miRNA Target Protectors (TPs) has been proposed as a promising option for
the development of effective tools for the correction of CFTR expression in people with CF. In this
context, we have here investigated the use of PNA strands as miRNA TPs. This strategy has the
advantage of protecting the CFTR mRNA from binding with the miRNAs, which remain free to
interact with their physiological mRNA targets. For this purpose, we have designed and synthesized
two negatively charged PNAs, PNAs 1 and 2 (Table 1), functionalized at the C-end with the negatively
charged tetrapeptide Gly-SerP-SerP-Gly to improve the water solubility and cellular uptake. The
chemico-physical characterization of PNA/nucleic acid heterocomplexes was performed through
CD, CD melting and UV experiments. To ease the nucleic acid handling during the CD and UV
investigations, all spectroscopic investigations were performed using the 3’UTR mRNA DNA mimic
(ODN in Table 1) rather than the corresponding RNA strand. This approach allowed us to avoid the
use of a nucleases-resistant chemically-modified RNA strand, which could have affected the binding
affinity with the studied PNAs. Circular dichroism measurements are useful in the characterization
of the secondary structure of nucleic acids and in the study of hybridization events. In this case, the
CD studies confirmed the capability of PNAs 1 and 2 to bind the target ODN strand and form the
corresponding heteroduplexes, whose melting temperatures were determined by derivatization of the
resulting CD melting curves (64 ◦C and 35 ◦C, respectively; Figure 3). In addition, the comparison of the
UV spectra shown in Figure 4 revealed a lower absorbance than the arithmetic sum of each component
alone for the 1/ODN heteroduplex. This confirms the occurrence of strong stacking interactions
between the DNA strand and 1. The same behavior was not observed for the UV spectra of 2/ODN
complex (Figure 5), even if the formation of the heteroduplex was supported by CD and molecular
dynamics studies. A possible explanation for this behavior could be found in the lower number of bases
involved in the Watson-Crick (W-C) base pairing for the 2/ODN complex relative to the total number of
bases in the two strands (PNA + ODN). Furthermore, the MD simulations of 2/RNA complex showed
high fluctuations for the terminal base pairs (Supplementary Materials, Figure S1C), indicating that
only four or five bases could be involved in stable W-C interactions in the heteroduplex. Finally, we
also performed MD simulations of 1/RNA and 2/RNA (1200 and 900 ns, respectively) to characterize
the structural features of these heteroduplexes conjugated to a negatively charged tetrapeptide tail. The
analysis of helicoidal parameters and torsion angles (Tables 2 and 3) revealed that both MD derived
PNA/RNA heteroduplexes showed similar structural features. PNA 1- and 2-containing helices were
slightly unwound and less bent with respect to the experimentally determined structures of PNA/RNA
heteroduplexes, as indicated by the lower twist values. On the other side, the helices appeared slightly
less bent than both NMR and XRAY derived structures because of lower roll values. The roll parameter,
indeed, indicated the degree of rotation with respect to the main helical axis, and, therefore, higher roll
values are associated to higher perturbation of the coplanarity of bases, inducing the bending of the
helix. The analysis of torsion angles of RNA and PNA backbones confirmed structural features very
similar to those of reference experimental structures. RNA strand torsion angles closely resembled
those found in the reference PNA/RNA NMR structure and in the canonical A-RNA structure. On the
other side, as previously reported [15,35–38], the PNA strand showed higher flexibility, particularly
in torsion angles α and ε, that may assume two sets of values −100◦ and 100◦ and −20◦ and 180◦,
respectively (Supplementary Materials, Figure S2 and Text S1). Taken together, these results indicated
that the negatively charged tetrapeptide slightly affects the structural features of the heteroduplexes
with respect to experimentally determined PNA/RNA heteroduplexes.
The ability of PNAs 1 and 2 to protect the miR-509-3p target site in the 3′UTR of CFTR gene
was evaluated by testing the effects on the expression of the luciferase gene cloned upstream. The
results have shown clearly that the transfection of the 7 bases long PNA 2 in A549 cells co-transfected
with miR-509-3p did not increase significantly the luciferase gene expression (Figure 6b), whereas
the co-transfection with the longer PNA 1 reduced the miR-509-3p gene inhibition by up to 70%
(Figure 6a). These results are apparently in contradiction with the results of our previous paper on the
efficacy of 7 and 14 bases long anti-miRNA PNAs to rescue the luciferase expression in the presence of
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miR-509-3p [15] (which showed almost the same potency for the two PNAs). A possible explanation
for the observed different behavior may be found in the different mechanism of action of the two
approaches. The anti-miRNA mechanism is based on the competition of PNAs with the miRNAs
for the mRNA target, whereas the activity of miRNA TPs is indeed the result of the formation of
heteroduplexes between PNAs and the target mRNA. In the latter case, the length of PNAs directly
correlates with the binding affinity for the target mRNA, due to the increasing number of base pairs
involved in longer duplexes. On the other side, the anti-miRNA approach requires that the PNAs
interact with miRNAs integrated in the RNA-induced silencing complexes, which result from the
association of miRNAs with proteins of the argonaute family [40]. Hence, the interaction of longer
PNAs with the miRNA-protein complex rather than with the free miRNA could be disfavored relative
to the interaction of shorter PNAs.
4. Materials and Methods
4.1. General Methods
All reagents and solvents were obtained from commercial sources and used without further
purification. Phosphoramidites for DNA syntheses were purchased from Glen Research (Sterling,
VA, USA). The ODNs were assembled by using the PerSeptive Biosystems Expedite DNA/RNA 8909
synthesizer using phosphoramidite chemistry. Peptide nucleic acid monomers were purchased from
Link technologies (Bellshill, Lanarkshire, UK). Fmoc-L-Ser[PO(OBzl)OH]-OH was purchased from Iris
Biotech GmbH (Marktredwitz, Germany). Fmoc-Gly-OH and the MBHA resin (1% divinylbenzene,
200–400 mesh, 0.5 mmol/g loading) were purchased from Sigma-Aldrich (Saint Louis, MO, USA).
The reactions on solid phase were performed using ISOLUTE®single fritted reservoirs (SG), 20 µm
PE (polyethylene), equipped with tube caps and luer tip caps Biotage (Uppsala, Sweden) which were
shaken in a Multi-reax vibrating shaker Heidolph (Schwabach, Germany). High performance liquid
chromatography (HPLC) analyses and purifications were carried out on a Jasco UP-2075 Plus pump
equipped with a Jasco (Easton, MD, USA) UV-2075 Plus UV detector using a 4.8 × 150 mm C-18
reverse-phase column (particle size 5 µm) eluted with a linear gradient of CH3CN containing 0.1%
(v/v) trifluoroacetic acid (TFA) in H2O containing 0.1% (v/v) TFA (from 0 to 100% in 45 min, flow
1.2 mL/min). UV spectra were recorded on a Jasco V-530 spectrophotometer (Jasco). CD spectra were
performed on a Jasco 1500 spectropolarimeter (Jasco) equipped with a Jasco PTC-348 WI Peltier-type
temperature controller in a 0.1 cm path length cuvette. ESI-MS experiments were performed on
an Applied Biosystems (Warrington, Cheshire, UK) 4000 QTRAP mass spectrometer in positive ion
electrospray mode, dissolving the compounds in H2O containing 0.1% (v/v) formic acid.
4.2. DNA Synthesis and Analysis
The oligonucleotide 5′GAAGCACCAATCA3′ was synthesized using solid phase β-cyanoethyl
phosphoramidite chemistry. After the synthesis, the oligomers were detached from the support and
deprotected by treatment with concentrated aqueous ammonia at 55 ◦C for 12 h. The combined filtrates
and washings were concentrated under reduced pressure, redissolved in H2O, and analyzed and
purified by HPLC on a Macherey Nagel (Düren, Germany) Nucleogel SAX column 1000-8/46 using
buffer A: 20 mM NaH2PO4 aqueous solution, pH 7.0, containing 20% (v/v) CH3CN; buffer B: 1 M
NaCl, 20 mM NaH2PO4 aqueous solution, pH 7.0, containing 20% (v/v) CH3CN; a linear gradient
from 0% to 100% B in 30 min and flow rate 1.2 mL/min were used. The oligomers were collected and
successively desalted by Sep-Pak cartridges (C18). The isolated oligomers were >99% pure (NMR).
The ODN concentration was determined spectrophotometrically at λ = 260 nm and 90 ◦C, using the
molar extinction coefficient ε = 200.9 cm−1·mM−1 calculated by the nearest neighbor mode.
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4.3. PNA Synthesis and Analysis
PNA sequences were synthesized using the Fmoc-solid-phase strategy. Fifty milligrams of MBHA
resin (0.5 mmol/g), after swelling in CH2Cl2 for 30 min and DMF washings, was treated with a
solution of 20% piperidine in DMF for 10 min. After washings in DMF (×5), the resin was reacted with
Fmoc-Gly (5 eq. in NMP 0.2 M), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium
3-oxid hexafluorophosphate (HATU) (5 eq. in DMF 0.2 M) and N,N-Diisopropylethylamine (DIPEA)
(5 eq.)/lutidine (7.5 eq.) for 45 min at room temperature. Couplings of Fmoc-L-Ser[PO(OBzl)OH]-OH
were achieved using the following conditions: Fmoc-Ser monomer (8 eq. in NMP 0.2 M), HATU (8 eq.
in DMF 0.4 M), and DIPEA (8 eq.)/lutidine (12 eq.) for 15 h at room temperature. After the serine
couplings, a further glycine residue was attached on the N-terminal of the serine tract following the
previously described coupling with the glycine monomer. PNA monomers were reacted using the
following conditions: monomer building block (10 eq. in NMP 0.2 M), HATU (10 eq. in DMF 0.2 M),
and DIPEA (10 eq.)/lutidine (15 eq.), 45 min at room temperature. After each coupling step, capping
with Ac2O in the presence of pyridine was performed for 20 min at r.t. Fmoc group was removed
by a treatment with a 5% 1,8-Diazabicyclo[5,4,0]undec-7-ene (DBU) in DMF solution (5 min). In the
case of Fmoc-Ser amino acids, the basic treatment was prolonged (20 min). At the end of synthetic
cycles, the PNAs were cleaved from the solid support by treatment with TFA/anisole/ethanedithiol
(9:1:1; v/v/v) for 4 h and the products were precipitated with cold diethyl ether. The precipitates
were recovered by centrifugation, washed twice with diethyl ether, dissolved in water, and finally
lyophilized. PNAs 3 and 4, chosen as the negative control and bearing the same functionalization of
PNAs 1 and 2, were synthesized using the same standard Fmoc-solid-phase strategy. The PNAs were
obtained with a 48–50% overall yield (94–95% medium yield for each coupling as estimated by Fmoc
spectrophotometric measurements). The crude sample was purified by semipreparative reverse phase
HPLC (see General methods). The collected fractions were lyophilized and the final pure product
was characterized by ESI-MS (positive mode): ESI-MS (m/z) calcd. for PNAs 1 and 3 4003.4; found
[M + 3H]3+ 1335.5, [M + 4H]4+ 1002.0; PNAs 2 and 4 2411.8; found [M + 2H]2+ 1206.9, [M + 3H]3+ 805.0.
The amount of each PNA sample dissolved in pure water was estimated by quantitative UV at 90 ◦C
using the following molar extinction coefficients: PNAs 1 and 3 ε = 126.5 mL·µmol−1·cm−1; PNAs 2
and 4 ε = 75.2 mL·µmol−1·cm−1 and DNA ε = 134.2 mL·µmol−1 ·cm−1.
4.4. Preparation of DNA/PNA Heteroduplexes (Annealing Procedure)
The PNA/ODN heteroduplexes (1.5:1) were obtained by dissolving the mixture of the samples at
the concentration of 2.0 × 10−5 M in 100 mM PBS and by heating the solution to 90 ◦C for 5 min and
then slowly cooling to room temperature over 12 h.
4.5. UV
The UV spectra were recorded with a Jasco V-530 UV spectrophotometer, in 100 mM PBS buffer
at the concentration of 20 µM. They were recorded at 20 ◦C (λ = 220–310 nm, 400 nm/min scanning
speed, 2.0 nm bandwidth).
4.6. CD and CD Melting Studies
The CD spectra were recorded with a Jasco 1500 spectropolarimeter equipped with a Peltier-type
temperature controller (PTC-348 WI) in a 0.1 cm cuvette, in 100 mM PBS buffer at the concentration of
20 µM. They were recorded at 5 ◦C (λ = 220–310 nm, 200 nm/min scanning speed, 2.0 nm bandwidth)
and averaged over three repetitions. A buffer baseline was subtracted from the CD spectra and the
spectra were normalized to have zero at 320 nm. Thermal denaturation experiments were also carried
out in the temperature range of 5–90 ◦C by monitoring the CD values at 266 nm for PNA 1/ODN and
at 264 nm for PNA 2/ODN at a heating rate of 1.0 ◦C/min.
Molecules 2017, 22, 1144 12 of 16
4.7. Molecular Dynamics (MD) Simulations
The initial structures were built following the same procedure described in [15], starting from
the NMR structure of the RNA(GAGUUC)/PNA(GAACTC) duplex (PDB-ID 176D) [28]. The
correct sequence was obtained by mutating the bases using the X3DNA software [41]. Each
heteroduplex was built including three flanking bases on both the 3′ and 5′ ends of the RNA segment
(Supplementary Materials, Table S1). Thermalization of the duplex and production of MD trajectories
were obtained using Amber 15 suite [30]. The leap module of Ambertools 15 was used to perform
the parameterization of the systems, using the ff14SB force field (AMBER99SB and frcmod.ff14SB
for peptide + ff99bsc0_chiOL3 for RNA) [42–44], and the Sanders et al. parameters for PNA [37],
whereas the parameters for serine phosphate were taken from [45]. TIP3P water molecules were
added with at least a minimum spacing of 14.0 Å between the edge of the box and the molecules. Na+
counterions were added to neutralize the system. The system was geometrically minimized in three
steps: (i) optimization of hydrogen atoms with 2000 steps of steepest descent algorithm and 8000 steps
of conjugate gradient algorithm, (ii) optimization of water molecules and counterions with 2000 steps
of steepest descent and 18,000 steps of conjugate gradient, and (iii) optimization of the whole system
with 2000 steps of steepest descent and 8000 steps of conjugate gradient. The equilibration of the
system was performed using the protocol described in [15]. Briefly: (i) the system was thermalized
in 240 ps, raising the temperature from 10 K to 298 K with a time step of 1 fs, and applying inter-
and intra-strand constraints of 20 kcal·mol−1·Å−2 in order to preserve, respectively, the W-C base
pairs and the torsional angles of the RNA sugar; ii) the constraints were gradually removed from
20 kcal·mol−1·Å−2 to 0.1 kcal·mol−1·Å−2 in 240 ps at constant pressure (1 bar) and temperature (298 K).
Finally, an equilibration step of 500 ps was run without constrains. Production runs were performed
using a time step of 2 fs. The SHAKE algorithm was used for all hydrogen atoms in conjunction with
periodic boundary conditions at constant pressure and temperature. Particle mesh Ewald was used for
the treatment of long range electrostatic interactions, and a cut-off of 9 Å was used for non-bonded
interactions. Each system was studied by means of 300 ns MD simulation runs in triplicate with
random seeding for the initial velocities. In order to investigate more deeply the stability of the PNA
1/RNA system, we extended one run to 600 ns, for a total of 1200 ns for the PNA 1/RNA and 900 ns for
the PNA 2/RNA. The analysis of the structure was carried out using the software Curves+ [31]. The
visualization of the trajectories and related snapshots were performed with Pymol [46] andVMD [47],
while the trajectory post-processing analysis was performed using Ambertools15 [30]. Cluster analysis
was performed through a hierarchical agglomerative (bottom-up) approach using a root-mean-square
(RMS) metric comparing the heavy atoms in the central duplex base-pairs. Correlation analysis was
performed calculating the Pearson correlation coefficient on torsion angles sampled each 0.01 ns.
4.8. Cell Line, Construct, and Transfections
A549 human lung carcinoma cells were purchased from ATCC (Manassas, VA, USA). The cells
were maintained in Dulbecco’s modified Eagle’s medium (Gibco Invitrogen, North Andover, MA, USA)
with 10% heat inactivated fetal bovine serum (HyClone Laboratories, South Logan, UT, USA) without
the addition of antibiotics. A Luciferase construct bearing the 3′UTR of the CFTR gene was used as
the miR-509-3p sensitive reporter system. The transfection of the A549 cells with miRNA-mimics
(Qiagen, Hilden, Germany) or PNAs was performed with the Attractene Transfection Reagent (Qiagen).
Briefly, the cells seeded in 96-well plates were cotransfected with the luciferase reporter construct,
miR-509-3p mimic and the PNAs. The luciferase activity level was measured 24 h after transfection
using the Dual-Glo Luciferase Assay System (Promega Corporation, Madison, WI, USA). The EnSpire
Multimode Plate Reader (Perkim Elmer, Waltham, MA, USA) was used for the luminescence assay
using 96-multiwell black plates. The relative reporter activity was obtained by normalization to the
Renilla luciferase activity.
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5. Conclusions
In this paper, we have proposed for the first time the use of PNAs as miRNA target protectors to
increase the expression of CFTR in CF. The negatively charged PNAs 1 and 2, conveniently modified at
their C-ends and fully complementary to the 3’UTR region of the CFTR mRNA recognized by the seed
region of miR-509-3p, were synthesized and characterized. To demonstrate the sequence dependent
activity of 1 and 2, two other PNAs (3 and 4, Table 1), containing scrambled sequences of 1 and 2,
respectively, were designed and synthesized. Spectroscopic data confirmed the ability of 1 and 2 to
bind their complementary ODN target by forming stable PNA/ODN heteroduplexes. The structural
features of 1/RNA and 2/RNA heteroduplexes were also determined through molecular dynamics
simulations. The results indicated that the presence of the negatively charged tetra peptide at the
C-end of 1 and 2 slightly affected the structural features of the resulting PNA/RNA heteroduplexes
(with respect to the experimentally determined PNA/RNA heteroduplexes). Biological studies show
that the PNA molecules are suitable to counteract the action of miR-509-3p (in this case) as miRNA
target protectors. These data confirm, once again, that a mRNA-targeted approach of a gene to increase
the expression of the protein could be a good therapeutic strategy (that, of course, could be also used in
other monogenic diseases). Moreover, the PNAs, showing a high affinity towards nucleic acid targets
and forming stable heteroduplex complexes, represent excellent candidates to be used for this approach.
Furthermore, this type of approach has the advantage of being relatively mutation-independent. For
this reason, it would be sufficient to increase the expression of a protein, even if mutated, to exceed the
threshold of minimal activity needed to obtain an optimal clinical phenotype.
Supplementary Materials: Supplementary materials are available online.
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Self-Assembly of G-Rich Oligonucleotides Incorporating
a 3’–3’ Inversion of Polarity Site: A New Route Towards
G-Wire DNA Nanostructures
Giorgia Oliviero,[b] Stefano D’Errico,[a] Brunella Pinto,[a] Fabrizia Nici,[a] Principia Dardano,[c]
Ilaria Rea,[c] Luca De Stefano,[c] Luciano Mayol,[a] Gennaro Piccialli,[a] and Nicola Borbone*[a]
1. Introduction
In the development of new nanotechnologies and biomateri-
als, the possibility of assembling ordered supramolecular struc-
tures starting from small building blocks and the exploitation
of self-assembly driving forces are very important and much
studied topics.[1–3] In the bottom-up approach, DNA strands
have been demonstrated to be very useful building blocks for
the assembly of supramolecular structures of various dimen-
sions and shapes. For example, the DNA nanotechnology
known as DNA origami allows the design and the construction
of tailored three-dimensional superstructures by exploiting the
Watson–Crick base-pairing scheme.[4–7] Besides the Watson–
Crick base-pairing scheme, also the Hoogsteen hydrogen
bonding one, which allows the formation of G-quadruplex
DNA, can be exploited to obtain DNA supramolecular struc-
tures. G-Quadruplexes are unusual secondary structures of
DNA, which form when guanine-rich DNA strands are annealed
in the presence of suitable monovalent or divalent cations.
The building block of G-quadruplexes is the G-quartet (Fig-
ure 1A), a planar arrangement of four guanines held together
by a cyclic array of eight Hoogsteen hydrogen bonds.[8–10] The
onset of p–p interactions among the stacked G-quartets great-
ly stabilizes the G-quadruplex assembly, which is generally
more stable than a DNA duplex of the same length. A G-quad-
ruplex can be formed by one, two, or four G-rich DNA strands
and can be classified as either parallel, antiparallel, or hybrid
type depending on the mutual orientation of the strands in-
Obtaining DNA nanostructures with potential applications in
drug discovery, diagnostics, and electronics in a simple and af-
fordable way represents one of the hottest topics in nanotech-
nological and medical sciences. Herein, we report a novel strat-
egy to obtain structurally homogeneous DNA G-wire nano-
structures of known length, starting from the short unmodified
G-rich oligonucleotide d(5’-CGGT-3’–3’-GGC-5’) (1) incorporat-
ing a 3’–3’ inversion of polarity site. The reported approach al-
lowed us to obtain long G-wire assemblies through 5’–5’ p–p
stacking interactions in between the tetramolecular G-quadru-
plex building blocks that form when 1 is annealed in the pres-
ence of potassium ions. Our results expand the repertoire of
synthetic methodologies to obtain new tailored DNA G-wire
nanostructures.
Figure 1. Schematic representations of a G-tetrad (A) and of interlocked (B)
and stacked (C) G-wire polymers.
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volved in the G-quartets formation.[11,12] Further factors that
contribute to the wide polymorphism of G-quadruplexes are
the length and the base composition of the loops (when pres-
ent), as well as the nature of the cations used to stabilize the
quadruple helix structure.[13–15] The biological implications of G-
quadruplexes in cellular processes[16–18] and their use as promis-
ing drugs[19–22] or in drugs delivery[23] and diagnostics[23–25] are
well known. In addition, G-quadruplexes possess greater con-
ductivity than DNA duplexes, thus suggesting their use for the
obtainment of electronic nano-biomaterials and nanodevi-
ces.[26–28] These properties indicate the G-quadruplex scaffold
as a useful structural motif to obtain supramolecular self-as-
semblies, including the so-called G-wires.[29–32] G-wire super-
structures can reach the length of thousands of nanometers
along the axis perpendicular to the G-tetrad planes. Depend-
ing on the topological arrangement of the G-rich strands par-
ticipating in their formation, G-wires can be classified into two
categories: i) interlocked G-wires, characterized by the coopera-
tive assembly of interlocked slipped strands (Figure 1B) and
ii) stacked G-wires, characterized by the multimerization of G-
quadruplex building blocks held together by end-to-end p–p
stacking (Figure 1C). Besides the well-known interlocked G-
wires[29–35] and G-wires containing both topological motifs,[36–38]
only a few examples of exclusively stacked G-wires have been
reported so far.[39–41]
In a previous study, we reported that in the presence of K+
cations the 7-mer d(CGGTGGT) can assemble into the octamer-
ic higher-ordered G-quadruplex complex d(CGGTGGT)8 (Fig-
ure S1 in the Supporting Information) through p–p stacking of
two unusual G(:C):G(:C):G(:C):G(:C) planar octads belonging to
two identical tetramolecular parallel G-quadruplexes.[42] Later,
we demonstrated that the same dimerization pathway is also
possible for all the other d(CGGXGGT) DNA strands, with X=A,
G, or C.[43] Herein, we report on the achievement of a new type
of stacked G-wire, here indicated as Qn (Figure 2) obtained by
exploiting the 5’–5’ p–p stacking interactions between the
G(:C):G(:C):G(:C):G(:C) octads formed at both ends of the tetra-
molecular G-quadruplex building block Q1 (Figure 2). The last
forms when the d(5’-CGGT-3’–3’-GGC-5’) DNA strand (1,
Figure 2), incorporating a 3’–3’ inversion of polarity site, is an-
nealed in the presence of K+ ions. The resulting G-wires were
obtained as a distribution of quadruplex multimers of different
length.
The n subscript in Qn indicates the number of tetramolecular
G-quadruplex building blocks participating in the G-wires elon-
gation. The actual formation of the target G-wires was con-
firmed by polyacrylamide gel electrophoresis (PAGE), HPLC size
exclusion chromatography (HPLC-SEC), circular dichroism (CD),
1H nuclear magnetic resonance (NMR) spectroscopy, and
atomic force microscopy (AFM) studies. The analytical results
allowed us also to gather information on the G-wires assembly
and stability, and to isolate and characterize the three shortest
Qn species (n=2–4).
2. Results and Discussion
2.1. Synthesis of d(5’-CGGT-3’–3’-GGC-5’) and G-Wires
The d(5’-CGGT-3’–3’-GGC-5’) (1) incorporating a 3’–3’ inversion
of polarity site was synthesized by using a solid-phase auto-
mated DNA synthesizer as described in the Experimental Sec-
tion. The inversion of polarity site was achieved by performing
the first four coupling cycles with 5’-phosphoramidites and the
remaining three with standard 3’-phosphoramidites. The Qn
species were obtained by heating 1—dissolved in 1.0m K+
containing buffer at the single strand concentration of 0.1 or
1.6 mm—at 90 8C for 10 min and then rapidly cooling it to 4 8C
(fast annealing procedure). All samples were stored at 4 8C for
24 h before further investigation.
2.2. PAGE Studies
The annealed 1.6 mm 1 was analyzed by PAGE to obtain infor-
mation on its propensity to form the tetramolecular G-quadru-
plex building block Q1 and/or the target Qn multimers. For this
purpose, we compared the electrophoretic mobility of
1 (lane 3 in Figure 3) with those of the G-quadruplexes
d(TGGGGT)4 (lane 1) and d(CGGTGGT)8 (lane 2), used as size
Figure 2. Formation of the G-quadruplex building block Q1 and its multi-
merization into Qn G-wire polymers starting from the ODN 1. The expected
stabilizing K+ ions are shown as red spheres.
Figure 3. Electrophoretic mobility of the ODNs under study annealed in
1.0m K+ buffer. Lane 1: d(TGGGGT)4 ; lane 2: d(CGGTGGT)8 ; lane 3: ODN 1;
lanes 4–7: isolated peaks from the HPLC-SEC fractionation of annealed 1;
lane 8: single-stranded DNA reference ladder.
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markers for the tetramolecular G-quadruplex building block Q1
and for its eight-stranded dimer Q2, respectively. At the studied
conditions, the annealed 1 migrated as a ladder of bands, thus
confirming its propensity to form G-quadruplex multimers. The
electrophoretic mobility of the two fastest bands matched
almost perfectly with that of the size markers in lanes 1 and 2,
thus confirming the formation of a tetra-stranded Q1 and octa-
stranded Q2 ; whereas the remaining slower bands in lane 3
were likely a result of longer Qn species (n+3). The electropho-
retic mobility of the isolated Q1–4 species, obtained by HPLC-
SEC fractionation (see the following section), was also assessed
(lanes 4–7). Taken together, the PAGE data suggested that the
oligodeoxynucleotide (ODN) 1 in the presence of K+ ions is ca-
pable of self-assembling in a distribution of G-wire species of
different lengths (Qn) obtained by the sequential stacking of
the tetramolecular G-quadruplex building block Q1 presenting
two “sticky” G(:C):G(:C):G(:C):G(:C) planar octads at both 5’-
ends.
2.3. SEC Studies
The Qn G-wire population was analyzed by HPLC-SEC at room
temperature on a ReproSil 200 SEC column 24 h after anneal-
ing and storage at 4 8C. The HPLC profile of the annealed
0.1 mm 1 showed a distribution of peaks in which low molecu-
lar weight species had greater retention times (Figure S2A in
the Supporting Information). To obtain information on the MW
of the observed product peaks, we used the same HPLC-SEC
conditions (see the Experimental Section) to determine the re-
tention times (Rt) of i) the single-stranded dT7 (panel B), ii) the
tetramolecular quadruplex d(TGGGGT)4 (panel C), and iii) the di-
meric quadruplex d(CGGTGGT)8 (panel D). Based on the HPLC-
SEC data, the peak at the highest retention time (Rt=
21.45 min) was attributed to the single-stranded 1, whereas
the two preceding peaks (at Rt=19.89 and 19.02 min) were as-
signed to the G-quadruplex building block Q1 and to its dimer
Q2, respectively. From these data, it was reasonable to hy-
pothesize that each peak in the HPLC-SEC profile belongs to
a species differing from those of the adjacent peaks for a MW
corresponding to the tetramolecular G-quadruplex building
block Q1 (i.e. 28 nucleotides). Exploiting the good peak resolu-
tion on the HPLC-SEC column, the species likely corresponding
to Q1–4 were recovered and their purity and electrophoretic
mobility assessed by PAGE (Figure 3, lanes 4–7). PAGE results
confirmed the purity and allowed us to match the species re-
sponsible for the four fast-moving bands in the PAGE (i.e. Q4,
Q3, Q2, and Q1 from the slowest to the fastest band in
Figure 3) with the four corresponding peaks in the HPLC-SEC
distribution (i.e. Q4, Q3, Q2, and Q1 from the least to the most
retained in Figure S2A in the Supporting Information). Further-
more, HPLC-SEC re-injection of the isolated Q1–4 species, per-
formed 24 h after their isolation and storage at 4 8C (Figure S3
in the Supporting Information), disclosed that the G-quadru-
plex building block Q1 and the first three Qn species (Q2–4) do
not interconvert each other and can be stored as single G-wire
segments of known length for at least 24 h. However, consider-
ing the contribution of entropy to the formation of Qn G-wires,
different behaviors could be anticipated for samples of 1 an-
nealed at different ODN concentrations. Thus, we exploited the
good chromatographic separation of Qn species to assess the
effect of the ODN annealing concentration on the formation
and size distribution of Qn species. As expected, the HPLC-SEC
profile of Qn obtained 24 h after the annealing of 1 at 1.6 mm
concentration (Figure 4) confirmed that the formation of
longer G-wires is strongly dependent on the ODN concentra-
tion during the annealing procedure. Indeed, in Figure 4 all Qn
species with n,8 are clearly distinguishable and almost equal-
ly populated, and an intense envelope peak attributable to
longer G-wires is present at Rt=13.6 min. Conversely, in the
HPLC-SEC profile obtained from the sample annealed at
0.1 mm ODN concentration (Figure S2A in the Supporting In-
formation), the envelope peak is absent and only the Qn spe-
cies with n,3 are significantly populated.
The effect of the temperature on the distribution of Qn spe-
cies was investigated by HPLC-SEC 24 h after the annealing of
0.1 mm 1 in 1.0m K+ buffer. HPLC-SEC analyses were per-
formed by injecting the sample 30 min after heating and equi-
libration at 25, 45, 65, and 85 8C (Figure S4 in the Supporting
Information). The profile obtained from the sample injected at
25 8C showed almost the same Qn distribution as the sample
injected at 4 8C, but showed that at room temperature the di-
meric Q2 species not only is more abundant than the building
block Q1 (whereas the opposite was observed in the sample
stored and injected at 4 8C), but represents the most abundant
species. The progressive heating of the sample determined the
reduction of the amount of Qn species and the contextual in-
crease of the single-stranded 1, which resulted in the only ob-
servable peak at 85 8C. However, two significant outcomes
emerged from the profiles obtained at 45 and 65 8C: 1) at
45 8C, although the most abundant species was represented
by the single-stranded 1, we observed that the distribution of
Qn species shifted towards longer G-wires, with the appear-
ance of a new peak at Rt=13.3 min and with the Q3 species
being even more abundant than Q2 ; 2) the analysis of the pro-
Figure 4. HPLC-SEC profile of Qn distribution obtained by annealing 1.6 mm
1 in 1.0m K+ containing buffer. ss= single-stranded 1.
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file obtained at 65 8C suggested that the Qn species melt
through a cooperative process, which drives directly to the
random coil 1 (the peak of the G-quadruplex building block Q1
was even less abundant than that of Q5 species). The higher
thermal stability of Qn species relative to Q1 was also con-
firmed by CD melting data (see the following section).
2.4. CD Studies
CD is a well-established diagnostic technique to provide pre-
liminary information about the topology of G-quadruplexes in
solution. Generally, the CD profile of parallel G-quadruplexes,
in which all guanosines in the G-tetrads are in the anti glycosi-
dic bond conformation (Type 1 stem), is characterized by a pos-
itive signal at around 264 nm and a negative signal at around
240 nm; whereas that of antiparallel G-quadruplexes with alter-
nating syn–anti glycosidic bonds along the stem (Type 3 stem)
shows a positive signal at 245 nm, a trough at around 260 nm,
and a second positive signal at 290 nm.[41,44–46] Considering the
formation of stacking interactions between the terminal G-tet-
rads of Q1 building blocks (required to obtain the Qn G-wires)
and the presence of the 3’–3’ inversion of polarity site within
the stem of Q1 and its multimers, the CD profile obtained for
the annealed 1 (containing a mixture of Qn of different
lengths), showing positive signals at 246 nm and 300 nm and
a negative signal at 270 nm (Figure 5, dashed line), was some-
what unexpected. In fact, although the latter structural fea-
tures anticipated for a Type 2 CD profile,[44] the experimental
result resembled that of a Type 3 stem. A Type 3 stem could be
obtainable from 1 only if the thymines of two ODN 1 strands
would participate in the formation of a propeller loop, thus al-
lowing the formation of a bimolecular antiparallel quadruplex
stem. However, this structural hypothesis has been ruled out
by PAGE and HPLC-SEC evidence, which indicated the exclusive
formation of the tetra-stranded quadruplex building block and
its multimers.
Indeed, the CD profile of Qn resembles those reported for
the G-quadruplexes formed by d(5’TG3’–3’GGT)4
[47] and
d(TGG3’–3’GGT)4
[48] incorporating a 3’–3’ inversion of polarity
site and characterized by the presence of all anti G-tetrads.
The occurrence of the same system of uninterrupted stacked
G-tetrads, including both clockwise and counter-clockwise di-
rectionality, in Q1 and Qn could explain the CD profiles shown
in Figure 5. The resulting structural hypothesis requires that
the thymines are projected outside the quadruplex stem to
form bulge loops,[49] as depicted in Figure 2. Unfortunately, the
strong positive signal at 300 nm induced by the presence of
the 3’–3’ inversion of polarity site precluded the observation of
the negative band at 290 nm, which, in our previous studies,
proved diagnostic for the formation of higher-ordered G-quad-
ruplex assemblies obtained by non-covalent p–p stacking of
planar G(:C):G(:C):G(:C):G(:C) octads.[42,43] Similar CD profiles
were obtained for the isolated Q1–4 (Figure 5, colored lines),
thus confirming that the CD profile of Qn was the result of the
presence of quadruplex assemblies of different lengths incor-
porating the 3’–3’ inversion of polarity site. The overall thermal
stability of the species populating the Qn distribution and that
of the isolated Q1–4 complexes was assessed by means of CD
denaturation experiments (Figure S5 in the Supporting Infor-
mation). The resulting apparent melting curves clearly provid-
ed evidence that the thermal stability of the quadruplex multi-
mers was higher than that of the parent quadruplex building
block Q1.
2.5. NMR Spectroscopy
The formation of G-quadruplex assemblies from suitable G-rich
ODN sequences is usually confirmed by water-suppressed
1H NMR spectroscopy. When the N-1 imino protons of guanine
bases are engaged in Hoogsteen-type hydrogen bonding with
the O-6 carbonyl oxygen atoms of flanking guanines in each
G-tetrad, they are protected from exchange with the hydrogen
atoms of the solvent and are thus visible in the 1H NMR spec-
trum as quadruplex-diagnostic slightly broad signals resonat-
ing between 10 and 12 ppm.[50,51] Depending on the orienta-
tion of the strands and on the glycosidic torsion angle of gua-
nosines participating in G-tetrads, the four imino protons in
each G-tetrad resonate as one, two, or four NMR signals.[52] The
downfield region of the water-suppressed 1H NMR spectra of
the Qn distribution—obtained by annealing 1 in 1m K
+ buffer
at 1.6 mm single strand concentration—recorded at 25, 45, 65,
and 85 8C are shown in Figure S6 in the Supporting Informa-
tion. In agreement with the CD evidence, the observation of
the G-quadruplex diagnostic imino protons signals in the 11–
12 ppm region confirmed the presence in solution of G-quad-
ruplex species at temperatures lower than 65 8C. However, the
intensity and the shape of imino and anomeric protons signals
differed significantly from those we observed in the 1H NMR
spectra of the dimeric higher-ordered G-quadruplexes formed
by CGGTGGT[42] and CGGAGGT.[43] In the two latter, four well-re-
solved imino protons (11.0–12.0 ppm) and intense anomeric
protons signals (5.5–6.5 ppm) were visible at temperatures up
to 65 8C. Conversely, in the NMR spectra of 1 recorded at 25
and 45 8C, all imino and anomeric signals appeared severely
broadened, thus suggesting the involvement of imino and
anomeric protons in chemical or conformational exchange
Figure 5. CD spectra of Qn distribution (dashed curve) and isolated Q1 (black
curve), Q2 (green curve), Q3 (red curve), Q4 (blue curve) G-quadruplexes.
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phenomena. The line broadening of the imino protons was so
intense as to require 10V software amplification for signal ob-
servation (see insets in Figure S6 in the Supporting Informa-
tion). As far as the low intensity of the imino proton signals is
concerned, we hypothesize that the presence of the bulge
loops connecting the stacked G3 and G5 tetrads destabilizes
the G-quadruplex stem, thus speeding up the imino proton ex-
change with water. The anomeric proton signal broadening, in-
stead, could be the result of side-by-side aggregation of G-
quadruplex units, as seen by Hu et al. in G-wire assemblies
formed by dGMP annealed in the presence of Sr2+ .[53] As we
have shown in our previous papers,[42,43] the anomeric protons
are located at the outer shell of 2Q-like quadruplexes, thus it is
conceivable that lateral contacts between flanking G-quadru-
plex structures participating in the Qn G-wire distribution could
be responsible for the observed anomeric signal broadening.
As we will see in the following section, AFM evidence supports
the formation of extended quadruplex layers by lateral aggre-
gation of quadruplex units. Although AFM gives us a picture of
quadruplex aggregates deposited on mica surfaces, we believe
that such aggregates could also form in solution considering
the relatively high ODN concentration used for the preparation
of the NMR samples (6.0 mm). In the light of this hypothesis,
the comparison of the NMR spectra recorded in the 25–85 8C
temperature range indicates that the breakdown of quadru-
plex aggregates and the melting of quadruplex units to the
random coil 1 are cooperative processes, which start at tem-
peratures between 45 and 65 8C and complete at temperatures
lower than 85 8C.
2.6. AFM Studies
Qn quadruplexes interact and self-assemble on mica surfaces in
different ways depending on their concentration in the starting
solution. The morphology of the obtained films has been in-
vestigated by AFM by using 1.6 mm and 16 mm solutions of
1 in 0.1m phosphate buffer, at pH 7.0. Muscovite mica was
used as the AFM support both for the super-hydrophilic prop-
erty of its surface, which guarantees a lower interaction be-
tween suspended molecules in aqueous solution during the
evaporation of the solvent, and for its flatness, with less than
0.5 nm of root mean-square (r.m.s.) roughness for a 1000V
1000 nm2 surface area. The AFM images of the G-quadruplexes
spontaneously adsorbed from 1.6 mm ODN freshly prepared
solutions showed a densely populated surface (Figure S7 in
the Supporting Information), characterized by aggregates of
different lengths and widths (x,y coordinates on panels A–C),
whereas their heights (z coordinate) are always around 2 nm.
These structures are due to the formation, after adsorption on
the mica surface, of rod-like shaped quadruplex aggregates
grown during the evaporation of a 2 mL drop of 1.6 mm solu-
tion (panel A, scale bar=1 mm). The preferential direction of
alignment of the G-rodlets is well evident in panel B—the
scale bar is 200 nm—where aggregates with lengths from 21
up to 166 nm (average value of 60:40 nm) are shown; widths
are in the tenths of nanometers range and are always less than
100 nm; heights are almost all about 2 nm (see the statistics
panels reported in Figure S7 in the Supporting Information).
The AFM results are compatible with reported SEC results con-
sidering that, differently from height measurements, the
length and width measurements are affected by the curvature
radius of the AFM tip. The preferred orientation can be as-
cribed to the interaction between G-quadruplexes and the
mica surface. The homogeneous values of heights recorded
suggested the formation of self-assembled monolayers in the
x,y plane owing to the evaporation of the buffer solution,
which promoted lateral and longitudinal aggregation of G-
quadruplexes, the first one being favored by side-packing.
A 100-times diluted solution gave different results, as can be
noted in Figure S8 in the Supporting Information. Even if a pre-
ferred orientation could still be envisaged, the structures
seemed sparser and less ordered (see panel A); lengths are in
the same interval as before, whereas the widths are smaller,
never exceeding 30 nm, as evident from the measurements in
panel B. Also in this case, a tip radius of curvature of about
10 nm must be taken in account. This result confirmed a side-
packing mechanism in the assembly of G-structures during
evaporation of the solution. The heights are always about
2 nm as before (see measurements in panel C), again endors-
ing the hypothesis of spontaneous formation of a monolayer.
In the case of diluted starting solution, the longitudinal aggre-
gation is competitive compared with the lateral one, owing to
steric conditions during the evaporation.
3. Conclusions
In this paper, we reported the successful results of our study
aimed at the obtainment of a new kind of G-wire DNA by ex-
ploitation of p–p stacking interactions between tetramolecular
G-quadruplex building blocks incorporating a 3’–3’ inversion of
polarity site and exposing G(:C):G(:C):G(:C):G(:C) planar “sticky”
octads at both 5’-ends. The main findings of the study can be
summarized as follows: 1) the obtained G-wires are unprece-
dented and are achievable by using the short 5’CGGT3’–
3’GGC5’ G-rich ODN as the starting material in a facile and af-
fordable way; 2) the use of a tetramolecular G-quadruplex
building block to obtain DNA G-wire polymers represents
a major improvement over the use of monomolecular G-quad-
ruplexes, which, possessing different end-faces and lateral nu-
cleotide loops, could induce the formation of different kinds of
aggregates thus reducing the amount of target G-wires; 3) the
reported G-wires can be easily monitored in their formation
and length-growth by PAGE and HPLC-size exclusion chroma-
tography. We also demonstrated that the HPLC-SEC technique
can be used to determine the number of quadruplex building
blocks in each Qn G-wire, as well as to isolate and recover the
three shortest Qn species (n=2–4).
Experimental Section
DNA Synthesis and Purification
DNA sequences d(TGGGGT) and d(CGGTGGT) were chemically syn-
thesized with an Expedite 8909 DNA synthesizer (PerSeptive Bio-
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systems, USA) using a universal CPG support purchased from Glen
Research. The syntheses were performed by adopting the standard
b-cyanoethyl phosphoramidite chemistry at 10–15 mm scale and
the products were purified as previously described.[54] The synthe-
sis of d(5’-CGGT-3’–3’-GGC-5’) (1) was performed with the same
DNA synthesizer. The inversion of polarity site within the sequence
was achieved by initially assembling the 5’-CGGT-3’ tract by using
5’-phorphoramidites and then the 3’-GGC-5’ tract with standard 3’-
phosphoramidites. After completion of the ODN sequence, the
support was treated with concentrated aqueous ammonia at 55 8C
for 15 h. The combined filtrates and washings were concentrated
under reduced pressure and purified through HPLC (JASCO
PU2089 pumps equipped with the JASCO 2075 UV detector) with
an anion exchange column (Macherey–Nagel, 1000-8/46, 4.4V
50 mm, 5 mm) using a linear gradient from 0 to 100% B in 30 min,
flow rate=1 mLmin@1 and detection at 260 nm (buffer A: 20 mm
NaH2PO4 aq. solution pH 7.0, containing 20% (v/v) CH3CN; buffer
B: 20 mm NaH2PO4 aq. solution pH 7.0, containing 1m NaCl and
20% (v/v) CH3CN).
Annealing Procedure
The ODN concentrations were determined in water by measuring
the absorbance at 260 nm at 90 8C by using the nearest-neighbor
calculated molar extinction coefficient of 5’-CGGTGGC-3’ (e=
63100m@1cm@1). The 0.1 and 1.6 mm solutions of 1 were obtained
by dissolving the lyophilized sample in 900 mm KCl and 100 mm
KH2PO4. The samples were annealed by heating at 90 8C for 10 min
and then quickly cooling to 4 8C. After the annealing procedure,
the samples were stored at 4 8C before measurements.
PAGE
Native gel electrophoresis experiments were performed on 20%
polyacrylamide gels containing TBE (8.9 mm Tris, 8.9 mm borate,
0.2 mm EDTA, from BIORAD) and 30 mm KCl, at room temperature,
120 V for 2 h. The ODN samples, annealed at 1.6 mm single strand
concentration in 1.0m K+ buffer, were diluted at 0.6 mm loading
concentration just before the PAGE runs. Glycerol was added (10%
final) to facilitate sample loading in the wells. The bands were fi-
nally visualized by ethidium bromide staining in a Bio-Rad Labora-
tories Gel DocTM XR+ image system.
HPLC-SEC Analyses and Isolation of Qn Species
HPLC-SEC analyses and purifications were performed with a Repro-
Sil 200 SEC column operating in the MW range of 2000–
70000 Dalton (Dr. Maisch GmbH, 300V8 mm, 5 mm) eluted with
90 mm KCl and 10 mm KH2PO4/CH3CN (80:20, v/v), flow rate
0.5 mLmin@1, detector at 260 nm. The analyses were performed at
room temperature.
CD
CD spectra and CD melting profiles were recorded with a Jasco
715 CD spectrophotometer (Jasco, Tokyo, Japan) equipped with
a Jasco JPT423S Peltier temperature controller in 1 mm optical
path quartz cuvettes (100 nmmin@1 scanning speed, 1 s response
time). The spectra were recorded in triplicate at 4 8C from 220 to
320 nm. CD samples were prepared in potassium buffer (90 mm
KH2PO4 and 10 mm KCl) at 20 mm final single strand concentration.
The buffer baseline was subtracted from each spectrum and the
spectra were normalized to have zero at 320 nm. CD melting
curves were registered at 268 nm, 1 8Cmin@1 heating rate, tempera-
ture range 5–90 8C.
NMR Spectroscopy
NMR data were recorded with a Varian UNITYINOVA 500 MHz spec-
trometer equipped with a broadband inverse probe with z-field
gradient. The data were processed by using the iNMR software
package (http://www.inmr.net). One-dimensional NMR spectra
were acquired as 16384 data points with a recycle delay of 1.0 s at
25, 45, 65, and 85 8C and the spectra were apodized with a shifted
sine bell squared window function. Water suppression was ach-
ieved by including a double pulsed-field gradient spin-echo
(DPFGSE) module[55,56] in the pulse sequence prior to acquisition.
NMR samples were prepared at the concentration of 1.6 mm single
strand in 200 mL of H2O/D2O 9:1 containing 900 mm KCl and
100 mm KH2PO4.
AFM
A XE-100 Park Systems instrument was used for the AFM imaging
of Qn G-wires. Surface imaging was obtained in non-contact mode
by using 125 mm long silicon/aluminium-coated cantilevers (PPP-
NCHR 10m ; Park Systems; tip radius lower than 10 nm), with a reso-
nance frequency of 200 to 400 kHz and nominal force constant of
42 Nm@1. The scan frequency was typically 0.5 Hz per line. When
necessary, the AFM images were processed by flattening to
remove the background slope, and the contrast and brightness
were adjusted. Muscovite mica of about 1 cm2 surface was used as
the substrate in the AFM study. Muscovite mica surfaces are typi-
cally used as AFM substrates owing to their perfect cleavage along
a <001> plane, yielding large atomically flat areas. Mica consists
of layers of an aluminium phyllosilicate lattice ionically bonded
through interstitial K+ ions. Upon cleavage, the K+ ions are highly
mobile and are readily exchanged with divalent cation species at
the solid–liquid interface. This exchange results in a positive over-
charging of the mica surface, which enables the deposition of mol-
ecules that hold a net negative charge, such as DNA.[57] Moreover,
the positive charge distribution after cleavage enables a super-hy-
drophilic surface that guarantees a lower interaction between sus-
pended biomolecules during the evaporation of aqueous solvent.
Mica was freshly cleaved by using adhesive tape prior to each dep-
osition to establish its cleanliness. Aliquots (2 mL) of the DNA/imag-
ing buffer were directly deposited by casting onto freshly cleaved
muscovite mica. After 2 min, every sample was gently washed with
deionized water and then dried by evaporation at room tempera-
ture under a ventilated fume hood.
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Available online xxxxBackground: G-quadruplex DNA is involved in many physiological and pathological processes. Both clinical and
experimental studies on DNA G-quadruplexes are slowed down by their enzymatic instability. In this frame,
more stable chemically modiﬁed analogs are needed.
Methods: The bis-end-linked-(gggt)2 PNAmolecule (BEL-PNA)was synthesized using in solution and solid phase
synthetic approaches. Quadruplex formation was assessed by circular dichroism (CD) and surface enhanced
Raman scattering (SERS).
Results: An unprecedented bimolecular PNA homo quadruplex is here reported. To achieve this goal, we devel-
oped a bifunctional linker that once functionalized with gggt PNA strands and annealed in K+ buffer allowed
the obtainment of a PNA homo quadruplex. The identiﬁcation of the strong SERS band at ~1481 cm−1, attribut-
able to vibrations involving the quadruplex diagnostic Hoogsteen type hydrogen bonds, conﬁrmed the formation
of the PNA homo quadruplex.
Conclusions: By tethering two G-rich PNA strands to the two ends of a suitable bifunctional linker it is possible to
obtain bimolecular PNA homo quadruplexes after annealing in K+-containing buffers. The formation of such CD-
unfriendly complexes can be monitored, even at low concentrations, by using the SERS technique.
General signiﬁcance:Given the importance of DNA G-quadruplexes in medicine and nanotechnology, the obtain-
ment of G-quadruplex analogs provided with enhanced enzymatic stability, and their monitoring by highly sen-
sitive label-free techniques are of the highest importance. This article is part of a Special Issue entitled “G-
quadruplex” – guest edited by Dr. Concetta Giancola and Dr. Daniela Montesarchio.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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G-rich oligonucleotide (ON) sequences have a natural propensity to
fold into unusual secondary structures, named G-Quadruplexes (G-Qs),
whose fundamental units are planar arrangements of four guanine
bases held together by Hoogsteen hydrogen bonds (G-quartets) and
stabilized by monovalent cations. Despite the G-Q core is always the
same – two or more stacked G-tetrads – G-Qs are characterized by
extremely high variability in regards to the folding topology, loopplex" Guest Editor: Dr. Concetta
Università degli Studi di Napoli
), gennaro.piccialli@unina.it
hesis and label free characteri
016.11.037orientation, molecularity and glycosidic bonds orientation [1–5].
Owing to the evidence of G-Qs formation within the vertebrate ge-
nomes [6–7], G-Qs have attracted great interest since their discovery.
It is well known that G-Qs are involved in a number of key biological
processes, including gene regulation [8–14] and protein activity modu-
lation [15–16]. Furthermore, the propensity of suitable G-rich ONs to
self-assemble into highly ordered supramolecular G-Qs indicates the
former as useful structural elements for the construction of nanoscale
assemblies to be used in nanotechnology and biosensing [17–20]. How-
ever, the use of natural G-rich ONs as G-Q building blocks is hampered
by their enzymatic instability towards the ubiquitous exonucleases
and endonucleases. Hence, much efforts have been devoted to the de-
velopment of quadruplex-forming ON analogs provided with improved
chemical and enzymatic resistance [21–25].
Among the most interesting DNA analogs are peptide nucleic acids
(PNAs), ﬁrst reported by P. E. Nielsen in 1991 [26]. PNAs are DNAzation of a bimolecular PNA homo quadruplex, Biochim. Biophys. Acta
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aminoethyl-glycine chain. PNAs are resistant to enzymatic hydrolysis
and recognize – by formation of standard Watson-Crick hydrogen
bonds – with high afﬁnity and speciﬁcity complementary fragments of
DNA or RNA to give the resulting PNA/DNA or PNA/RNA hetero du-
plexes [27–35], triplexes [36–40] and quadruplexes [41–44], respective-
ly. Notwithstanding the stronger binding afﬁnity of PNA strands with
complementary ONs and the remarkable stability of PNA/DNA hetero
triplex and quadruplex structures, only few papers have reported
about the formation of stable PNA homo G-Qs [45–46]. Indeed, to the
best of our knowledge, only tetramolecular PNA homo G-Qs have
been reported so far; despite their unfavorable kinetic and thermody-
namic parameters [46]. In trying to ﬁll this gap, we have undertaken a
series of studies aimed at the obtainment of stable PNA homo G-Qs,
exploiting the standard PNA solid phase synthetic strategy and our ex-
perience in the preparation of bis- and tetra-end linkers (BEL and TEL,
respectively) [47].
Herein, we report the results of our study aimed at the design and
structural characterization by Circular Dichroism (CD) and Surface En-
hanced Raman Scattering (SERS) of an unprecedented bimolecular
PNA homo G-Quadruplex obtained by annealing the BEL-g3t (g = gua-
nine PNA monomer; t = thymine PNA monomer) building block 19
(Scheme 2) synthesized using the suitable protected tri-functionalized
linker 8 (Scheme 1).
CD spectroscopy is the techniquemost widely used to investigate G-
quadruplex topologies. The main attraction of CD spectroscopy is its
ability to discriminate between parallel and anti-parallel strands orien-
tation, although some exceptions to the general rules have been report-
ed [48–49].
As it is well known, Raman Scattering (RS) is a quite useful analytical
tool for the structural analysis of biomolecules [50]. It has recently
emerged as a formidable alternative to ﬂuorescence technique, usually
considered the spectroscopic gold-standard in biology, thanks to its in-
trinsic label-free character and to the low Raman cross section of water,
whichmakes RS ideally suited for the analysis of samples in aqueous so-
lution. The Raman spectrumof amolecule consists of numerous discrete
bands associated with its speciﬁc normal modes of vibration and, as
such, can be used as a sensitive and selective ﬁngerprint of three-di-
mensional structure and intermolecular interactions. Thus, RS has
been widely used for the analysis of DNA, starting from single
nucleobases to the complex architecture of DNA occurring in telomeres
[51]. In particular, RS has been widely used to reveal DNA folding in
quadruplexes. Indeed, speciﬁc Raman markers have been identiﬁed to
probe the hydrogen bonding at guanine N7 sites, therefore being diag-
nostic of quadruplexes formation [52]. Moreover, Raman spectra allow
to probe the conformation of both the phosphodiester backbone andScheme 1. i) Fmoc-N-hydroxy succinimide ester, Py, r.t., 16 h, or Fmoc-Cl, NaHCO3(aq), CH2Cl2, r.
r.t., 16 h; v) sat. NH3 in MeOH, r.t., 16 h; vi) Fmoc-Cl, Py, r.t., 16 h; vii) 3HF*TEA, THF, r.t. 16 h;
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their parallel or antiparallel arrangement. The other side of the coin of
RS is its very low efﬁciency, associated with the small cross-section of
the inelastic scattering process, typically up to 12 orders of magnitude
smaller than ﬂuorescence. This makes Raman detection of low-concen-
trated samples prohibitive. SERS has recently emerged as a technique
suitable for overcoming this limitation. As amatter of facts, the huge en-
hancement (up to 12 orders of magnitude) of the Raman signal associ-
ated with this technique has constituted a huge step forward to the
concrete use of Raman spectroscopy for the analysis of precious, low-
concentrated samples such as DNA. The signal enhancement observed
in SERS spectra occurs when the analyte is reasonably close (within a
few nanometres) to a proper metallic nanostructure, and derives from
the coupling of the Raman probewith the Localized Plasmon Resonance
(LPR) of themetal surface. Recently, we have demonstrated that SERS is
a suitable tool for revealing the arrangement of guanine-rich DNA
strands in quadruplexes, also providing information on the relative sta-
bility of G-quadruplex structures with different numbers of G-tetrads
[53].
In the light of these observations, in this paper we have for the ﬁrst
time explored the application of SERS to monitor the formation of
PNA-based quadruplexes. In particular, our spectra clearly revealed
the presence of a band (around 1484 cm−1) associated with hydrogen
bonding at guanine N7 sites, which, being diagnostic for the Hoogsteen
hydrogen bonding in G-tetrads, conﬁrmed the formation of the target
bimolecular PNA homo quadruplex.
2. Materials and methods
2.1. General methods
All reagents and solvents were obtained from commercial sources
and used without further puriﬁcation. MBHA resin (1% divinylbenzene,
200–400 mesh, 0.5 mmol/g loading) was purchased from Sigma-Al-
drich. The reactions on solid phasewere performedusing ISOLUTE® sin-
gle fritted reservoirs (SG), 20 μm PE, equipped with tube caps and luer
tip caps (Biotage) which were shaken in a Multi-reax vibrating shaker
(Heidolph). High performance liquid chromatography (HPLC) analyses
and puriﬁcations were carried out on a Jasco UP-2075 Plus pump
equipped with a Jasco UV-2075 Plus UV detector using a 4.8 ×
150 mm C-18 reverse-phase column (particle size 5 μm) eluted with a
linear gradient of CH3CN containing 0.1% (v/v) TFA in H2O containing
0.1% (v/v) TFA (from 0 to 100% in 45min, ﬂow 1.2 mL/min). UV spectra
were recorded on a Jasco V-530 spectrophotometer. CD spectra were
performed on a Jasco 1500 spectropolarimeter in a 0.1 cm path length
cuvette. 1H NMR experiments were performed using Varian Mercuryt., 16 h; ii) 1) CF3COOEt, DCM, r.t., 1 h, iii)MeOH, r.t., 30min; iv) TBDMSCl, imidazole, DMF,
viii) 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite, DIPEA, CH2Cl2,THF, r.t., 1 h.
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D2O, and acetone-d6 solvents. Chemical shifts are reported in parts per
million (δ) relative to residual solvents signals – CD2HOD 3.31,
(CD3)(CD2H)CO 2.09 – and assigned by H\\H COSY experiments. 31P
NMR experiments were performed on a Varian UNITYINOVA 500 MHz
spectrometer using 85% H3PO4 as an external standard (0 ppm). Data
were processed using the Varian VNMR software package. The abbrevi-
ations s, d, dd, m, bs, bd, bt represent singlet, doublet, doublet of dou-
blets, multiplet, broad singlet, broad doublet and broad triplet,
respectively. ESI-MS experiments were performed on a AB Sciex 4000
QTRAP mass spectrometer in positive ion electrospray mode. Column
chromatography was performed on silica gel 60 (70–230 mesh ASTM,
Merck) and analytical TLC analyses were performed on F254 silica gel
plates (0.2 mm thick, Merck) with TLC spots being detected under UV
light (λ= 254 nm).
2.2. Synthesis of Fmoc protected BEL-linker 8
2.2.1. N,N’-(2-hydroxypropane-1.3-diyl)bis(2,2,2-triﬂuoroacetamide) (4)
To an ice-cooled solution of 1.3-diamino-2-propanol 1 (0.10 g,
1.1 mmol) in CH2Cl2 (1 mL), CF3COOEt (0.6 mL, 5.0 mmol) was added
dropwise. The mixture was stirred at 0 °C for 60 min (TLC monitoring:
CH2Cl2/CH3OH = 95:5) and then quenched with CH3OH at r.t. for
30 min. Volatiles were removed by rotary evaporation, thus obtaining
4 (0.302 g, 97% yield) as an amorphous solid that was used for the
next reaction step without puriﬁcation. 1H NMR (400 MHz, CD3OD) δ
3.92–3.84 (m, 1H, CH), 3.37 (dd, J = 4.7, 13.7 Hz, 2H, 2 × Ha), 3.28
(dd, J=7.2, 13.7 Hz, 2H, 2 × Hb). ESI-MS (m/z) calcd. for C7H8F6N2NaO3
[M+ Na]+ 305; found 305.
2.2.2. N,N’-(2-((tert-butyldimethylsilyl)oxy)propane-1.3-diyl)bis(2,2,2-
triﬂuoroacetamide) (5)
tert-butyldimethylsilyl chloride (0.96 g, 0.6 mmol) and imidazole
(0.06 g, 1.0 mmol) were dissolved in dry DMF and the solution cooled
at 0 °C in an ice-bath. Compound 4 (0.150 g, 0.53 mmol), dissolved in
dry DMF (2 mL), was added dropwise and the mixture was stirred for
24 h (TLC monitoring: CH2Cl2/CH3OH = 95:5). The reaction was
quenched by adding CH3OH and the mixture was diluted with AcOEt
(30 mL) and washed with Brine (3 × 30 mL). The organic phase was
dried over Na2SO4 and evaporated. The crude was puriﬁed over a silica
gel column eluted with increasing amounts of CH3OH in CH2Cl2 (up to
3%) giving pure 5 (0.13 g, 62% yield) as a white foam. 1H NMR
(400 MHz, CD3OD) δ 4.06–3.98 (m, 1H, CH), 3.38–3.26 (m, 4H, 2 ×
CH2), 0.89 (s, 9H, tBu), 0.089 (s, 6H, 2 × CH3). ESI-MS (m/z) calcd. For
C13H22F6N2NaO3Si [M+ Na]+ 419; found 419.
2.2.3. 2-((tert-butyldimethylsilyl)oxy)propane-1.3-diamine (6)
Compound 5 (0.13 g, 0.33mmol)was dissolved in sat. NH3 in CH3OH
(1 mL) and kept at r.t. for 16 h (TLC monitoring: CH2Cl2/CH3OH/
NH3(aq)= 7:3:0.2). The solvents were removed under reduced pressure
and the crude was puriﬁed over a silica gel column eluted with increas-
ing amounts of CH3OH in CH2Cl2 (up to 30%), giving pure 6 (0.07 g, 99%
yield) as an oil. 1H NMR (400 MHz, CD3OD) δ 4.22–4.15 (m, 1H, CH),
3.12–3.02 (m, 4H, 2 × CH2), 0.94 (s, 9H, tBu), 0.18 (s, 6H, 2 × CH3).
ESI-MS (m/z) calcd. for C9H25N2OSi [M+ Na]+ 205; found 205.
2.2.4. bis((9H–ﬂuoren-9-yl)methyl) (2-((tert-butyldimethylsilyl)oxy)pro-
pane-1.3-diyl)dicarbamate (7)
To a solution of 6 (0.05 g, 0.25 mmol) in dry pyridine (5 mL), Fmoc-
Cl (0.14 g, 0.54 mmol) was added and the mixture was shaken at r.t for
16 h (TLC monitoring: CHCl3/CH3OH = 95:5). The reaction was
quenched by addition of CH3OH, solvents were removed under reduced
pressure and the crude puriﬁed over a silica gel column eluted with in-
creasing amounts of CH3OH in CHCl3 (up to 2%), affording pure 7
(0.11 g, 90% yield) as an amorphous white solid. 1H NMR (400 MHz,
CD3OD) δ 7.76–7.19 (complex signal, 16H, arom. Fmoc), 4.30 (d, J =Please cite this article as: B. Pinto, et al., Synthesis and label free characteri
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(d, J = 5.5 Hz, 4H, 2 × CH2), 0.82 (s, 9H, tBu), 0.00 (s, 6H, 2 × CH3).
ESI-MS (m/z) calcd. for C39H44N2NaO5Si [M+ Na]+ 671; found 671.
2.2.5. bis((9H–ﬂuoren-9-yl)methyl) (2-hydroxypropane-1.3-diyl)
dicarbamate (2)
Compound 7 (0.08 g, 0.12 mmol) was dissolved in THF (8 mL) and
treated with TEA*3HF (196 μL, 1.2 mmol) at r.t. for 16 h (TLC monitor-
ing: CHCl3/CH3OH, 95:5). Volatiles were removed under reduced pres-
sure and the crude puriﬁed over a silica gel column eluted with
increasing amounts of CH3OH in CHCl3 (up to 5%), giving pure 2
(0.06 g, 90% yield) as an amorphous white solid. 1H NMR (400 MHz,
CD3OD) δ 7.90–7.20 (complex signal, 16H, arom. Fmoc), 4.35 (bd, 4H,
2 × CH2 Fmoc), 4.23 (bt, 2H, 2 × CH Fmoc), 3.73–3.61 (m, 1H, CH),
3.05–3.23 (complex signal, 4H, 2 × CH2). ESI-MS (m/z) calcd. for
C33H31N2O5 [M + H]+ 535; found 535.
2.2.6. bis((9H-ﬂuoren-9-yl)methyl)(2-(((2-cyanoethoxy)(diisopropylamino)
phosphino)oxy)propane-1.3-diyl)dicarbamate (8)
2 (0.06 g, 0.11 mmol) was dissolved in a 1:1 (v/v) mixture of dry
CH2Cl2/THF (3 mL), DIPEA was added (60 μL, 0.33 mmol) followed by
addition of 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite
(40 μL, 0.18mmol). Themixture was stirred for 1 h at r.t. (TLCmonitor-
ing: n-hexane/AcOEt/DIPEA = 6:4:0.1) then diluted with AcOEt
(30 mL) and washed with brine (4 × 30 mL). The organic phase was
dried over Na2SO4 and evaporated under reduced pressure. The crude
was puriﬁed over a silica gel column eluted with increasing amounts
of AcOEt in n-hexane (up to 40%), giving pure 8 (0.048 g, 59% yield) as
awhite foam. 1HNMR (500MHz, acetone-d6) δ 7.86–7.25 (complex sig-
nal, 16H, arom. Fmoc), 4.36 (d, J= 8.6 Hz, 2H, CH2 Fmoc), 4.33 (d, J=
8.6 Hz, 2H, CH2 Fmoc), 4.26–4.17 (m, 2H, 2 × CH Fmoc), 4.01–3.93 (m,
1H, CHO), 3.90–3.70 (complex signal, 2H, CH2O), 3.67–3.59 (m, 1H,
CHN), 3.36–3.28 (m, 4H, 2 × CH2N), 2.71–2.65 (m, 2H, CH2CN), 1.18–
1.13 (two overlapped doublets, J = 6.5 and 6.6 Hz, 12H, 4 × CH3). 31P
NMR (202 MHz, acetone-d6) δ 149.5 (s). ESI-MS (m/z) calcd. For
C42H47N4NaO6P [M+ Na]+ 757; found 757.
2.2.7. Synthesis of BEL-PNA 19
BEL-PNA19was synthesizedusing the Fmoc-solid-phase strategy. In
particular, 50mgofMBHA resin 9 (0.5mmol/g), after swelling in CH2Cl2
for 30min andDMFwashings, was treatedwith a solution of 20% piper-
idine in DMF for 10 min, giving solid support 10. After washings with
DMF, the resin 10 was swelled in a 1:1 solution of CH2Cl2/THF (1 mL)
and reacted with compound 8 (74 mg, 0.1 mmol) in the presence of
1-H-tetrazole (13mg, 0.19mmol) for 2 h at r.t., affording, afterwashings
with a 1:1 solution of CH2Cl2/THF, the solid support 13. The last was
swelled in THF (1 mL) and treated with tBuOOH (5.5 M in decane,
50 μL, 0.25 mmol) for 30 min at r.t. giving, after washings with THF
and then CH2Cl2, the solid support 14. The resin 14 was swelled in
CH2Cl2 for 30 min, washed with DMF and treated with a solution of
20% piperidine in DMF for 10 min, thus obtaining solid support 15.
The eluate was collected and the coupling yield was estimated by
Fmoc spectrophotometric measurements (98%). PNA chains were as-
sembled by reacting PNAmonomers (11 or 12, 5 equiv.) in the presence
of HATU (5 equiv), DIPEA (5 equiv) and lutidine (6 equiv.), for 30min at
r.t. After each coupling step, capping with Ac2O in the presence of pyri-
dine was performed by shaking the corresponding support with the re-
agents mixture for 20 min at r.t. At the end of synthetic cycles,
cyanoethyl groups were removed suspending the resin 17 in conc.
NH4OH(aq) for 2 h at r.t., affording solid support 18. Next, the synthe-
sized BEL-PNA was cleaved off suspending the resin 18 in a TFA/m-cre-
sol (4:1, v/v) solution for 4 h at r.t. and precipitated with cold diethyl
ether. The precipitates were recovered by centrifugation, washed
twice with diethyl ether, dissolved in water and ﬁnally lyophilized.
BEL-PNA 19 was obtained with a 48–50% overall yield (94% average
yield for each coupling). The crude sample was puriﬁed byzation of a bimolecular PNA homo quadruplex, Biochim. Biophys. Acta
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tions were lyophilized and the ﬁnal pure product was characterized
by ESI-MS (positive mode): ESI-MS (m/z) calcd. for C91H123N53O29P
[M+ H]+ 2453; found 2453.
2.3. Obtainment of G-quadruplexes (annealing)
The target dimeric PNAG-Qwas obtained by dissolving the BEL-PNA
19 at the concentration of 2.0 × 10−5 M in 100 mM K+ buffer (KH2PO4
10 mM, KCl 90 mM, pH 7.0) and by heating the solution at 90 °C for
10 min and then slow cooling to room temperature over 3 h. The solu-
tion was equilibrated at 4 °C for 72 h before characterizations [46].
2.4. UV and CD studies
The concentration of 19, dissolved in purewater, was determined by
UVmeasurements at 260 nm at 90 °C using the nearest-neighbor calcu-
latedmolar extinction coefﬁcient of the gggt PNA strandmultiplied by 2
(the number of PNA strands linked to BEL) (calculated ε = 43.9 mL
cm−1 μmol−1). The CD spectra were recorded both in pure water and
in the 100 mMK+ buffer described above at ﬁnal single strand concen-
tration of 20 μM. The spectra were recorded at 5 °C (λ= 220–310 nm,
200 nm/min scanning speed, 2.0 nm bandwidth) and averaged over
50 repetitions. A buffer baseline was subtracted from the CD spectra
and the spectrawere normalized to have zero at 320 nm. Thermal dena-
turation experiments on 19 were also carried out in the temperature
range of 5–90 °C by monitoring CD values at 282 nm at a heating rate
of 1.0 °C/min.
2.5. 2.5. SERS studies
Ag colloids, used as the SERS substrate, were prepared according to
the protocol reported in [54]. Brieﬂy, AgNO3 (90 mg) was dissolved in
500 mL of H2O and brought to the boil. Next, a sodium citrate solution
(1%w/w)was added under vigorous stirring and then the resultingmix-
turewas kept boiling for 1 h. All chemicals were purchased from Sigma-
Aldrich. Before use, the silver solution was appropriately diluted with
distilled water. SERS spectra were recorded using the WiTec Alpha
300 system [55], a confocal Raman system endowed with a Raman
probe at 532 nm focused on the sample through a Nikon 60× dry objec-
tive (NA = 0.8 and WD = 300 μm). The back-scattered light from theScheme2.Reagents: (i) piperidine/DMF, r.t., 10min; (ii)8, 1-H-tetrazole, DCM, THF, r.t., 2 h; (iii)
30 min; (vi) 12, HATU, DIPEA, lutidine, DMF, r.t., 30 min; (vii) conc. aq NH4OH, MeOH, r.t., 2 h
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to a high throughput spectrometer equipped with two diffraction grat-
ings with 600 and 1800 gmm−1, providing a resolution, respectively, of
3.6 and 1.5 cm−1. Photons were detected by a back-illuminated
Andor CCD camera (DV401A-BV-352, 1024 × 400 pixels) operating at
−60 °C. The confocal conditions were imposed by the 25 μm core (act-
ing as a pin-hole) of the multimode ﬁbre delivering the signal to the
spectrometer. SERS analysis was performed on samples at a concentra-
tion of 20 μM. For the measurements, a proper diluted aliquot of the sil-
ver-colloid solution was added to the sample and the analyte was
allowed to bind for 2 h at room temperature prior to spectrum acquisi-
tion. To avoid any photochemical-induced effect, the Raman probe
power impinging on the samplewas limited to 50 μWwhile the integra-
tion timewas 5 s. Under this condition, SERS spectrawere comparative-
ly stable and the signal-to-noise ratio was higher than 100 on the single
acquisition.
3. Results and discussion
The elongation of PNA chains was accomplished by solid-phase syn-
thesis, growing the strands along the two primary amino functions of
the resin-bonded bis-end linker 15 (Scheme 2). The last was obtained
by connecting the Fmoc-protected BEL 8 to the MBHA resin 10 through
a phosphoramidite bond (13), which was then oxidized to
phosphoramidate 14 before the removal of the Fmoc protecting groups,
as shown in Scheme 2. In particular, for the preparation of compound 8
the key reaction step was the selective Fmoc protection of the primary
amino functions of 1. Literature studies [56] reported that a selective
Fmoc NH2 protection in the presence of OH groups could be performed
by using Fmoc-N-hydroxy succinimide ester or Fmoc-Cl reagents. Un-
fortunately, in our case these procedures failed, allowing the recovery
of the target bis-Fmoc derivative 2 only in low yield, together with
other variously protected by-products. The inability of modulating the
nucleophilicity of the functional groups in the compound 1 towards
Fmoc reagents forced us to explore an alternative synthetic route for
the preparation of compound 2, exploiting the protection of the OH
group during the synthetic steps. Starting with the full protection of
the three functional groups in 1with an excess of CF3COOEt, we obtain-
ed the tri-protected derivative 3 in 97% yield. At this stage, we explored
the selective deprotection of the OH group. Pleasingly, the treatment of
the compound 3 with methanol afforded the derivative 4 by selectivetBuOOH, THF, r.t., 30min; (iv) Ac2O/Py, r.t., 20min; (v) 11, HATU,DIPEA, lutidine, DMF, r.t.,
; (viii)m-cresol, TFA, r.t., 4 h.
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5B. Pinto et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxmethanolysis of the triﬂuoroacetic ester. The alcohol 4 was then
silylated, affording the derivative 5 in 62% yield. The quantitative
deprotection of both amino groups in 5was accomplishedwith saturat-
ed NH3 inMeOH, to give compound 6 thatwas successfully transformed
in its bis-Fmoc derivative 7 in 90% yield by reaction with Fmoc-Cl. Next,
compound 7 was desilylated by treatment with the 3HF*TEA complex
and the free OH group of compound 2 reacted with (iPr)2NP(OCE)Cl
to afford the phosphoramidite derivative 8. Thereafter, solid support
10, after reaction with 8 in the presence of 1-H-tetrazole and oxidation
with tBuOOH, gave the phosphoramidate containing support 14. Cleav-
age of both Fmoc protecting groups on the functionalized resin 14 in
basic solution allowed the construction of PNA strands using the stan-
dard protocols. At the end of the synthetic cycles, treatment of solid sup-
port 17 with concentrated NH4OH(aq) gave the support 18 from which
the BEL-PNA 19was detached. Puriﬁcation and analysis of crude prod-
uctwere carried out usingHPLC as outlined inGeneralMethods. The ob-
tainment of pure compound 19 was assessed by ESI-MS analyses.
Puriﬁed sample was dissolved in K+ buffer and subjected to the anneal-
ing procedure. The propensity of 19 to fold into the target bimolecular
PNA quadruplex was then supported by CD and SERS experiments.
Typically, parallel and antiparallel G-Qs show CD proﬁles character-
ized bypositive andnegative Cotton effects at distinctwavelengths. Par-
allel-stranded DNA G-Qs show a negative Cotton effect at 240 nm and a
positive one at 260 nm,whereas negative and positive Cotton effects for
antiparallel G-Qs are typically at around 260 and 290 nm, respectively
[57]. It is to be noted that the backbone of PNAs is inherently achiral,
so PNA G-Qs show a weak CD spectrum in comparison to their DNA an-
alogs [46]. As shown in Fig. 1, BEL-PNA 19when dissolved and annealed
in pure water (solid line) does not exhibit a signiﬁcant CD proﬁle,
whereas the same dissolved and annealed in 0.1 M K+ buffer (dottedFig. 2. Average SERS signal from BEL-PNA 19 annealed in 0.1 M K+ buffer. This spectrum exh
G-quadruplex formation.
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suggesting the formation of an antiparallel bimolecular PNA G-Q
whose apparent melting temperature was estimated to be around
25 °C by CD thermal denaturation (Fig. 1, right panel). The antiparallel
orientation of PNA strands could be the result of steric hindrance and
charge repulsion between the phosphate-linker moieties. To support
the above structural hypothesis, we decided to ascertain the formation
of the target BEL-PNA G-Q by using the SERS technique.
SERS analysis of BEL-PNA 19 annealed in K+ buffer was performed
by acquiring the signals in 100 randomly selected points under the ex-
perimental conditions described above. Importantly, a signiﬁcant num-
ber of the acquired spectra (more than80%) exhibit a quite reproducible
spectral pattern, being the relative height of peaks within 15% of their
mean value. These spectra are dominated by features due to guanine
residues, with only some contributions from the PNA backbone. The re-
maining spectra (~20%) exhibit numerous bands associated with CH
vibration bands in the region 1350–1650 cm−1, whose partial overlap-
ping gives rise to a broad background. As it is well known, enhanced
bands in SERS spectra are generally due to vibrational modes occurring
inmolecularmoieties in close contactwith the silver colloids. Therefore,
the substantial reproducibility of spectra can be read in terms of a ten-
dency of molecules to assume a well-deﬁned orientation on the SERS
substrate. A similar propensity to be ordered, mainly ruled by the elec-
trostatic interaction of charged groupswith the colloid surface, was pre-
viously observed by our group for DNA-based quadruplexes on Ag-
colloids [53] and by Briones et al. for PNA strands on gold colloids
[58]. The reproducibility of SERS signals, together with the favourable
exposure of guanines in PNA strands to the SERS substrate, revealed in
most of SERS spectra, allowed us to get precious information on their
structural arrangement.ibits the typical band around 1484 cm−1 (highlighted by the blue arrow) diagnostic of
zation of a bimolecular PNA homo quadruplex, Biochim. Biophys. Acta
Table 1
Assignment of the prominent SERS features observed in this work.
Observed position (cm-1) Assignment References
785 Guanine ring 58
966 ν(C\\C) 63
1160 ν(C\\N) + δ(C\\H), T 62
1220 PO2− 61
1300 Amide III 63
1484 C8 = N7-H2 52, 59, 53
1542 Amide II 63
1572 C2 = N3 of guanine 60
1630 Amide III 63
1650 Amide III, ν(CO2), ν(C6O6) 63
6 B. Pinto et al. / Biochimica et Biophysica Acta xxx (2016) xxx–xxxThe average SERS signal of BEL-PNA annealed in K+ buffer, obtained
from a subset of spectra described above, is shown in Fig. 2. To better
highlight the SERS features a forth order baseline was removed and
the spectrum was normalized to the height of the prominent peak at
1572 cm−1. Table 1 summarizes the main SERS bands observed and
their assignment. SERS spectra of unstructured PNA molecules (single
strands) were ﬁrstly reported by Colaianni et al. [59]; in this case, the
spectra were mainly characterized by single nucleobase contributions
as well as Amide I band due to the PNA backbone. Differently, the
SERS signals of BEL-PNA 19 annealed in K+ buffer are dominated in
the 1300–1600 cm−1 region by spectral features clearly due to guanine
residues, also exhibiting some clear similarities with the spectral
features observed in both spontaneous Raman scattering of telomeric
DNA quadruplexes [60] and in SERS spectra of guanine-rich
DNA sequences [53]. Notably, the SERS spectrum shows a strong band
at ~1484 cm−1 easily attributable to the C8_ N7-H2 deformation of
the guanine tetrad, being therefore diagnostic for the Hoogsteen hydro-
gen bonding of G. G pairs in G-tetrads [52–53,59]. To the best of our
knowledge, this outcome constitutes the ﬁrst SERS-based evidence of
PNA-quadruplex formation and conﬁrms the indications provided by
CD-measurements, which suggested the formation of G-Q assemblies
due to the antiparallel arrangements of BEL-PNA 19when annealed in
K+ containing buffer.
The other intense SERS peak at 1572 cm−1 can be identiﬁedwith the
C2_ N3 guanine band appearing in the spontaneous Raman spectrum
of quadruplexes around 1580 cm−1. The ~8 cm−1 shift of this band for
the SERS case has been previously observed by Pagba et al. [61] in the
analysis of quadruplex-folded DNA and is likely due to the speciﬁc sur-
face-induced selection rules of SERS. The band around 1220 cm−1 can
be assigned to PO2− bonds [62], which are present in the BEL linkers.
Numerous other bands of the spectrum in Fig. 2 are clearly due to the
peptide components of the molecule and to single unpaired compo-
nents. For instance, the peak at 1165 cm−1 is likely due to a combination
of ν(C\\N) and δ(C\\H) vibrationswith some contributions of unpaired
thymine residues [63], while the band at 791 cm−1 is certainly a ring
mode from the moieties [59]. Moreover, many protein-related Raman
bands can be observed in the Amide III (1200–1310 cm−1), Amide II
(1540–1560 cm−1) and Amide I (1610–1700 cm−1) regions, the latter
band mainly involving the C _ O vibration [64]. In particular, the
Amide I band probably masks the presence of guanosine N1H bands
which, being sensitive for theN1H environment, is usually a valuable in-
dicator of the guanine interbase interaction strength [52,60].
4. Conclusions
In summary, we have reported the unprecedented obtainment of a
PNA bimolecular homo quadruplex. This goal was accomplished by
growing two gggt PNA strands to the ends of the solid support-bonded
bis-end linker 15 to obtain, after detachment from the solid support, the
corresponding BEL-(gggt)2 (19). The annealing of 19 in K+ containing
buffer gave the target bimolecular PNA quadruplex, which was charac-
terized by CD and SERS spectroscopies. Importantly, these resultsPlease cite this article as: B. Pinto, et al., Synthesis and label free characteri
(2016), http://dx.doi.org/10.1016/j.bbagen.2016.11.037constitute a robust basis for the introduction of SERS as a label-free an-
alytical technique, complementary to CD, to monitor the formation of
PNA quadruplexes.
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Abstract
Cyclic N1-pentylinosine monophosphate (cpIMP), a novel simplified inosine derivative of cyclic ADP-ribose (cADPR) in which
the N1-pentyl chain and the monophosphate group replace the northern ribose and the pyrophosphate moieties, respectively, was
synthesized. The role played by the position of the phosphate group in the key cyclization step, which consists in the formation of a
phosphodiester bond, was thoroughly investigated. We have also examined the influence of the phosphate bridge on the ability of
cpIMP to mobilize Ca2+ in PC12 neuronal cells in comparison with the pyrophosphate bridge present in the cyclic N1-pentyl-
inosine diphosphate analogue (cpIDP) previously synthesized in our laboratories. The preliminary biological tests indicated that
cpIMP and cpIDP induce a rapid increase of intracellular Ca2+ concentration in PC12 neuronal cells.
Introduction
Nucleosides and nucleotides (NNs) are widely used as key
intermediates and important core structures in the field of syn-
thetic medicinal chemistry [1,2]. They represent versatile syn-
thetic building blocks towards the synthesis of biologically rele-
vant compounds such as antiviral and antineoplastic drugs
[3-8], antibiotics and antifungal agents [9-11]. Furthermore,
Beilstein J. Org. Chem. 2015, 11, 2689–2695.
2690
several NNs act as potent second messengers involved in the
regulation of key metabolic pathways [12]. Among these NNs
there is the cyclic ADP-ribose (cADPR 1, Figure 1), a metabo-
lite strictly involved in the homeostasis of cellular calcium ions.
cADPR is a second messenger that activates the ryanodine
receptors of the sarcoplasmic reticulum and mobilizes Ca2+ ions
in many cell types of protozoa, plants, animals and humans
[13].
Figure 1: Structures of cADPR (1), cIDPR (2), cpIDP (3) and cpIMP
(4).
Furthermore, there is a strong evidence that cADPR is an
important second messenger in the nervous system where it is
involved in the handling of Ca2+ ions that control several func-
tions. Indeed, the administration of cADPR to cell cultures
produces three patterns of response in terms of variation of
intracellular concentration of calcium ions ([Ca2+]i): (a) a rapid
response after direct microinjection of the messenger into the
cells; (b) a slow variation of [Ca2+]i when cADPR is added to
the cell culture medium; c) a progressive potentiation of [Ca2+]i
increasing due to a depolarization. In fact, cADPR induces Ca2+
release from presynaptic and postsynaptic intracellular stores
and plays an important role in the activity-dependent synaptic
plasticity, including long-term depression [14]. In addition,
enzymes able to catalyze the hydrolysis of cyclic ADP-ribose to
ADP-ribose are expressed ubiquitously in the mouse brain.
Specifically, wild-type mice show the highest cyclase activity in
the hypothalamus, and then in the cerebellum, cerebrum and
posterior pituitary [15].
Unfortunately, the lability of the N-1 glycosidic bond of
cADPR towards enzymatic and/or non-enzymatic hydrolysis to
ADP-ribose, even in a neutral aqueous solution, greatly hinders
the studies aimed at elucidating its physiological role [16].
Several enzymes involved in the metabolism of cADPR have
been described. Among them is the ubiquitous ADP-ribosyl
cyclase, an enzyme first isolated from Aplysia Californica [17].
Using the Aplysia ADP-ribosyl cyclase many metabolite
analogues of cADPR have been produced starting from NAD+
and NADP+ [18-21]. However, the specificity of the enzymatic
cyclization mechanism drastically limits its applicability for
enzymatic or chemo-enzymatic procedures. For this reason, to
obtain new cADPR derivatives the exploitation of chemical
synthetic strategies is still necessary. A lot of modifications
regarding the northern and southern ribose as well as the purine
base of cADPR have been proposed so far [22,23]. Matsuda and
co-workers were the first who synthesized new analogues of the
cADPR in which the adenine base was replaced by a hypoxan-
thine ring [24]. This kind of modification produced the cyclic
inosine diphosphate ribose (cIDPR) 2 which proved to be stable
in hydrolytic physiological conditions and showed significant
Ca2+ mobilizing activity, thus fostering the synthesis of a
variety of cIDPR analogues. In particular, the N1, N9 and
C8-substituted cIDPR were the most interesting [24-33]. In the
last few years several cIDPR analogues were also synthesized
in our laboratory [34-37]. Among these, the N1-pentyl analogue
cpIDP (3, Figure 1) [34] showed interesting activity on the
PC12 cell line previously differentiated with the Nerve Growth
Factor (NGF) (data not previously published). Starting from
these data, we here report the synthesis and the preliminary bio-
logical activity of the new cyclic N1-pentylinosine monophos-
phate (cpIMP) (4, Figure 1), in which the pyrophosphate group
of 3 was replaced by a monophosphate moiety connecting the
southern ribose with the N1-pentyl chain. The here reported
results significantly contribute to the understanding of the role
played by the pyrophosphate moiety of cADPR and cIDPR
analogues on the mobilization of Ca2+ ions. To date, such struc-
ture-activity relationship has only been poorly investigated [38-
41]. We anticipate here that compounds 3 and 4 induce the
same effect on Ca2+ mobilization in NGF-differentiated PC12
cells. In particular, both compounds produced a transient
increase of intracellular concentration of Ca2+ when added to
the cells, thus demonstrating their ability to cross the plasma
membrane.
Results and Discussion
Chemistry
The key step for the preparation of all cADPR/cIDPR analogues
is the macrocyclization via pyrophosphate bond formation,
which is usually performed by joining the two phosphate
moieties at the end of the multistep synthesis [24-29]. Similarly,
the preparation of the new cpIMP derivative 4 could be
performed by the cyclization of a monophosphate precursor via
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Figure 2: Synthetic strategies explored in the cyclization step via phosphodiester bond formation.
Scheme 1: i) (iPr)2NP(OCE)Cl, DIPEA, THF, 1 h, rt; ii) 1) 1H-tetrazole, THF, 2) t-BuOOH, 2 h, rt; iii) 1) (iPr)2NP(OCE)2, 1H-tetrazole, THF, 2 h, rt,
2) t-BuOOH, 2 h, rt; iv) TEA/pyridine, 1:1 v/v, 16 h, rt; v) activating agent (EDC in DMF or DCC in DMF or MSNT in pyridine) 16 h, rt; vi) conc. aq
NH4OH, MeOH, 50 °C, 16 h.
phosphodiester bond formation. For this purpose we investi-
gated both the possible synthetic strategies (pathways A and B,
Figure 2) in which the phosphate group (or its synthon) has
been attached either on the end of the N1-pentyl chain
(precursor A) or on the 5’-ribose position (precursor B).
At first, to obtain the cpIMP (4) we followed the synthetic
pathway A by using the strategy reported in Scheme 1 that
employed the N1-ω-hydroxypentylinosine derivative 5 as the
starting material [34]. Compound 5 was phosphorylated on the
ω-hydroxyalkyl function by using the phosphitylating chloro-
amidite agent 6. The reaction of 5 with 6 furnished the sole
regioisomer 7 equipped with the reactive phosphorous(III)
group. Unfortunately, the activation of the phosphoramidite
function with 1H-tetrazole aimed at inducing the cyclization on
the 5’-OH ribose function produced only a complex mixture.
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Scheme 2: i) DNCB, K2CO3, DMF, 4 h, 80 °C; ii) 5-aminopentan-1-ol, DMF, 16 h, 50 °C; iii) Ac2O, pyridine, 2 h, rt, iv) NH4F, MeOH, 16 h, reflux;
v) 1) (iPr)2NP(OCE)2, 1H-tetrazole, THF, 2 h, rt, 2) t-BuOOH, 2 h, rt; vi) conc. NH4OH(aq), MeOH, 50 °C, 16 h; vii) EDC, DMF; viii) TFA, H2O, 16 h, rt.
No traces of the target cyclic compound were detected after the
usual phosphorous oxidation step.
This failure prompted us to use the alternative phosphitylating
reagent bis(cyanoethyl)phosphoramidite 8, which, after the
regioselective reaction with the 5’-hydroxyalkyl function of 5
led to the phosphotriester product 9 after the phosphorous oxi-
dation with t-BuOOH. Starting from 9 we explored two syn-
thetic routes, differing for the degree of esterification at the
phosphate moiety, to achieve the cyclization of the
17-membered ring of 4. The treatment of 9 with a mixture of
triethylamine/pyridine furnished the phosphodiester product 10
in almost quantitative yield. Instead, the complete removal of
both 2-cyanoethyl groups of 9 with concentrated aqueous
ammonia gave the phosphomonoester 11. Unfortunately, neither
linear precursors 10 nor 11 underwent the expected cyclization
step, even when treated with the most common phosphate acti-
vating agents (EDC, DCC, MSNT) in very diluted conditions.
In our opinion, the target intramolecular cyclizations failed
because of the poor mobility of the 5’-OH ribose function, as
well as because of the unfavourable anti conformation of the
N-glycosidic bond induced by the presence at the N1 position of
the purine base of the bulky ω-phosphate adduct formed with
the activating agent.
For this reason, we decided to switch to the synthetic pathway B
(Figure 2), in which the monophosphate group is installed at the
5’-ribose position. This strategy, reported in Scheme 2, used as
the starting material the 5’-TBDMS-2’,3’-O-isopropylideneino-
sine (12). The protected inosine 12 was initially converted into
the N1-dinitrophenyl derivative 13, which, after reaction with
the 5-aminopentan-1-ol, furnished the N1-ω-hydroxypentylino-
sine derivative 14 [35]. This compound was acetylated on the
ω-hydroxy function (compound 15) and then deprotected on the
5’-hydroxy function thus obtaining 16. The phosphorylation of
the 5’-OH function of 16, by using the (iPr)2NP(OCE)2/
t-BuOOH system, already used in the preparation of compound
9, furnished the 5’-O-phosphotriester inosine derivative 17. The
treatment of 17 with concentrated aqueous ammonia allowed
the removal of both the OCE phosphate protecting groups
together with the acetate function, thus obtaining the key inter-
mediate 18 as triethylammonium salt after HPLC purification.
The derivate 18, dissolved in DMF at the final concentration of
2 mM was treated with EDC (1.2 equiv) and the reaction
allowed to stand at room temperature for 48 h. From this mix-
ture it was possible to isolate cyclic compound 19 (30% cycliza-
tion yield) whose structure was confirmed by NMR and high-
resolution mass analyses. Eventually, the treatment of com-
pound 19 with aqueous 20% TFA afforded the target com-
pound 4.
Ca2+-mobilizing activity of 3 and 4 in PC12
cells
To study the biological activity of compounds 3 and 4, we eval-
uated their effect on the mobilization of Ca2+ ions in PC12 cells
differentiated with NGF. Interestingly, compounds 3 and 4
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Figure 3: Effect of 3 and 4 on intracellular [Ca2+] in NGF-differentiated PC12 cells. (A) and (B): representative single-cell traces of the effect of 3 and
4 (100 nM) on [Ca2+]i,. (C): quantification of [Ca2+]i increase calculated, after the addition of each compound, as the percentage change of plateau/
basal value. Each bar represents the mean (±S.E.M.) of the values obtained in three independent experimental sessions. For each experiment, 10 to
40 individual cells were monitored. *, P < 0.05 versus basal level.
caused a rapid and transient increase of the intracellular [Ca2+]
([Ca2+]i) when added to the medium at the concentration of
100 nM (Figure 3). This pattern of response could be ascribed
to the initial release of Ca2+ ions from the intracellular
organelles followed by a depolarization-induced Ca2+ influx.
The biological assays also confirmed that the cIDPR analogues
3 and 4 retained the ability to pass the plasma membrane of
neuronal cells.
Conclusion
cADPR is a second messenger synthesized by neuronal cells
that modulates the Ca2+ homeostasis in the nervous system
[42]. Unfortunately, cADPR is characterized by a low ability to
cross the plasma membranes. This behaviour hinders the studies
on the effects of cADPR on cell functions. To overcome this
limitation and to understand the role played by the pyrophos-
phate bridge on the biological activities of cADPR, we synthe-
sized the lipophilic derivative cpIMP (4) in which the pyrophos-
phate group of 3 was replaced by a monophosphate moiety
connecting the southern ribose with the N1-pentyl chain. We
compared the activity of 4 in modulating the concentration of
[Ca2+]i with that of the previously synthesized cpIDP (3). To
study the effect of 3 and 4 on [Ca2+]i, these compounds were
added to PC12 cells previously differentiated with NGF at the
concentration of 100 nM. Both compounds caused a fast and
transient increase in [Ca2+]i. This pattern of response could be
ascribed to the initial release of Ca2+ from intracellular
organelles followed by a depolarization-induced Ca2+ influx.
The reported preliminary results indicate that 3 and 4 possess
almost the same activity, thus indicating that the role of the
pyrophosphate bridge is not stringent and that the introduction
of an alkyl chain in the N1 position of the purine base improves
the permeation of the cell membrane by passive diffusion or
through an active uptake system expressed on the membrane.
Experimental
General
All solvents were dried by standard methods and all reactions
were carried out under inert atmosphere (argon or nitrogen). All
reagents were obtained and used from commercial sources
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(Sigma-Aldrich, Germany) without further purification. 1H and
13C NMR experiments were performed using a Varian Mercury
Plus 400 MHz spectrometer in CD3OD, D2O, CDCl3 and
acetone-d6 solvents. Chemical shifts are reported in parts per
million (δ) relative to residual solvents signals: CD2HOD 3.31,
HOD 4.80, (CD3)(CD2H)CO 2.09 for 1H NMR and CD3OD
49.0 for 13C NMR. 31P NMR experiments were carried out on a
Varian Unity INOVA 500 MHz instrument in CD3OD solvent
using 85% H3PO4 as an external standard (0 ppm). High perfor-
mance liquid chromatography (HPLC) was performed using a
Jasco UP-2075 Plus pump equipped with a Jasco UV-2075 Plus
UV detector and a 4.8 × 150 mm C-18 reversed-phase column
(particle size 5 µm) eluted with a linear gradient of CH3CN in
0.1 M triethylammonium bicarbonate (TEAB) buffer (from 0 to
50% in 45 min, flow 1.3 mL/min). UV spectra were recorded on
a Jasco V-530 UV spectrophotometer. High-resolution MS
spectra were recorded on a Bruker APEX II FT-ICR mass spec-
trometer using the electrospray ionization (ESI) technique.
Column chromatography was carried out on silica gel-60
(Merck, 0.063–0.200 mm) or on C-18 reversed-phase silica gel-
60 (Merck, 0.040–0.063 mm). Analytical TLC analyses were
performed using F254 silica gel plates (0.2 mm thick, Merck).
TLC spots were detected under UV light (254 nm).
Cell cultures and [Ca2+]i measurements
PC12 cells, grown on plastic dishes in RPMI medium composed
of 10% horse serum, 5% FBS, 100 UI/mL penicillin and
100 μg/mL streptomycin, were differentiated in neurons with
NGF (50 ng/mL; 7 days). Cells were cultured in an atmosphere
of 5% CO2. The culture medium was changed every 2 days. For
microfluorimetric studies with Fura 2-AM, cells were seeded on
glass coverslips (Fisher, Springfield, NJ, USA) coated with
poly-L-lysine (5 μg/mL) (Sigma, St. Louis, Missouri, USA) and
used at least 12 h after seeding. Intracellular Ca2+ concentra-
tion ([Ca2+]i) was measured by single cell computer-assisted
video QImaging [43]. Briefly, differentiated PC12 cells cultured
on poly-L-lysine-coated glass coverslips were loaded with
10 µM Fura-2AM for 1 h at 22 °C in Krebs–Ringer saline solu-
tion containing the following: 5.5 mM KCl, 160 mM NaCl,
1.2 mM MgCl2, 1.5 mM CaCl2, 10 mM glucose, and 10 mM
HEPES-NaOH, pH 7.4. At the end of the loading period, the
coverslips were placed in a perfusion chamber (Medical
System, Greenvale, NY, USA), mounted on a Zeiss Axiovert
200 microscope (Carl Zeiss, Germany) equipped with a FLUAR
40X oil objective lens. The experiments employed a digital
imaging system composed of a MicroMax 512BFT cooled CCD
camera (Princeton Instruments, Trenton, NJ, USA), LAMBDA
10-2 filter wheeler (Sutter Instruments, Novato, CA, USA), and
Meta-Morph/MetaFluor Imaging System software (Universal
Imaging, West Chester, PA, USA). After loading, the cells were
illuminated alternately at 340 and 380 nm by a Xenon lamp.
The emitted light was passed through a 512 nm barrier filter.
Fura-2AM fluorescence intensity was measured every 3 s. Forty
to sixty-five individual cells were selected and monitored simul-
taneously from each cover slip. Results are presented as the
cytosolic Ca2+ concentration. Calibrations used the relation of
Grynkiewicz et al. [44] assuming that the KD for Fura-2AM
was 224 nM.
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Synthesis of C6-Pyridylpurine Nucleosides by Reaction of Nebularine N1-Oxide
with Pyridinyl Grignard Reagents
Stefano D’Errico,[a] Giorgia Oliviero,*[a] Nicola Borbone,[a] Fabrizia Nici,[a]
Vincenzo Piccialli,[b] Brunella Pinto,[a] Daniele D’Alonzo,[b] Luciano Mayol,[a] and
Gennaro Piccialli[a]
Keywords: Synthetic methods / Grignard reaction / Transmetallation / Nucleosides / Nucleobases
A general synthesis of C6-pyridylpurine nucleosides is de-
scribed. The reported synthetic procedure exploits the
regioselective addition of pyridinyl Grignard reagents,
obtained by bromine/magnesium exchange between mono-
or dihalopyridines and iPrMgCl, to the C6–N1–O– moiety of
nebularine N1-oxide. The regioselective transmetallation of
Introduction
Natural nucleosides and nucleotides play a central role
in cell metabolism and in signal transduction, acting as syn-
thetic precursors and regulatory agents. In addition, they
are substrates of polymerases and, in some cases, can con-
trol the activity of these enzymes so as to regulate nucleic
acid construction. Several nucleoside and nucleotide ana-
logues have been approved for the treatment of viral dis-
eases and some of them are in clinical trials for cancer treat-
ment.[1] Therefore the preparation of modified nucleosides
and nucleotides continues to attract the interest of chemical
and biomedical research. Modifications of nucleobases can
affect the hydrogen-bonding patterns and base-pairing in
nucleic acids or confer on them peculiar properties such as
fluorescence, which allows monitoring of their fate in cells
and analysis of DNA and RNA structures.[2] Purine nucleo-
sides bearing a C substituent at C-6 represent an important
subclass of nucleoside analogues possessing a broad spec-
trum of biological activities[3] and this has prompted syn-
thetic efforts towards these substances. The introduction of
C substituents at C-6 in the purine nucleus has been mostly
accomplished by metal-mediated cross-coupling processes
starting from 6-halopurines,[3b,4] whereas N, O, and S sub-
stituents have been introduced by direct nucleophilic aro-
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unsymmetrical dihalopyridines with iPrMgCl allowed C6-
halopyridylpurine nucleosides to be obtained through the
addition of halopyridinyl Grignard reagents. The presence of
a halogenated pyridine ring in these nucleosides allows for
further useful synthetic transformations.
matic substitution.[5] We have recently discovered a new ap-
proach to accessing C6-alkyl/aryl nucleosides. In particular,
we observed that the sugar-protected nebularine N1-ox-
ide[6a] (1, Scheme 1) can regioselectively react with Grignard
reagents at the more electrophilic C-6 position leading to
adduct 2, which is re-aromatized by treatment with Ac2O/
pyridine to furnish the C6-substituted purine nucleoside 3
in high yields. We have also shown that a second alkyl/aryl
substituent can be introduced at C-2 by a similar strategy,
that is, by the addition of a Grignard reagent to the C6-
substituted nebularine N1-oxides 4 through the opening/re-
closing of the pyrimidine ring induced by the Grignard rea-
gent itself. Through this approach we have synthesized new
collections of 6-alkyl(aryl)purine nucleosides 3 and 2,6-di-
alkyl(aryl)purine nucleosides 5.[6]
Scheme 1. Reaction of nebularine N1-oxide 1 with Grignard rea-
gents. Functionalization of the C-6 and C-2 positions of the purine.
C6-Pyridinyl nucleosides are appealing nucleoside ana-
logues because the presence of a nitrogen atom in the C-6
residue can potentially alter the hydrogen-bonding capabili-
ties of the nucleoside as well as promote its coordination to
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biologically important metals, such as platinum and ruth-
enium.[7] In addition, a number of pharmaceuticals, natural
products, and active products for agriculture are pyridine
derivatives.[8] However, the introduction of a pyridinyl resi-
due at the C-6 position of purine nucleosides has scarcely
been studied. As far as we know, the only known substances
of this type are 6-(2-pyridyl)nebularine and the nucleotide
corresponding to 6-(5-bromo-3-pyridyl)nebularine (see 9a
and 9e in Table 1), both displaying interesting biological ac-
tivities. These compounds were synthesized by the Pd-cata-
lyzed cross-coupling of 6-chloropurine riboside with Rieke
organozinc reagents[9] and 5-bromopyridine-3-boronic
acid,[10] respectively. However, Hocek et al. reported the
failure to introduce 3- and 4-pyridyl residues at C-6 by
Suzuki–Miyaura coupling with the more reactive catalytic
system Pd(OAc)2/2-(dicyclohexylphosphanyl)biphenyl.[11]
These precedents and the lack of a general synthetic
procedure for obtaining C6-pyridylpurine nucleosides
prompted us to explore the addition of pyridinyl Grignard
reagents 7a–h (Scheme 2) to nebularine N1-oxide (1) by
using our procedure. We report here that it can be success-
fully applied to the synthesis of various C6-pyridinyl nucleo-
sides 9a–c and C6-halopyridinyl nucleosides 9d–h (Table 1)
in moderate-to-good yields.
Table 1. Product yields of compounds 9a–j.
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Results and Discussion
The required pyridinyl Grignard reagents 7a–h (Table 1)
were prepared by bromine/magnesium exchange between
bromopyridines 6a–h and iPrMgCl (Scheme 2). This pro-
cedure has previously been efficiently employed by Trécourt
et al. for the transmetallation of 2-, 3-, and 4-bromopyr-
idines, as well as for the regioselective transmetallation of
2,3-, 2,5-, 2,6-, and 3,5-dibromopyridines to obtain various
pyridinyl Grignard reagents.[12] Our general strategy for the
bromine/magnesium exchange makes use of a 1:1 ratio of
iPrMgCl and bromopyridines 6a–h (2 h at room temp.).
The complexes 7a–h (5 equiv.) obtained in this way were
added in one portion to 1 and the reaction mixtures
were left at room temp. for 2 h. After work-up (see
the Exp. Sect.), the crude products 8a–h were treated with
Ac2O/pyridine to form the purine rings 9a–h by re-aromati-
zation.
Scheme 2. Reagents and conditions: i) iPrMgCl, THF, 2 h, room
temp., N2; ii) 7a–h, THF, 2 h, room temp., N2; iii) Ac2O/pyridine
(4:6, v/v), 1 h, 50 °C.
Reactions of Bromopyridines 6a–c
Following our procedure, the 2-pyridyl residue could be
easily introduced at the C-6 purine position by the reaction
of 1 with 2-pyridylmagnesium chloride (7a, Table 1), and
compound 9a was obtained in a yield higher than pre-
viously reported (55%, reported 27 %).[9] Compound 9b,
embodying a 3-pyridyl residue, was obtained by treating 1
with 3-pyridylmagnesium chloride (7b). The process pro-
ceeded smoothly and the product was obtained in 60%
yield. In contrast, 4-brompyridine (6c) is an unstable com-
pound and has to be prepared immediately prior to use by
neutralization of the corresponding hydrochloride salt
(commercially available). Initially we used the recom-
mended procedure in which the hydrochloride salt is treated
with a 5% aqueous Na2CO3 solution, followed by extrac-
tion with Et2O, and drying with MgSO4.[12] Disappoint-
ingly, 4-bromopyridine prepared in this way, when treated
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with iPrMgCl, gave a very low yield of the corresponding
Grignard reagent 7c, as suggested by its unproductive reac-
tion with 1.
We ascribed this failure to the difficulty in obtaining very
dry 4-bromopyridine after aqueous treatment and drying
with MgSO4. On the other hand, bromopyridine is a vola-
tile liquid and it could not be dried effectively under re-
duced pressure. We succeeded in obtaining 4-bromopyr-
idine suitable for the preparation of the Grignard reagent
by treatment of its hydrochloride salt with 1 equiv. of NaH
in dry THF. The pyridine 6c obtained was transmetallated
in situ by the addition of iPrMgCl to give the 4-bromopyr-
idinyl Grignard reagent 7c, which was immediately treated
with 1. By this procedure, compound 9c was obtained in
55% yield, which compares well with the yields of 9a and
9b. Therefore the 3- and 4-pyridyl nucleosides 9b and 9c
could be synthesized by our procedure, whereas the Suzuki–
Miyaura coupling reaction was unsuccessful.[11]
Reactions of Dihalopyridines 6d–h
Halopyridines are known to undergo a number of useful
synthetic transformations.[13] Therefore the introduction of
a halopyridine ring at the C-6 position of a purine nucleo-
side would allow its further synthetic elaboration. Thus, di-
bromopyridines 6d–g and the 2-chloro-3-bromopyridine
(6h) were transmetallated with iPrMgCl, as described for
bromopyridines 6a–6c, to furnish the corresponding Grig-
nard reagents 7d–h. Bromopyridinyl nucleosides 9d and 9e
were obtained from symmetrical dibromopyridines 6d and
6e in yields of 50 and 60 %, respectively, on coupling with
1. The fully ribose-deprotected compound 9e was recently
prepared by the reaction of 6-chloropurine riboside under
Suzuki–Miyaura cross-coupling conditions in 40% yield.
Interestingly, its nucleotide derivative was active towards
human and rat DNHP1 enzymes, showing itself to be a
competitive inhibitor of dGMP binding with a micromolar
affinity.[10]
Grignard reagents prepared in the usual manner from
unsymmetrical 2,5- and 2,3-dibromopyridines 6f and 6g
and used in the coupling/aromatization sequence afforded
compounds 9f and 9g, respectively, which were analyzed by
2D NMR experiments. In particular, the correlations ob-
served in the HMBC spectrum of 9f between the 2-H and
4-H protons of the pyridine ring, which resonate at δ =
10.2 and 8.86 ppm, respectively, and C-6 at δ = 152.2 ppm
of the purine nucleus (Figure 1) clearly indicate the forma-
tion of the C3–C6 bond during the coupling step. This
confirms the expected preferential transmetallation at C-5
of the 2,5-dibromopyridine ring. On the other hand, in the
case of compound 9g, a significant correlation in the
HMBC spectrum was seen between the 4-H proton at δ
= 8.00 ppm and the C-6 purine carbon at δ = 156.5 ppm
(Figure 1), which indicates the connection C3–C6 in this
compound and, accordingly, confirms the preferential
transmetallation at C-3 of the 2,3-dibromopyridine ring.
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Figure 1. HMBC correlations between 4-H, 2-H and C-6 for 9f
and 4-H and C-6 for 9g.
In addition, we tested the preparation and reactivity of
the Grignard reagent 7h obtained from 3-bromo-2-chloro-
pyridine (6h). The transmetallation of the latter proved to
be chemoselective giving the 2-chloro-3-pyridinyl Grignard
reagent and then compound 9h, which was obtained in 65%
yield on reaction with 1. In an attempt to further expand
the scope of the process and access new C6-heteroaryl
nucleosides, we tested the introduction at this position of a
quinolyl residue. Purine ribonucleosides bearing a quinoline
ring at C-6 are unprecedented. Application of the strategy
used for bromopyridines was initially attempted and the re-
quired Grignard reagents were prepared in the usual man-
ner by treating 2-bromoquinoline (6i) and 3-bromoquinol-
ine (6j) with iPrMgCl (1 equiv.). However, the subsequent
reaction with 1 gave complex reaction mixtures from which
the expected C6-quinolyl derivative 9i was obtained in 20%
yield after purification, whereas no compound correspond-
ing to 9j could be recovered. We attributed these unsatisfac-
tory results to the low-yielding formation or the absence of
any formation of Grignard reagents 7i and 7j, respectively.
In fact, it is reported that bromoquinolines preferably un-
dergo nucleophilic attack at C–Br rather than transmetalla-
tion due to the low energy of their LUMO levels.[14] An
alternative approach to the use of quinolyl Grignard rea-
gents exploits the reactivity of lithium tri(quinolyl)magnes-
ate complexes, obtained by the transmetallation reaction of
lithium tributylmagnesate and 2- or 3-bromoquinolines, a
procedure reported to yield C-functionalized quinolones.[14]
Disappointingly, by using this procedure (data not shown),
we could not improve on the yield of compound 9i, and
again the formation of compound 9j was not observed in
this case. The structures of all the synthesized compounds
were ascertained by spectroscopic investigations (1H and
13C NMR, UV, IR, and MS data).
Conclusions
In this paper we describe the synthesis of a collection of
C6-pyridylpurine ribonucleosides exploiting the electro-
philicity of the C-6 purine position of the sugar-protected
nebularine N1-oxide towards a series of pyridinyl Grignard
reagents, prepared by transmetallation reactions between
iPrMgCl and mono- and dihalopyridines. The bromine/
magnesium exchange reactions proved to be regioselective
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when using unsymmetrical dihalopyridines, allowing
bromo- and chloropyridylpurine nucleosides to be ob-
tained. The presence of a halogen atom on the pyridinyl
residue in the latter allows for further synthetic elaborations
towards more diverse substituted nucleosides. An attempt
to extend the synthetic strategy to the preparation of un-
precedented C6-quinolylpurine nucleosides was also made
by using 2- and 3-bromoquinolines; a C6-(2-quinolyl)purine
nucleoside was obtained, but in a low yield. This result,
although unsatisfactory, is promising and prompts further
efforts towards the synthesis of this type of substance. Stud-
ies are ongoing in our laboratories both towards this goal
and to explore the reactivity of the halogenated pyridine
ring in the newly prepared nucleosides.
Experimental Section
General Methods: All the reagents were obtained from commercial
sources (Sigma–Aldrich) and were used without further purifica-
tion. 1H and 13C NMR spectra were acquired with a Varian Mer-
cury Plus 400 MHz spectrometer in CD3OD or C6D6. Chemical
shifts (δ) are reported in parts per million (ppm) relative to the
residual solvent signals: CD2HOD 3.31 ppm, C6D5H 7.15 ppm for
1H NMR; CD3OD 49.0 ppm, C6D5H 128.6 ppm for 13C NMR.
The 1H NMR chemical shifts were assigned on the basis of 2D
NMR experiments. The abbreviations s, d, dd, and m represent
singlet, doublet, doublet of doublets, and multiplet, respectively.
UV spectra were recorded with a Jasco V-530 UV spectrophotome-
ter. High-resolution MS spectra were recorded with a Bruker
APEX II FT-ICR mass spectrometer using the electrospray ioniza-
tion (ESI) technique in positive mode. IR spectra were recorded
with a Jasco FT-IR 430 spectrophotometer. Optical rotations were
determined with a Jasco polarimeter using a 1-dm cell at 25 °C;
concentrations are given in g/100 mL. Column chromatography
was performed on silica gel 60 (70–230 mesh ASTM, Merck) and
analytical TLC analyses were performed on F254 silica gel plates
(0.2 mm thick, Merck) with TLC spots being detected under UV
light (254 nm).
General Procedure for the Reaction of 1 with Grignard Reagents
7a–i. Synthesis of 9a–i: In a representative experiment, iPrMgCl
(0.12 mL, 0.24 mmol) was added to 2-bromopyridine (6a;
0.023 mL, 0.24 mmol) in dry THF (0.5 mL) at room temperature
under nitrogen. After 2 h, 1 (30 mg, 0.049 mmol) dissolved in dry
THF (0.5 mL) was added to the reaction mixture, which was then
stirred for a further 2 h (TLC monitoring: hexane/AcOEt, 3:7) at
room temperature. The reaction was then quenched by the addition
of a 1 m solution of NH4Cl (1 mL), diluted with AcOEt (10 mL),
and washed with brine (10 mL). The organic layer was separated,
dried (Na2SO4), filtered, and concentrated under rotary evapora-
tion. The crude 8a was dissolved in a mixture of Ac2O/pyridine
(4:6, 0.5 mL) and the solution kept at 50 °C for 1 h (TLC monitor-
ing: AcOEt/MeOH, 9.5:0.5). The mixture was evaporated in vacuo
and purified on a column of silica gel eluted with increasing
amounts of MeOH in AcOEt (up to 5%). The fractions containing
the product were collected and evaporated to afford pure 9a.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(3-pyridyl)nebularine (9b):
TLC monitoring (hexane/AcOEt, 1:1), purification through a col-
umn of silica gel eluted with increasing amounts of AcOEt in hex-
ane (up to 30%). Amorphous solid (19 mg, 60%). [α]D = –42.0 (c
= 1.1, CH3OH). 1H NMR (400 MHz, CD3OD): δ = 9.92–9.88 (m,
1 H, arom.), 9.18–9.13 (m, 1 H, arom.), 9.0 (s, 1 H, 2-H), 8.75 (s,
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1 H, 8-H), 8.72–8.69 (m, 1 H, arom.), 7.69–7.63 (m, 1 H, arom.),
6.21 (d, J = 5.6 Hz, 1 H, 1-H), 4.95–4.90 (m, 1 H, 2-H), 4.49–
4.44 (m, 1 H, 3-H), 4.20–4.15 (m, 1 H, 4-H), 4.09 (dd, J = 11.3,
4.6 Hz, 1 H, 5-Ha), 3.87 (dd, J = 11.3, 3.1 Hz, 1 H, 5-Hb), 0.98
[s, 9 H, C(CH3)3], 0.96 [s, 9 H, C(CH3)3], 0.78 [s, 9 H, C(CH3)3],
0.18 (s, 3 H, CH3), 0.17 (s, 3 H, CH3), 0.16 (s, 6 H, 2 CH3), –0.016
(s, 3 H, CH3), –0.28 (s, 3 H, CH3) ppm. 13C NMR (100 MHz,
CD3OD): δ = 153.8, 153.5, 152.9, 151.9, 151.3, 146.4, 138.9, 133.2,
132.9, 125.3, 89.6, 87.4, 77.1, 73.7, 63.8, 26.6, 26.4, 26.2, 19.4, 18.9,
18.7, –4.1, –4.2, –4.3, –4.9, –5.2, –5.3 ppm. IR (neat): νmax = 2950,
2923, 2857, 1577, 1465, 1320, 1256, 1127, 834, 779 cm–1. UV
(CH3OH): λmax = 288 nm. HRMS (ESI): calcd. for C33H58N5O4Si3
[M + H]+ 672.3797; found 672.3794.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(4-pyridyl)nebularine (9c):
4-Bromopyridine hydrochloride (47 mg, 0.24 mmol) was suspended
in dry THF (1 mL) under nitrogen and the mixture cooled to 0 °C.
NaH (5.8 mg, 0.24 mmol) was added in one portion and the mix-
ture stirred for 15 min. After warming to room temp., iPrMgCl
(0.12 mL, 0.24 mmol) was added as for 6a. TLC monitoring (hex-
ane/AcOEt, 6:4), purification through a column of silica gel eluted
with increasing amounts of AcOEt in hexane (up to 30%).
Amorphous solid (18 mg, 55%). [α]D = –34.3 (c = 0.5, CH3OH).
1H NMR (400 MHz, CD3OD): δ = 9.06 (s, 1 H, 2-H), 8.81–8.74
(complex signal, 5 H, 4 arom., 8-H), 6.22 (d, J = 5.6 Hz, 1 H, 1-
H), 4.95–4.91 (m, 1 H, 2-H), 4.49–4.45 (m, 1 H, 3-H), 4.20–4.17
(m, 1 H, 4-H), 4.09 (dd, J = 11.4, 4.5 Hz, 1 H, 5-Ha), 3.88 (dd, J
= 11.3, 2.9 Hz, 1 H, 5-Hb), 0.99 [s, 9 H, C(CH3)3], 0.97 [s, 9 H,
C(CH3)3], 0.79 [s, 9 H, C(CH3)3], 0.19 (s, 3 H, CH3), 0.17 (s, 3 H,
CH3), 0.16 (s, 6 H, 2 CH3), –0.009 (s, 3 H, CH3), –0.28 (s, 3 H,
CH3) ppm. 13C NMR (100 MHz, CD3OD): δ = 154.2, 153.4, 152.6,
150.8, 146.9, 144.9, 133.5, 125.0, 89.7, 87.4, 77.1, 73.7, 63.8, 26.6,
26.4, 26.2, 19.4, 18.9, 18.7, –4.1, –4.3, –4.9, –5.2, –5.3 ppm. IR
(neat): νmax = 2956, 2923, 2851, 1569, 1412, 1254, 1091, 793 cm–1.
UV (CH3OH): λmax = 290 nm. HRMS (ESI): calcd. for
C33H58N5O4Si3 [M + H]+ 672.3797; found 672.3792.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(6-bromo-2-pyridyl)nebu-
larine (9d): TLC monitoring (CH2Cl2/AcOEt, 95:5), purification
through a column of silica gel eluted with increasing amounts of
AcOEt in CH2Cl2 (up to 5 %). Oil (18 mg, 50%). [α]D = –36.7 (c =
1.1, CH3OH). 1H NMR (400 MHz, CD3OD): δ = 9.0 (s, 1 H, 2-
H), 8.88–8.84 (m, 1 H, arom.), 8.79 (s, 1 H, 8-H), 7.97–7.90 (m, 1
H, arom.), 7.80–7.75 (m, 1 H, arom.), 6.22 (d, J = 5.7 Hz, 1 H, 1-
H), 4.95–4.90 (m, 1 H, 2-H), 4.48–4.44 (m, 1 H, 3-H), 4.20–4.15
(m, 1 H, 4-H), 4.08 (dd, J = 11.3, 4.5 Hz, 1 H, 5-Ha), 3.87 (dd, J
= 11.3, 2.9 Hz, 1 H, 5-Hb), 0.98 [s, 9 H, C(CH3)3], 0.95 [s, 9 H,
C(CH3)3], 0.78 [s, 9 H, C(CH3)3], 0.17 (s, 3 H, CH3), 0.16 (s, 3 H,
CH3), 0.15 (s, 6 H, 2 CH3), –0.021 (s, 3 H, CH3), –0.29 (s, 3 H,
CH3) ppm. 13C NMR (100 MHz, CD3OD): δ = 154.8, 154.4, 153.4,
147.1, 143.6, 141.0, 133.1, 131.3, 126.8, 89.7, 87.5, 77.1, 73.7, 63.8,
26.6, 26.4, 26.2, 19.4, 19.0, 18.7, –4.1, –4.3, –4.9, –5.2 ppm. HRMS
(ESI): calcd. for C33H57BrN5O4Si3 [M + H]+ 750.2902; found
750.2907. IR (neat): νmax = 2956, 2928, 2857, 1566, 1429, 1256,
1072, 834, 790 cm–1. UV (CH3OH): λmax = 304 nm.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(5-bromo-3-pyridyl)nebu-
larine (9e): TLC monitoring (hexane/AcOEt, 8:2), purification
through a column of silica gel eluted with increasing amounts of
AcOEt in hexane (up to 10%). Oil (22 mg, 60%). [α]D = –41.6 (c
= 0.7, CH2Cl2). 1H NMR (400 MHz, C6D6): δ = 10.48–10.46 (m,
1 H, arom.), 9.49–9.46 (m, 1 H, arom.), 8.96 (s, 1 H, 2-H), 8.71–
8.68 (m, 1 H, arom.), 8.37 (s, 1 H, 8-H), 6.22 (d, J = 4.4 Hz, 1 H,
1-H), 4.95–4.90 (m, 1 H, 2-H), 4.55–4.50 (m, 1 H, 3-H), 4.29–
4.24 (m, 1 H, 4-H), 4.01 (dd, J = 11.4, 4.2 Hz, 1 H, 5-Ha), 3.72
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(dd, J = 11.4, 2.6 Hz, 1 H, 5-Hb), 1.00 [s, 9 H, C(CH3)3], 0.96 [s,
9 H, C(CH3)3], 0.91 [s, 9 H, C(CH3)3], 0.13 (s, 3 H, CH3), 0.12 (s,
3 H, CH3), 0.094 (s, 3 H, CH3), 0.078 (s, 3 H, CH3), 0.048 (s, 3 H,
CH3), –0.082 (s, 3 H, CH3) ppm. 13C NMR (100 MHz, C6D6): δ =
153.4, 153.2, 152.9, 151.7, 150.4, 144.9, 139.7, 134.1, 133.1, 121.7,
89.9, 85.9, 76.6, 72.5, 62.9, 26.8, 26.6, 26.5, 19.2, 18.9, 18.7, –3.6,
–3.9, –4.0, –4.1, –4.7, –4.8 ppm. IR (neat): νmax = 2956, 2923, 2857,
1580, 1459, 1325, 1256, 1105, 834, 779 cm–1. UV (CH3OH): λmax
= 302 nm. HRMS (ESI): calcd. for C33H57BrN5O4Si3 [M + H]+
750.2902; found 750.2898.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(6-bromo-3-pyridyl)nebu-
larine (9f): TLC monitoring (hexane/AcOEt, 85:15), purification
through a column of silica gel eluted with increasing amounts of
AcOEt in hexane (up to 10%). Amorphous solid (20 mg, 55%). [α]
D = –41.3 (c = 0.6, CH2Cl2). 1H NMR (400 MHz, C6D6): δ = 10.2
(d, J = 2.2 Hz, 1 H, arom.), 8.92 (s, 1 H, 2-H), 8.86 (dd, J = 8.4,
2.4 Hz, 1 H, arom.), 8.35 (s, 1 H, 8-H), 7.03 (d, J = 8.4 Hz, 1 H,
arom.), 6.20 (d, J = 4.2 Hz, 1 H, 1-H), 4.88–4.83 (m, 1 H, 2-H),
4.51–4.46 (m, 1 H, 3-H), 4.25–4.20 (m, 1 H, 4-H), 3.96 (dd, J =
11.5, 4.1 Hz, 1 H, 5-Ha), 3.68 (dd, J = 11.4, 2.5 Hz, 1 H, 5-Hb),
0.96 [s, 9 H, C(CH3)3], 0.93 [s, 9 H, C(CH3)3], 0.88 [s, 9 H, C(CH3)
3], 0.075 (s, 3 H, CH3), 0.067 (s, 3 H, CH3), 0.059 (s, 3 H, CH3),
0.043 (s, 3 H, CH3), 0.013 (s, 3 H, CH3), –0.10 (s, 3 H, CH3) ppm.
13C NMR (100 MHz, C6D6): δ = 153.1, 153.0, 152.8, 152.2, 145.8,
144.7, 139.6, 132.9, 131.7, 128.5, 89.9, 85.8, 76.6, 72.4, 62.8, 26.8,
26.6, 26.5, 19.3, 18.9, 18.7, –3.6, –3.9, –4.0, –4.7, –4.8 ppm. IR
(neat): νmax = 2950, 2923, 2851, 1580, 1459, 1322, 1256, 1072, 834,
773 cm–1. UV (CH3OH): λmax = 299 nm. HRMS (ESI): calcd. for
C33H57BrN5O4Si3 [M + H]+ 750.2902; found 750.2910.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(2-bromo-3-pyridyl)nebu-
larine (9g): TLC monitoring (hexane/AcOEt, 7:3), purification
through a column of silica gel eluted with increasing amounts of
AcOEt in hexane (up to 25%). Oil (18 mg, 48%). [α]D = –32.1 (c
= 0.7, CH3OH). 1H NMR (400 MHz, CD3OD): δ = 9.05 (s, 1 H,
2-H), 8.76 (s, 1 H, 8-H), 8.54 (dd, J = 4.8, 1.8 Hz, 1 H, arom.),
8.00 (dd, J = 7.6, 1.8 Hz, 1 H, arom.), 7.63 (dd, J = 7.6, 4.9 Hz, 1
H, arom.), 6.23 (d, J = 5.9 Hz, 1 H, 1-H), 4.95–4.90 (m, 1 H, 2-
H), 4.48–4.43 (m, 1 H, 3-H), 4.22–4.16 (m, 1 H, 4-H), 4.08 (dd,
J = 11.3, 4.7 Hz, 1 H, 5-Ha), 3.88 (dd, J = 11.3, 3.0 Hz, 1 H, 5-
Hb), 0.98 [s, 9 H, C(CH3)3], 0.95 [s, 9 H, C(CH3)3], 0.78 [s, 9 H,
C(CH3)3], 0.18 (s, 3 H, CH3), 0.16 (s, 3 H, CH3), 0.15 (s, 6 H, 2
CH3), –0.012 (s, 3 H, CH3), –0.29 (s, 3 H, CH3) ppm. 13C NMR
(100 MHz, CD3OD): δ = 156.5, 153.4, 153.2, 152.1, 147.1, 141.9,
141.3, 135.2, 133.6, 124.3, 89.7, 87.8, 77.2, 73.9, 63.9, 26.6, 26.4,
26.2, 19.4, 19.0, 18.8, –4.1, –4.2, –4.3, –4.8, –5.2, –5.3 ppm. IR
(neat): νmax = 2956, 2923, 2857, 1594, 1462, 1391, 1253, 1163, 1108,
834, 774 cm–1. UV (CH3OH): λmax = 272 nm. HRMS (ESI): calcd.
for C33H57BrN5O4Si3 [M + H]+ 750.2902; found 750.2911.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(2-chloro-3-pyridyl)nebu-
larine (9h): TLC monitoring (hexane/AcOEt, 7:3), purification
through a column of silica gel eluted with increasing amounts of
AcOEt in hexane (up to 25%). Oil (22 mg, 65%). [α]D = –28.0 (c
= 0.8, CH2Cl2). 1H NMR (400 MHz, C6D6): δ = 9.12 (s, 1 H, 2-
H), 8.34 (s, 1 H, 8 H), 8.04 (dd, J = 4.8, 1.9 Hz, 1 H, arom.), 7.76
(dd, J = 7.6, 1.9 Hz, 1 H, arom.), 6.51 (dd, J = 7.5, 4.8 Hz, 1 H,
arom.), 6.24 (d, J = 4.5 Hz, 1 H, 1-H), 4.99–4.94 (m, 1 H, 2-H),
4.57–4.52 (m, 1 H, 3-H), 4.30–4.25 (m, 1 H, 4-H), 4.03 (dd,
J = 11.4, 4.4 Hz, 1 H, 5-Ha), 3.74 (dd, J = 11.4, 2.7 Hz, 1 H, 5-
Hb), 1.01 [s, 9 H, C(CH3)3], 0.94 [s, 9 H, C(CH3)3], 0.91 [s, 9 H,
C(CH3)3], 0.13 (s, 3 H, CH3), 0.12 (s, 3 H, CH3), 0.076 (s, 6 H, 2
CH3), 0.064 (s, 3 H, CH3), 0.039 (s, 3 H, CH3), –0.087 (s, 3 H,
CH3) ppm. 13C NMR (100 MHz, CD3OD): δ = 155.8, 153.1, 152.8,
www.eurjoc.org © 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2015, 2244–22492248
151.2, 150.9, 145.1, 141.1, 134.3, 132.3, 122.4, 89.9, 86.0, 76.6, 72.6,
63.0, 26.8, 26.6, 26.5, 19.2, 18.9, 18.7, –3.6, –3.9, –4.0, –4.2, –4.7,
–4.8 ppm. IR (neat): νmax = 2956, 2923, 2857, 1591, 1462, 1399,
1328, 1254, 1064, 834, 774 cm–1. UV (CH3OH): λmax = 273 nm.
HRMS (ESI): calcd. for C33H57ClN5O4Si3 [M + H]+ 706.3407;
found 706.3412.
2,3,5-Tri-O-(tert-butyldimethylsilyl)-6-(2-quinolyl)nebularine (9i):
TLC monitoring (hexane/AcOEt, 7:3), purification through a col-
umn of silica gel eluted with increasing amounts of AcOEt in hex-
ane (up to 30%). Oil (7.1 mg, 20%). [α]D = –39.5 (c = 0.5, CH3OH).
1H NMR (400 MHz, CD3OD): δ = 9.14 (s, 1 H, 2-H), 8.88–8.81
(complex signal, 2 H, arom., 8-H), 8.59–8.54 (m, 1 H, arom.), 8.39–
8.37 (m, 1 H, arom.), 8.05–8.03 (m, 1 H, arom.), 7.87–7.83 (m, 1
H, arom.), 7.72–7.68 (m, 1 H, arom.), 6.27 (d, J = 5.8 Hz, 1 H, 1-
H), 5.00–4.95 (m, 1 H, 2-H), 4.51–4.46 (m, 1 H, 3-H), 4.22–4.18
(m, 1 H, 4-H), 4.11 (dd, J = 11.3, 4.7 Hz, 1 H, 5-Ha), 3.90 (dd, J
= 11.3, 3.1 Hz, 1 H, 5-Hb), 0.99 [s, 9 H, C(CH3)3], 0.97 [s, 9 H,
C(CH3)3], 0.79 [s, 9 H, C(CH3)3], 0.19 (s, 3 H, CH3), 0.18 (s, 3 H,
CH3), 0.17 (s, 6 H, 2 CH3), –0.003 (s, 3 H, CH3), –0.27 (s, 3 H,
CH3) ppm. 13C NMR (100 MHz, CD3OD): δ = 154.6, 154.5, 154.4,
153.5, 149.4, 147.1, 138.5, 133.4, 131.4, 130.8, 130.1, 129.2, 128.9,
123.5, 89.7, 87.6, 77.1, 73.9, 63.9, 26.6, 26.4, 26.2, 19.4, 19.0, 18.8,
–4.1, –4.3, –4.8, –5.1, –5.2 ppm. IR (neat): νmax = 2956, 2923, 2857,
1572, 1459, 1377, 1256, 1072, 834, 779 cm–1. UV (CH3OH): λsh =
243, 257 nm. HRMS (ESI): calcd. for C37H60N5O4Si3 [M + H]+
722.3953; found 722.3960.
Supporting Information (see footnote on the first page of this arti-
cle): 1H and 13C NMR spectra of all new compounds.
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Abstract: The synthesis of four novel platinum complexes, bearing N6-(6-amino-
hexyl)adenosine or a 1,6-di(adenosin-N6-yl)-hexane respectively, as ligands of mono-
functional cisplatin or monochloro(ethylendiamine)platinum(II), is reported. The chemistry 
exploits the high affinity of the charged platinum centres towards the N7 position of the 
adenosine base system and a primary amine of an alkyl chain installed on the C6 position 
of the purine. The cytotoxic behaviour of the synthesized complexes has been studied in A549 
adenocarcinomic human alveolar basal epithelial and MCF7 human breast adenocarcinomic 
cancer cell lines, in order to investigate their effects on cell viability and proliferation. 
Keywords: platinum complexes; nucleosides; cisplatin; chemotherapy 
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1. Introduction 
The discovery of the anti-proliferative properties of cisplatin [1] marked the beginning of modern 
chemotherapy based on the use of metal complexes capable of blocking the replication of cancer cells 
targeting the nuclear DNA [2,3]. In fact, it is widely accepted that cisplatin, once inside the cell, may 
form a highly reactive species [4,5] that can react with DNA through the formation of intra-strand 
linkages [6,7]. Such linkages alter the secondary structure of DNA, resulting in an inhibition of 
transcription and replication, ultimately leading to cell death [4]. However, the poor solubility in 
biological fluids [8], the serious side effects [9,10], and, more importantly, the intrinsic and acquired 
resistance of many types of tumors [5], have limited its use in the clinic. Carboplatin and oxaliplatin, 
second and third generation anti-neoplastic agents, respectively, are able to enhance the quality of life 
of patients in terms of dosage and drug administration. However, they can still trigger mechanisms of 
resistance (intrinsic and/or acquired) during repeated cycles of oncological treatment [5]. It was then 
discovered that the presence of more charged metal centres separated by unbranched alkylamine chains 
leads to complexes capable of being uptaken by cells via active import [11] and of overcoming the 
intrinsic and/or acquired resistance in some tumors [6,12–15]. Based on the understanding that they 
may exert anti-tumoral activities through inter-strand linkages with DNA that cannot be repaired by 
enzymes [16], many multinuclear platinum complexes have recently been synthesized, by varying the 
diamine backbone chain length, or by introducing modified linkers [8,10–12,17,18]. In addition, new  
Pt-based compounds have been obtained by conjugating biologically important substances or drugs to 
Pt-containing subunits [19–24] and novel drug-delivery based methodologies have been explored to 
vehiculate platinum-based anti-cancer complexes directly against tumors [25,26]. 
Nucleoside and nucleotide anti-metabolites and their base analogues are able to inhibit specific 
pathways of the cancer cell metabolism by blocking the biosynthesis or the function of nucleic acids. 
For example, the combination of cisplatin and 5-fluorouracil, a chemotherapeutic agent that inhibits 
thymidylate synthase, has been extensively used in clinical practice to treat various types of cancer. 
Acyclovir, a guanosine nucleoside analogue containing an open-chain sugar surrogate, has been used 
as a ligand for platinum and the corresponding complex exhibits high in vitro activity against various 
herpes viruses [27]. Furthermore, the synthesis and the preliminary pharmacological activity of novel 
modified adenosines and thymidines, employed as N-donor ligands of platinum(II) dichloride 
complexes, have been recently reported [28,29]. 
Recently, we have reported the solid-phase synthesis and the pharmacological activity of the first 
examples of bis-platinated nucleoside complexes in which the mono-functional metal is linked both to 
N-7 of the purine nucleus of inosine and to the terminal amino-group of a hexylamine side chain 
installed on N-1 (compounds 1–3, Figure 1) [30]. The amino-alkyl chain was introduced on the purine 
base system through a chemical strategy recently developed by us [30–36]. These complexes showed 
very good water solubility thanks to the charged platinum centres and to the ribose hydroxyl groups. 
They were tested against four different human tumor cell lines and, in particular, the complex bearing 
two monofunctional cisplatin units was revealed to be more cytotoxic than cisplatin against the MCF7 
cancer cell line in a short-term exposure assay [30].  
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Figure 1. Bis-platinated nucleoside complexes synthesized starting from inosine [30]. 
 
In the light of the above results, to investigate the importance of nucleoside scaffolds in the 
construction of novel platinum complexes we have speculated about the antitumoral activity of 
cisplatin-adenosine complexes. As a result, in this paper we report on the synthesis of four dinuclear 
platinum complexes 8a,b and 10a,b (Scheme 1) carrying N6-(6-aminohexyl)adenosine (compound 5, 
Scheme 1) or a 1,6-di-(adenosin-N6-yl)-hexane (compound 9, Scheme 1) respectively, as ligands of 
mono-functional cisplatin or monochloro(ethylene diamine)platinum(II) (compounds 7a and 7b, 
respectively, Scheme 1). 
Scheme 1. Synthesis of complexes 8 and 10.  
 
Reagents and conditions: (i) NH2(CH2)6NH2 (7 equiv.), TEA, EtOH, 3 h, reflux; (ii) 4 (1.5 equiv.), 
TEA, EtOH, 5 h, reflux; (iii) AgNO3 (0.9 equiv.), DMF, 16 h, r.t.; (iv) 7a,b, 16 h, r.t.. 
N
NN
N
R
O
N4
N
NN
N
R
O
HCO3-
N4
HCO3-
R =
O
HO OH
HO
Ribose
1 2
Pt
Cl
+
HCO3-H3N
H3N Pt NH3
NH3
+
HCO3-
H2
Pt
Cl
+
N
N
H2
H2 Pt N
N
H2
H2
+
N
NN
N
R
O
N4
3
Pt+
HCO3-
H3N Pt
NH3
NH3
+
H2
NH3Cl
Cl
HCO3-
H2
Cl Cl
N
NN
N
R
Cl
N
NN
N
R
HN NH24
N
NN
N
R
HN NH4
N
N N
N
R
N
NN
N
R
HN NH4
N
N N
N
R
N
NN
N
R
HN N4 Pt L
L
Cl
Pt
Cl ++
HCO3-HCO3-
R =
O
HO OH
HO
Ribose
a   L = L = NH3,    
b   L = L = NH2(CH2)2NH2
4 5 8a,b
4
6a 7a
7a,b
7a,b
9 10a,b
i iv
iv
ii
6b 7b
L
L
Pt
Cl+
HCO3-
L
L
Pt +
HCO3-L
Cl
L
H2
Pt
iii
H3N NH3
Cl Cl DMF
NO3-
Pt
iii
H2N NH2
Cl Cl PtCl
+
NO3-
H2N NH2
Pt
H3N NH3
Cl
DMF
+
1
234
5 67
9
8
Molecules 2014, 19 9342 
 
In the case of complexes 8a,b the monofunctional platinum centres are linked to the N-7 of the 
purine base and to the terminal amino group of a hexylamine side chain bonded to N-6, whereas for the 
complexes 10a,b they are both linked to N-7. 
Platinum complexes, endowed with particular structural strains, have been designed to evaluate 
alternative interactions with DNA strands [8,12,17,37,38]. The novel prepared complexes 8a,b and 
10a,b are characterized by a rigid planar purine substructure joined to a flexible hexylamine chain. On 
this basis, it could be expected that they may alter the binding mode with DNA through, for example, 
base-stacking or by the formation of multiple hydrogen bonds. Therefore, we have investigated the 
preliminary effects of these compounds on viability and proliferation in two different human cancer 
cell lines. 
2. Results and Discussion 
2.1. Synthesis and Characterization 
The synthesis of the novel modified adenosine-based platinum complexes 8a,b and 10a,b is 
depicted in Scheme 1. 6-Cloropurine riboside 4 proved to be a good candidate to obtain the key 
intermediate 5 from which the construction of complexes 8a,b and 10a,b has been accomplished. As 
reported by Schammells et al. [39] seven equivalents of 1,6-diaminohexane have proved sufficient to 
convert 4 into 5 in a very good yield (86%), avoiding the formation of dimeric species, which would 
complicate the purification procedure. In fact, the recovery of 5 from the reaction mixture was easily 
performed thanks to its insolubility in EtOH upon cooling. Compound 9 was prepared by reacting 4 
with a slight excess of 5. During the reaction, this substance precipitated from the reaction mixture as a 
white solid which was then collected in 93% yield by filtration. This represents a very good 
improvement on the reported yield for 9 (12%) [40]. 
Next, the platinum-containing moieties were installed. In particular, treatment of 5 and 9 with a 
seven-fold excess of the suitable platinating complex 7a,b, activated by overnight reaction with 
AgNO3 (0.9 equiv.) in DMF, furnished the bisplatinated compounds 8a,b and 10a,b. Purification  
of these substances could be accomplished by reverse-phase HPLC only using a gradient of CH3CN  
in 0.1 M triethylammonium bicarbonate buffer (TEAB) as the solvent mixture, whereas complex 
chromatographic patterns were observed in the absence of the TEAB. 
The structures of complexes 8a,b and 10a,b (yields 58%–62%) were supported by 2D-NMR and 
positive mode high resolution mass spectrometry (HRMS) data; whereas their purity was ascertained 
by CHN analyses.  
In Figure 2 (panel A) the representative HRMS spectrum of complex 8a is reported; in particular, 
the isotopic pattern of the base peak (expansion, panel B) perfectly fits with that of the calculated one 
(expansion, panel C), confirming the presence of two Pt and two Cl atoms and a net 2+ charge. 
In the1H-NMR spectra of 8a,b and 10a,b the downfield shift of H-8, compared with the resonance 
of the same proton in 5 and 7 (∆δ = 0.6 and 0.5, respectively), confirmed the presence of the  
N(7) → Pt bond in all these substances [41,42]. In Table 1 the differences between the 13C-NMR shifts 
of the Pt-coordinated and not-coordinated purine carbon atoms (∆δ = δcomplex − δligand, ppm) are listed: 
in the case of complexes 8a,b significant coordination shifts were found for the C-5 and C-8 atoms, 
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whereas for the complexes 10a,b the C-5 atoms underwent the major shifts. Further evidence of 
metallation at N-7 come from the increased acidity of the H-8 as indicated by the reduced intensity of 
the pertinent signal in the 1H-NMR spectra of 8a,b and 10a,b, when these complexes were dissolved in 
D2O and the spectra acquired after several hours [43]. 1H-NMR analyses excluded also the presence of 
equilibria involving migrations of the platinum moieties from N-7 to N-1 of the nucleobases; such 
migrations would shift the H-2 resonances of complexes 8a,b and 10a,b to higher frequences in 
comparison to the same signals of compounds 5 and 9, respectively [44]. The resonances of the 
methylene protons belonging to the CH2-NH2-Pt moieties were seen as broad partly overlapped triplets 
in the range 2.3–2.7 ppm, in the proton spectra of 8b and 10b, likewise the protons of the methylene 
group geminal to platinum in 8a resonated as a triplet at δ 2.6. In 13C-NMR spectra of 8a and 8b the  
5 ppm downfield shift of the ω-methylene carbon could be a consequence of the NH2 platination. 
Figure 2. HRMS spectrum of complex 8a (panel A). Expansion of the isotopic pattern of 
the base peak (panel B) and of the corresponding calculated one (panel C). 
 
In the UV spectra of the complexes 8a,b and 10a,b the maxima of absorption appeared red-shifted 
(∆λ = 10–13 nm) in respect to those of the free ligands, in accordance with literature data [45]. 
Comparison of the IR spectra of the ligands and complexes did not provide evidence about the bonding 
mode of the ligands in the complexes; in fact in the 4000–2700 cm−1 region very little information 
could be obtained about the nature of metal-ligand interaction, because of the presence of broad and 
intense bands belonging to hydrogen-bonded hydroxyls of the ribose moieties. The 1800–400 cm−1 
region, where vibration frequencies of purine and ribose skeletons fall, did not furnish significant 
differences between platinated and not-platinated nucleosides. Furthermore, in the region 550–400 cm−1, 
where the resonances of Pt-N could be expected [45,46], no distinctive bands were observed. 
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Table 1. Differences between the 13C-NMR shifts of the Pt-coordinated and not-coordinated 
purine carbons (∆δ = δcomplex − δligand, ppm). 
Entry 
13C-NMR (∆δ, ppm) 
C-2 C-4 C-5 C-6 C-8 
8a [39] −1.0 −1.4 −2.9 0.9 2.1 
8b [39] −1.0 −1.3 −2.8 0.9 2.1 
10a −1.9 −2.3 −4.2 −0.1 0.9 
10b −2.0 −2.5 −4.2 0.1 1.1 
2.2. Cytotoxicity Studies 
The synthesized complexes were subjected to preliminary cell viability and proliferation assays.  
In particular, the cytotoxic behaviour was studied in A549 adenocarcinomic human alveolar basal 
epithelial and MCF7 human breast adenocarcinomic cancer cell lines by MTT and BrdU assays, to 
investigate the potential effects of platinum complexes on cell viability and proliferation, respectively. 
The incubation of A549 cells with 8a,b and 10a,b (50, 100 and 200 µM) for 72 h caused a 
concentration-dependent reduction of cell survival (Figure 3, panel A) as well as an inhibition of cell 
proliferation at the higher concentrations (Figure 3, panel B) compared to untreated cells. Indeed, 
comparable results were obtained when the cell number was directly determined by cell counting (data 
not shown).  
Figure 3. Effect of 8a, 8b, 10a and 10b on cell viability and proliferation. A549 cells were 
incubated with cisplatin, 8a, 8b, 10a and 10b (50, 100 and 200 µM) for 72 h. Thereafter, 
cell viability (panel A) and proliferation (panel B) were determined, respectively, by MTT 
and BrdU assay as described in the Experimental Section (*** p < 0.001, ** p < 0.01,  
* p < 0.05 vs. untreated cells).  
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Figure 3. Cont. 
 
The compounds 8b, 10a and 10b (50, 100 and 200 µM) modified the viability and proliferation of 
MCF7 cells at higher concentrations, according to the published evidence that these cells have been 
associated with cisplatin resistance [47]. The compound 8a proved to reduce the proliferation of the 
MCF7 cell line with a greater ability than the other compounds. Strikingly, compound 8a was able to 
inhibit the cell proliferation slightly better than cisplatin, but only at 50 µM concentration (Figure 4). 
Figure 4. Effect of 8a, 8b, 10a and 10b on cell viability and proliferation. MCF7 cells 
were incubated with cisplatin, 8a, 8b, 10a and 10b (50, 100 and 200 µM) for 72 h. 
Thereafter, cell viability (panel A) and proliferation (panel B) were determined, respectively, 
by MTT and BrdU assay as described in the Experimental Section (*** p < 0.001,  
** p < 0.01, * p < 0.05 vs. untreated cells).  
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3. Experimental Section  
3.1. General Methods 
All the reagents and solvents were obtained from commercial sources and used without further 
purification. 1H- and 13C-NMR spectra were acquired on Varian Mercury Plus 400 MHz instrument 
using D2O or (CD3)2SO as solvents. Chemical shifts were reported in parts per million (δ) relative to 
the residual solvent signal (1H: HDO 4.80; 13C: (CD3)(CD2H)SO 40.4) and assigned by 2D-NMR 
experiments. UV spectra were recorded on a Jasco V-530 UV spectrophotometer. IR spectra were 
recorded on a Jasco FT-IR 430 spectrophotometer. High-resolution MS spectra were recorded on a 
Thermo Orbitrap XL mass spectrometer using the electrospray ionization (ESI) technique in positive 
mode. Elemental analyses were performed on a Thermo Finnigan Flash EA 1112 CHN analyzer.  
RP-HPLC analyses and purifications were carried out on a Jasco UP-2075 Plus pump, equipped with a 
Jasco UV-2075 Plus UV detector, using a C-18 reverse-phase column (5 µm, 4.8 × 150 mm), eluted 
with a linear gradient of CH3CN in 0.1 M triethylammonium bicarbonate (TEAB) buffer (System A: 
from 0% to 50% in 90 min, flow 1.3 mL/min, or System B: from 0% to 100% in 90 min, flow  
1.3 mL/min). Human alveolar basal carcinoma epithelial cells (A549) and human breast cancer cells 
(MCF7) were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
Foetal bovine serum (FBS), 100 U/mL penicillin and 100 U/mL streptomycin at 37 °C under 5% CO2. 
The cell lines were all from the ATCC catalogue. All media and supplements for cell culture were 
purchased from Gibco-Invitrogen (GE Healthcare). 
N6-(6-Aminohexyl)adenosine (5). Compound 5 (326 mg) was obtained by reaction of 4 (297 mg,  
01.04 mmol) in accordance to the procedure by Schammells et al. [37]. Spectroscopic data and yields 
were in agreement with those reported by the authors. 
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1,6-Di-(adenosin-N6-yl)-hexane (9). Compound 5 (100 mg, 0.27 mmol), 6-chloropurine riboside (4, 
116 mg, 0.40 mmol), Et3N (41 µL, 0.30 mmol) were refluxed in EtOH (1 mL). During the reaction, a 
colourless solid precipitated from the reaction. After 5 h it was filtered, washed with boiling EtOH and 
dried, giving 9 as a colourless powder (164 mg, 93%). El. An. Calcd. for C26H36N10O8: C, 50.64; H, 
5.88; N, 22.72. Found: C, 50.68; H, 5.90; N, 22.69. 1H-NMR and UV data were in agreement with 
those reported in literature [38]. 13C-NMR (100 MHz, (CD3)2SO) δ 155.6 (C-2), 153.3 (C-6), 149.1  
(C-4), 140.5 (C-8), 120.7 (C-5), 88.9 (C-1'), 86.9 (C-4'), 74.4 (C-2'), 71.6 (C-3'), 62.6 (C-5'), 40.8 
(CH2NH, covered by residual solvent signal), 30.0 (CH2), 27.1 (CH2); IR (KBr pellet) 3336, 2935, 
2861 1630, 1587, 1537, 1474, 1418, 1369, 1334, 1307, 1221, 1185, 1130, 1097, 1058, 985, 866, 822, 
793, 641, 554 cm−1; m/z 639.2620 (HRESIMS) ([M + Na]+, C26H36N10NaO8, requires 639.2615). 
3.2. General Procedure for the Preparation of Dinuclear Platinum Complexes 8a,b and 10a,b 
In a representative experiment, cisplatin (57 mg, 0.19 mmol) was activated by treatment with 
AgNO3 (29.0 mg, 0.17 mmol) in DMF (2 mL) in the dark (16 h, r.t.). AgCl was removed by filtration 
and the resulting solution of [Pt(NH3)2(Cl)DMF]+(NO3)− in DMF was added to compound 5 (10 mg, 
0.027 mmol). The solution was shaken in the dark (16 h, r.t.) and then filtered over a GHP Acrodisc  
13 mm syringe filter (0.45 µm GHP membrane). The filter was washed with the minimal amount  
of DMF and the clarified solution was then subjected to HPLC purification [system A for 8a,b (tR: 
38.7 min and 38.4 min respectively) and system B for 10a,b (tR: 31.0 min and 31.5 min respectively), 
see General Methods]; the fractions containing the title compound were evaporated under reduced 
pressure and then lyophilized affording pure 8a. 
Compound 8a. Bis-bicarbonate salt (17 mg, 60%). El. An. Calcd. for C18H40Cl2N10O10Pt2: C, 21.24; H, 
3.96; N, 13.76. Found: C, 21.21; H, 3.98; N, 13.79. 1H-NMR (400 MHz, D2O) δ 8.84 (s, 1H, H-8), 
8.33 (s, 1H, H-2), 6.12 (bs, 1H, H-1'), 4.78–4.76 (m, 1H, H-2', partially covered by solvent signal), 
4.43–4.36 (m, 1H, H-3'), 4.31–4.25 (m, 1H, H-4'), 3.97–3.76 (m, 2H, Ha,b-5'), 3.67–3.55 (m, 2H, CH2N), 
2.62 (t, J = 6.4 Hz, 1H, CH2NH2Pt), 1.86–1.72 (m, 2H, CH2), 1.71–1.59 (m, 2H, CH2), 1.57–1.34 
(complex signal, 4H, 2 × CH2); 13C-NMR (100 MHz, D2O) δ 160.2 (2 × HCO3−), 153.7 (C-2), 153.2 
(C-6), 146.8 (C-4), 141.6 (C-8), 116.8 (C-5), 89.1 (C-1'), 85.9 (C-4'), 73.9 (C-2'), 70.1 (C-3'), 61.0  
(C-5'), 45.7 (CH2NH2), 40.7 (CH2NH), 29.8 (CH2), 28.0 (CH2), 25.4 (CH2), 25.2 (CH2). IR (KBr 
pellet) 3246, 2930, 1626, 1589, 1492, 1339, 1084, 1058, 835, 790, 553 cm−1; UV (H2O) λmax = 277 nm; 
HRESI-MS: (m/z) 447.0870, calcd. [M]2+ 447.0859. 
Compound 8b. Bis-bicarbonate salt (17 mg, 58%). El. An. Calcd. for C22H44Cl2N10O10Pt2: C, 24.70; H, 
4.15; N, 13.09. Found: C, 24.73; H, 4.13; N, 13.06. 1H-NMR (400 MHz, D2O) δ 8.85 (s, 1H, H-8), 
8.39 (s, 1H, H-2), 6.16 (d, J = 5.0 Hz, 1H, H-1'), 4.80 (m, 1H, H-2', covered by solvent signal),  
4.48–4.41 (m, 1H, H-3'), 4.37–4.30 (m, 1H, H-4'), 4.00–3.84 (m, 2H, Ha,b-5'), 3.78–3.67 (m, 2H, 
CH2N), 2.85–2.50 (complex signal, 10H, CH2NH2Pt and 4 × CH2 ethylene diamine moieties)  
1.91–1.78 (m, 2H, CH2), 1.77–1.62 (m, 2H, CH2), 1.61–1.36 (complex signal, 4H, 2 × CH2); 13C-NMR 
(100 MHz, D2O) δ 160.2 (2 × HCO3−), 153.7 (C-2), 153.2 (C-6), 146.9 (C-4), 141.6 (C-8), 116.9  
(C-5), 89.1 (C-1'), 85.9 (C-4'), 73.9 (C-2'), 70.1 (C-3'), 61.0 (C-5'), 48.3, 48.0, 47.1 (4 × CH2 ethylene 
diamine moieties), 45.9 (CH2NH2), 40.7 (CH2NH), 29.9 (CH2), 28.1 (CH2), 25.5 (CH2), 25.2 (CH2); IR 
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(KBr pellet) 3406, 3208, 2931, 1627, 1589, 1470, 1336, 1303, 1232, 1079, 1054, 834, 790, 555,  
472 cm−1; UV (H2O) λmax = 278 nm; HRESI-MS: (m/z) 473.1037, calcd. [M]2+ 473.1031.  
Compound 10a. Bis-bicarbonate salt (12 mg, 60%). El. An. Calcd. for C28H50Cl2N14O14Pt2: C, 26.53; 
H, 3.97; N, 15.47. Found: C, 26.50; H, 3.95; N, 15.45. 1H-NMR (400 MHz, D2O) δ 8.85 (s, 2H, 2 × H-8), 
8.26 (s, 2H, 2 × H-2), 6.14 (bs, 2H, 2 × H-1'), 4.80 (m, 2H, 2 × H-2', covered by solvent signal),  
4.50–4.40 (m, 2H, 2 × H-3'), 4.38–4.29 (m, 2H, 2 × H-4'), 4.03–3.76 (complex signal, 6H, 2 × Ha,b-5' 
and 2 × CHaN), 3.67–3.53 (m, 2H, 2 × CHbN), 1.94–1.75 (m, 4H, 2 × CH2), 1.73–1.51 (m, 4H, 2 × CH2); 
13C-NMR (100 MHz, D2O) δ 160.2 (HCO3−), 153.7 (C-2), 153.2 (C-6), 146.8 (C-4), 141.4 (C-8), 116.5 
(C-5), 89.1 (C-1'), 85.8 (C-4'), 74.0 (C-2'), 70.0 (C-3'), 61.0 (C-5'), 40.5 (CH2NH), 27.8 (CH2), 25.2 
(CH2); IR (KBr pellet) 3280, 2933, 1626, 1589, 1492, 1415, 1339, 1306, 1230, 1085, 1059, 985, 864, 
790, 552 cm−1; UV (H2O) λmax = 277 nm; HRESI-MS: (m/z) 572.1213, calcd. [M]2+ 572.1226. 
Compound 10b. Bis-bicarbonate salt (13 mg, 62%). El. An. Calcd. for C32H54Cl2N14O14Pt2: C, 29.12; 
H, 4.12; N, 14.86. Found: C, 29.15; H, 4.10; N, 14.83. 1H-NMR (400 MHz, D2O) δ 8.81 (s, 2H, 2 × H-8), 
8.24 (s, 2H, 2 × H-2), 6.14 (bs, 2H, 2 × H-1'), 4.80 (m, 2H, 2 × H-2', covered by solvent signal),  
4.49–4.41 (m, 2H, 2 × H-3'), 4.37–4.31 (m, 2H, 2 × H-4'), 4.04–3.83 (m, 4H, 2 × Ha,b-5'), 3.81–3.60 
(m, 4H, 2 × CH2N), 2.84–2.50 (complex signal, 8H, 4 × CH2, ethylene diamine moieties), 1.95–1.74 
(m, 4H, 2 × CH2), 1.72–1.52 (m, 4H, 2 × CH2); 13C-NMR (100 MHz, D2O) δ 160.1 (HCO3−), 153.6 
(C-2), 153.2 (C-6), 146.6 (C-4), 141.6 (C-8), 116.5 (C-5), 89.1 (C-1'), 85.7 (C-4'), 74.1 (C-2'), 70.1  
(C-3'), 61.2 (C-5'), 48.1, 47.3 (2 × CH2 ethylene diamine moieties) 40.5 (CH2NH), 27.7 (CH2), 25.1 
(CH2); IR (KBr pellet) 3284, 2930, 1625, 1592, 1490, 1417, 1338, 1310, 1233, 1083, 1061, 980, 860, 
791, 554 cm−1; UV (H2O) λmax 276 nm; HRESI-MS: (m/z) 598.1391, calcd. [M]2+ 598.1382. 
3.3. MTT Viability Assay 
The cells were plated in 96 culture wells (20 × 104 cells/well) and allowed to adhere overnight. 
Thereafter, the medium was replaced with fresh medium and the cells were incubated in the absence  
or presence of cisplatin, 8a, 8b, 10a and 10b (50, 100 and 200 µM). After 72 h, the cell viability  
was determined by using 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazoliumbromide (MTT) 
conversion assay [48]. Briefly, 10 µL of MTT (5 mg/mL) were added to the cells and incubated for  
an additional 3 h. After this time point, the cells were lysed and the dark blue crystals solubilized  
with 150 µL of a solution containing 50% (v:v) DMF, 20% (w:v) SDS with an adjusted pH of 4.5.  
The optical density (OD) of each well was measured with a microplate spectrophotometer (Multiskan 
MCCC/340, Titertek, Huntsville, AL, USA) equipped with a 620 nm filter. The experiment was 
performed twice in triplicate. The vitality inhibition, induced by each compound at the indicated 
concentrations, was expressed as a percentage versus the untreated cells (the control). The viable cells 
were also counted by the trypan blue exclusion assay and light microscopy. 
3.4. BrdU Cell Proliferation Assay 
The cells were plated onto 96-well plates (2 × 104 cells/well) overnight. Then, the medium was 
replaced with fresh medium and the cells were incubated in the absence or presence of cisplatin (50, 
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100 and 200 µM), 8a, 8b, 10a and 10b (50, 100 and 200 µM). After 72 h, 5-bromo-2'-deoxyuridine 
(BrdU; 10 µM) was added and the cells were cultured for a further 12 h. The mitogenic activity was 
determined according to the manufacturer’s instructions (BrdU cell proliferation assay kit, Cell 
Signaling). The experiment was performed three times in triplicate. The proliferation inhibition, 
induced by each compound at the indicated concentrations, was expressed as a percentage versus the 
untreated cells (the control).  
3.5. Statistical Analysis 
The results are expressed as the means ± SEM of n experiments. The statistical significance was 
calculated by one-way analysis of variance (ANOVA) and Bonferroni-corrected p-value for multiple 
comparison testing. The level of statistically significant difference was defined as p < 0.05. 
4. Conclusions 
In summary, in this paper we have reported the synthesis of four novel platinum complexes embodying 
a N6-(6-aminohexyl)adenosine or a 1,6-di-(adenosin-N6-yl)-hexane as ligands of monofunctional 
cisplatin or monochloro(ethylene diamine)platinum(II) moieties, starting from commercially available 
6-chloropurine riboside. The designed synthetic route allowed us to obtain the desired platinum 
complexes without blocking the ribose hydroxyl groups and through easy purification steps. 
The effects of these platinum complexes on cell viability and proliferation have been studied in 
A549 and MCF7 cell lines. Our data demonstrate that these compounds are able to inhibit the survival 
and proliferation of sensitive cancer cells. Nevertheless, cisplatin remains the most active molecule 
under our experimental conditions. Further experiments are necessary to understand the mechanism by 
which 8a penetrates into the cells and inhibits cell proliferation in the MCF7 cell line.  
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